Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,29470,0.142308302636774,0.00359129307472341,0.135269368210316,0.149347237063232,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,24683,-0.152638979760474,0.00361663979439083,-0.15972759375748,-0.145550365763468,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,29180,0.218787929275486,0.00551530312394764,0.207977935152548,0.229597923398423,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29256,-0.116098469874461,0.00218925780723971,-0.120389415176651,-0.111807524572271,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,28491,0.451044776014284,0.00828112818783525,0.434813764766127,0.467275787262441,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29449,-0.352665069819221,0.00829213660754306,-0.368917657570005,-0.336412482068436,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,24653,0.297211223365873,0.00551517640101051,0.286401477619893,0.308020969111854,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24529,0.166646438827535,0.00375548681402444,0.159285684672047,0.174007192983023,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,29132,0.176017842806299,0.00289197651745781,0.170349568832082,0.181686116780517,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,29409,0.199370427648474,0.00444565411245974,0.190656945588053,0.208083909708895,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29132,-0.105275312855028,0.00213458511809566,-0.109459099686495,-0.101091526023561,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29271,-0.0798753032526755,0.00193294812360294,-0.0836638815749372,-0.0760867249304137,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,24669,0.145824553478482,0.00271094949397715,0.140511092470286,0.151138014486677,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,29038,0.136113716066744,0.00275850030149892,0.130707055475806,0.141520376657682,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,23848,0.27966566745618,0.00659619359976937,0.266737128000632,0.292594206911728,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,29034,0.271808634433285,0.00612461876872764,0.259804381646578,0.283812887219991,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,29381,0.362490079380448,0.00949819085930393,0.343873625296212,0.381106533464683,1.11476300660362e-308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,28908,0.0774851543992267,0.00203279021355655,0.0735008855806559,0.0814694232177975,1.12844316913951e-308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,29172,0.159107601536989,0.00422181816663144,0.150832837930392,0.167382365143587,1.56982441327385e-303
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,24683,-0.0644124962599358,0.00170684608684182,-0.0677579145901458,-0.0610670779297259,4.8623958677786e-303
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,28727,-0.135557702363785,0.00367599355455614,-0.142762649730715,-0.128352754996855,6.78127072818613e-291
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,29273,0.0863553748069421,0.0023457467190863,0.081757711237533,0.0909530383763513,4.68495264493247e-290
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,29193,0.131779687404086,0.00358085675421315,0.124761208165828,0.138798166642344,7.5583672509434e-290
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,29122,0.132907831173998,0.00365471725660602,0.125744585351051,0.140071076996946,3.21662293247874e-283
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,29132,0.10241462510083,0.00281690457211244,0.0968934921394892,0.10793575806217,4.37161579346624e-283
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,29359,0.289652916396585,0.00811497386940495,0.273747567612552,0.305558265180619,3.48437519618108e-273
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,24699,-0.164544834008657,0.00460597020594564,-0.17357253561231,-0.155517132405004,1.43733982867151e-272
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FURIN,Furin,29256,0.0807563406160144,0.00229679907024986,0.0762546144383247,0.0852580667937042,2.72386377949697e-265
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,29172,-0.108658520261138,0.00322417206381103,-0.114977897506208,-0.102339143016069,2.72053527139605e-244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,28631,0.179155761121146,0.00547641605382923,0.168421985655641,0.189889536586651,1.74533762990362e-230
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,24653,0.20364610879919,0.00629797319187244,0.19130208134312,0.21599013625526,1.10849748553101e-224
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29445,-0.137460054306402,0.00428419160745832,-0.145857069857021,-0.129063038755784,4.74475649316697e-222
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,28612,0.144763467137379,0.00455687042783828,0.135832001098816,0.153694933175942,1.08783676952041e-217
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28612,0.182581231128215,0.00575834634160662,0.171294872298666,0.193867589957764,7.06003764594182e-217
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,29409,-0.0776633011886908,0.00245474787436929,-0.0824746070224546,-0.072851995354927,4.68889921123825e-216
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,29091,0.220317913980504,0.0070174188758365,0.206563772983865,0.234072054977144,8.2758126383034e-213
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,23979,0.110535964160257,0.00353320970818727,0.10361087313221,0.117461055188304,1.28508605900452e-210
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,24119,0.0617448784536236,0.0019756505885681,0.0578726033000302,0.0656171536072171,3.17709538794525e-210
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,28986,0.16080635595244,0.00518148738560057,0.150650640676663,0.170962071228217,4.68760777219612e-208
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28612,0.110040271440959,0.00356692562391179,0.103049097218092,0.117031445663826,1.31086524780129e-205
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,27142,0.0862158106509279,0.00280729219132458,0.0807135179559317,0.0917181033459241,1.23247848135387e-203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23567,0.0669534394786834,0.00221611610002762,0.0626098519226292,0.0712970270347375,9.30028810526584e-197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,29132,-0.0558745713890258,0.00185780794644002,-0.0595158749640482,-0.0522332678140033,1.00241352573972e-195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,24669,-0.122430017071847,0.00407877147046652,-0.130424409153961,-0.114435624989733,1.8868816302186e-194
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,24683,-0.106780351302956,0.00355981348264206,-0.113757585728934,-0.0998031168769775,3.38732355532619e-194
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24119,-0.0626208671620196,0.00211290866023296,-0.0667621681360762,-0.058479566187963,1.2446489498582e-189
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,29120,0.171950629280255,0.00581793976777419,0.160547467335418,0.183353791225092,3.52378247744252e-189
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24538,0.172694435062477,0.00588319807480096,0.161163366835867,0.184225503289087,3.53808854280039e-186
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFM,Afamin,24699,0.0390389145624625,0.00134529726008978,0.0364021319326865,0.0416756971922385,4.34619191821482e-182
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,29145,0.108396351441241,0.0037672042725496,0.101012631067044,0.115780071815438,1.49363734349324e-179
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24315,0.0516485102513198,0.00180521910884188,0.0481102807979897,0.0551867397046499,4.26612308767738e-177
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,29231,0.0358652132364464,0.00125838301826026,0.0333987825206563,0.0383316439522365,2.94733124197132e-176
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,29034,0.157337152413522,0.00556052494746462,0.146438523516491,0.168235781310552,9.04372470500354e-174
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29314,0.0922186728489943,0.00326140303912044,0.0858263228923183,0.0986110228056704,1.47562288393164e-173
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,29198,-0.0385727074906037,0.00136898375318951,-0.0412559156468552,-0.0358894993343523,2.33412312592852e-172
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,29409,0.0654851805692655,0.00233786494464701,0.0609029652777573,0.0700673958607736,2.09207372302514e-170
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,29507,0.10103214144605,0.00361045973454877,0.0939556403663344,0.108108642525766,4.3588334671783e-170
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,29314,-0.0536801498215454,0.00192053249151535,-0.0574443935049155,-0.0499159061381753,1.0938638580714e-169
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,29226,0.0637722908428606,0.00229655914727571,0.0592710349142002,0.068273546771521,1.56239924141415e-167
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,24539,0.138368444809175,0.00498200843802307,0.12860370827065,0.148133181347701,3.49035388823866e-167
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,28467,0.0972965391298362,0.00356847959620462,0.0903023191212751,0.104290759138397,1.30252312031503e-161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,29230,0.0577480880848012,0.00212079515752569,0.0535913295760509,0.0619048465935516,3.00946493942294e-161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,23940,0.152428148658196,0.00560706509741359,0.141438301067265,0.163417996249127,2.66012915394643e-160
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29280,-0.0715797344646299,0.00264021278402538,-0.0767545515213196,-0.0664049174079401,6.85856724078836e-160
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28629,0.147115411225624,0.00543856314714933,0.136455827457211,0.157774994994037,3.80292034498181e-159
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29409,0.0691377620393354,0.00255890554314711,0.0641223071747671,0.0741532169039037,7.83639877092038e-159
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,29245,0.0610039290511002,0.00225883414854885,0.0565766141199445,0.065431243982256,1.09287294853678e-158
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,28491,0.141246186999913,0.00530055402172504,0.130857101117332,0.151635272882494,1.50964077387345e-154
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,29317,0.0889650697751651,0.00335340920450298,0.0823923877343392,0.0955377518159909,2.85252777728512e-153
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29034,0.145636523981094,0.00551285473723554,0.134831328696112,0.156441719266075,5.40797717763235e-152
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,24067,0.0688274757470184,0.0026091620614135,0.063713518106648,0.0739414333873889,3.36315840914235e-151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29359,0.0766352852517972,0.00291809134388445,0.0709158262177837,0.0823547442858107,2.84190753831626e-150
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,29034,0.101821879000963,0.00389508847295119,0.0941875055939791,0.109456252407948,6.60908445121088e-149
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,28908,0.0592398369842892,0.0022725012113216,0.0547857346100988,0.0636939393584795,4.33493442100006e-148
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,24441,0.0455652994273621,0.00175359261814009,0.0421282578958075,0.0490023409589167,7.43889270631844e-147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,24653,0.0505614102734147,0.00196609780397326,0.0467078585776271,0.0544149619692023,6.0407259702285e-144
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29507,-0.0606111281249906,0.00236258678539527,-0.0652417982243654,-0.0559804580256159,1.41691256504039e-143
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28491,0.105166135149013,0.00410147499054141,0.0971272441675518,0.113205026130474,2.25956823583827e-143
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,29293,0.105641887066405,0.00413898912324709,0.0975294683848403,0.113754305747969,3.87673803837902e-142
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29231,-0.0518498331750401,0.0020431582663997,-0.0558544233771835,-0.0478452429728967,1.50013654749647e-140
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,29470,0.0494975763749519,0.00196710027716708,0.0456420598317045,0.0533530929181994,2.96868262577948e-138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,24602,0.0769658834401674,0.00307193341184987,0.0709448939529417,0.0829868729273932,8.10805848199845e-137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29280,-0.0572314615462962,0.00230699789627243,-0.0617531774229902,-0.0527097456696023,1.81552080510123e-134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,29132,-0.0642735267199209,0.00259127823318005,-0.0693524320569538,-0.059194621382888,2.03212677991951e-134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29034,0.117106647407899,0.00472520780446715,0.107845240111143,0.126368054704654,3.37382780481739e-134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28491,0.108936482562384,0.00439678799085915,0.100318778100301,0.117554187024468,4.24926190467115e-134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29346,0.0538178387775575,0.00217847813894954,0.0495480216252164,0.0580876559298986,2.22340769280736e-133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,28725,0.252181809180835,0.0102114729669353,0.232167322165642,0.272196296196028,2.91399520498639e-133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24579,0.12887742109835,0.00528838127058541,0.118512193808002,0.139242648388697,1.23472457560442e-129
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,23979,0.107204246958589,0.00445809168523278,0.0984663872555332,0.115942106661646,2.80500052915682e-126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29172,0.0503471009929253,0.00211262731839648,0.0462063514488682,0.0544878505369824,2.43848883852435e-124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29070,0.0892326947523116,0.0037443752030278,0.0818937193543772,0.0965716701502461,2.48376828535144e-124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29034,0.134618495991827,0.00565104729744761,0.12354244328883,0.145694548694824,3.09570023243626e-124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24119,0.0621605987403906,0.00260741426914142,0.0570500667728734,0.0672711307079078,3.52630309697679e-124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,28458,0.0982605822624373,0.00412903093960027,0.0901676816208208,0.106353482904054,5.78314238116053e-124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28491,0.135196714377765,0.00570192407345978,0.124020943193784,0.146372485561746,4.36637848059544e-123
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,29381,-0.0356255603124316,0.00150423644111959,-0.038573863737026,-0.0326772568878372,7.58411689254054e-123
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,29132,0.0529258849151385,0.00223546054927867,0.0485443822385523,0.0573073875917246,9.31667969401818e-123
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29507,-0.0402933789084785,0.00171050517736435,-0.0436459690561127,-0.0369407887608444,1.43401420413288e-121
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,29367,0.0327729091582118,0.00139612115172751,0.0300365117008259,0.0355093066155977,9.70279128007999e-121
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,29264,0.105435840788599,0.00452753675484348,0.0965618687491058,0.114309812828092,7.1438366909404e-119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,29169,-0.0848353770197149,0.0036435885985989,-0.0919768106729687,-0.0776939433664611,7.93128815849785e-119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,29507,0.0811573105569428,0.00349912345389721,0.0742990285873042,0.0880155925265813,6.01525233476096e-118
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,29132,0.0902118044305692,0.00389657206953566,0.0825745231742793,0.0978490856868591,1.61729816385274e-117
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29122,0.0445202366742742,0.00192371911341146,0.0407497472119878,0.0482907261365607,1.97716050968273e-117
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,24539,0.177079362841229,0.00771064859467197,0.161966491595672,0.192192234086786,1.70458376733855e-115
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29034,0.168562674474558,0.00735101106884044,0.154154692779631,0.182970656169485,2.4463311065485e-115
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,29172,0.0974023455304674,0.00425495028821607,0.0890626429655639,0.105742048095371,5.83049834629279e-115
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,29127,-0.281792704193682,0.0123111922347415,-0.305922640973775,-0.257662767413589,6.17463937963389e-115
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,29130,-0.0715755674355564,0.00312904624084642,-0.0777084980676154,-0.0654426368034974,8.57339174768697e-115
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29079,0.0798310502783119,0.0034924342229062,0.0729858792014157,0.086676221355208,1.24174443567631e-114
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,24648,0.0447096018700188,0.00195752873490101,0.0408728455496128,0.0485463581904247,2.83946160581404e-114
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24669,0.0521706551168278,0.0022857811888627,0.0476905239866569,0.0566507862469987,4.03835138383346e-114
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29256,0.0567080886882501,0.00249135550684663,0.0518250318948307,0.0615911454816695,1.0653184486129e-113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29034,0.136200156234048,0.00603255427688756,0.124376349851349,0.148023962616748,6.64424724420549e-112
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,29390,-0.0562730801543147,0.00249295166475019,-0.0611592654172251,-0.0513868948914043,7.17513434030666e-112
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,29271,-0.0674751450310456,0.002996747954249,-0.0733487710213736,-0.0616015190407175,2.55196948035781e-111
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28631,0.0848675133365559,0.00382648193938484,0.0773676087353616,0.0923674179377501,4.46769233621799e-108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24103,0.0729974048503289,0.00329293908659854,0.0665432442405958,0.079451565460062,8.40219540223907e-108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,29409,0.19698819362724,0.00889536018669628,0.179553287661315,0.214423099593164,8.87567820586819e-108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29034,0.0609672597895726,0.00275448091651124,0.0555684771932106,0.0663660423859346,1.16308804368988e-107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24529,0.0806599611850298,0.00364813000491315,0.0735096263754,0.0878102959946595,2.83724226858406e-107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,23979,0.0830366526343716,0.00375915400551097,0.0756687107835701,0.0904045944851731,4.70241204686633e-107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23979,0.087941058896399,0.0039915889780265,0.080117544499467,0.0957645732933309,1.63772055029848e-106
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,23535,-0.0660764261449644,0.00301363589383275,-0.0719831524968766,-0.0601696997930522,1.67999559920253e-105
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,29280,0.10365051083597,0.00473268124992605,0.0943744555861149,0.112926566085825,1.78977745622081e-105
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29409,0.0519535335125825,0.00238162588255707,0.0472855467827707,0.0566215202423944,1.14986750600735e-104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24378,0.0480327118056372,0.00221107833575749,0.0436989982675525,0.0523664253437218,1.18172339000987e-103
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,29423,0.0757807840743907,0.00349182091121505,0.0689368150884092,0.0826247530603722,1.26915291351837e-103
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29132,-0.0405524505109316,0.00187536208193089,-0.0442281601915161,-0.036876740830347,6.92762264292607e-103
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,28790,0.0712756197659174,0.00329834595610719,0.0648108616919473,0.0777403778398875,9.60367955397646e-103
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,29438,-0.0805888864752291,0.00375437112188655,-0.0879474538741267,-0.0732303190763315,1.97201421381548e-101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29256,0.051950929018139,0.00242479140012529,0.0471983378738934,0.0567035201623846,4.69178836115006e-101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,24293,0.0355075384935732,0.00165997499942927,0.0322539874946919,0.0387610894924546,1.39261039137455e-100
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,29470,0.0672611365696456,0.00315450900867454,0.0610782989126435,0.0734439742266477,4.04026899190473e-100
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,29470,0.0508698835536385,0.00239066629973985,0.0461841776061484,0.0555555895011286,1.0121504793051e-99
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28612,0.135283364877933,0.00638595594670922,0.122766891222383,0.147799838533483,7.63772302727153e-99
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28337,0.0806735774710406,0.00383522865460767,0.0731565293080095,0.0881906256340716,1.75321307676087e-97
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29409,0.0478694196058834,0.00227825479705269,0.0434040402036601,0.0523347990081066,2.68037751363957e-97
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24119,0.0724783797895799,0.00344981660370745,0.0657167392463133,0.0792400203328465,4.00218377949955e-97
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29507,0.0575197412717588,0.00274353857717061,0.0521424056605044,0.0628970768830131,6.90415786553809e-97
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29172,0.0494203867241327,0.00235896320482113,0.0447968188426833,0.0540439546055821,9.6899444823713e-97
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,29256,0.0582990105774155,0.00278836538981655,0.052833814413375,0.0637642067414559,2.30198756117074e-96
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,24119,0.0586506605055882,0.00280523820653589,0.0531523936207778,0.0641489273903985,3.26815052465899e-96
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,29071,0.0431529408362176,0.00206865683700206,0.0390983734356935,0.0472075082367416,6.20486755361984e-96
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,29381,0.0536782189273164,0.00257666694743871,0.0486279517103365,0.0587284861442963,1.0845184345857e-95
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,29470,0.043907717546808,0.00210877280391169,0.0397745228511411,0.0480409122424749,1.3525946192733e-95
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,23979,-0.0882376096564856,0.00424419972834233,-0.0965562411240366,-0.0799189781889346,3.6776487990224e-95
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,29132,-0.0414351191289621,0.00199617690409225,-0.0453476258609829,-0.0375226123969413,5.14895573364594e-95
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEP,Leptin,29172,0.0967990047927399,0.00466490974675198,0.087655781689106,0.105942227896374,5.90419348949747e-95
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24653,0.0954416297878548,0.00460115075715204,0.0864233743038368,0.104459885271873,9.16097475957007e-95
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,29132,0.0338671814340667,0.00163471212231435,0.0306631456743306,0.0370712171938028,1.16153622823176e-94
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,29172,0.0915446018700863,0.00441931606688593,0.0828827423789898,0.100206461361183,1.22907650418043e-94
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,29034,0.0512883437651016,0.00248015664075835,0.0464272367492152,0.056149450780988,2.54155801255981e-94
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29034,0.0993548085412408,0.00482839823546283,0.0898911479997337,0.108818469082748,2.04385225445353e-93
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,29409,0.0656579545693802,0.00320660555365568,0.0593730076842151,0.0719429014545454,1.56566743541033e-92
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24602,0.0823360670722892,0.00403507855185962,0.0744273131106444,0.0902448210339341,8.68667811048274e-92
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,24669,-0.0538244523893822,0.00263995337653025,-0.0589987610073815,-0.0486501437713829,1.20864334803483e-91
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28248,0.142682292003011,0.00703494447642288,0.128893800829223,0.1564707831768,8.2482042337515e-91
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,23979,0.0840632674311038,0.00420548288832395,0.0758205209699889,0.0923060138922188,3.59657660664307e-88
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24620,-0.0676796557912752,0.00341266178505641,-0.0743684728899857,-0.0609908386925646,7.53589816691925e-87
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29256,0.0303614635865545,0.00153725896258318,0.0273484360198915,0.0333744911532175,2.90925644797033e-86
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29122,0.0703174159792321,0.0035609584466843,0.0633379374237309,0.0772968945347333,3.1411622549685e-86
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29172,-0.0371829010288419,0.00188987335381574,-0.0408870528023208,-0.0334787492553631,1.2751148759845e-85
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,24653,0.0776401360658179,0.00394504481618762,0.0699078482260902,0.0853724239055456,1.44262186683364e-85
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24579,-0.0503492326993153,0.00256090648764038,-0.0553686094150905,-0.0453298559835402,2.12483040368872e-85
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,24390,0.0374381218398334,0.00190435393174574,0.0337055881336117,0.041170655546055,2.21236851203966e-85
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28297,0.0267429807357933,0.0013667533129388,0.0240641442424333,0.0294218172291534,1.07898005760253e-84
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29470,-0.0353322165004311,0.00180709628850273,-0.0388741252258964,-0.0317903077749657,1.36730917443192e-84
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,29173,0.0430457240950246,0.00220287574640602,0.0387280876320688,0.0473633605579804,1.72048396599108e-84
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,29122,0.0651103262596401,0.00333247467521718,0.0585786758962144,0.0716419766230658,1.8118718711306e-84
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,29409,0.0388789310550575,0.00199028960817901,0.0349779634230267,0.0427798986870884,1.92744983349121e-84
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,24683,0.0374790139407888,0.0019235467178424,0.0337088623738177,0.0412491655077599,6.37912404627764e-84
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,28986,0.0349832731244249,0.00180111234946487,0.0314530929194738,0.0385134533293761,1.67253129639857e-83
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24683,0.0299471742213404,0.00154826337228607,0.0269125780116597,0.0329817704310211,9.68794618444714e-83
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28467,0.0705681325505786,0.00368096410363183,0.0633534429074602,0.077782822193697,2.10664431935236e-81
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,24653,0.109236405270011,0.00569608461295381,0.0980720794286219,0.120400731111401,2.23909384681676e-81
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,28908,0.0694835463126951,0.00362785226067413,0.0623729558817738,0.0765941367436164,2.92796505032472e-81
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29228,-0.0412776374696949,0.0021599289434394,-0.0455110981988361,-0.0370441767405537,6.4266428281457e-81
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29280,-0.0582060714111893,0.00304761245662481,-0.064179391826174,-0.0522327509962047,8.00871889749239e-81
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,29507,0.0783671303720261,0.00411161280635233,0.0703083692715755,0.0864258914724766,1.65791550206157e-80
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29381,0.069192725044187,0.00363545651586793,0.0620672302730858,0.0763182198152881,2.78287307219e-80
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,29231,-0.0366965620523816,0.00193225356814516,-0.0404837790459461,-0.0329093450588171,6.07549405874491e-80
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,29470,0.0432529560589326,0.00228327607830422,0.0387777349454563,0.0477281771724088,1.48982765903908e-79
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24119,0.100061477321152,0.00528142931338859,0.0897098758669107,0.110413078775394,1.8055791850788e-79
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,28853,0.0952656780269438,0.0050552124721206,0.0853574615815874,0.1051738944723,9.60390677706578e-79
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29423,0.0266168021167196,0.00142648802126514,0.0238208855950399,0.0294127186383993,2.98519042945434e-77
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,29507,0.0571166243216816,0.00306990290629927,0.051099614625335,0.0631336340180282,8.01284070241189e-77
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,29034,0.089444301420359,0.00486409186243569,0.079910681369985,0.0989779214707329,4.32576562302832e-75
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,29409,0.0339688437213809,0.00185213046171486,0.0303386680164198,0.0375990194263421,1.02911410846217e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,28908,0.0717001767469034,0.00391590268786754,0.064025007478683,0.0793753460151237,1.81820065093689e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,28908,0.0533365935001781,0.00291566859478275,0.0476218830544039,0.0590513039459523,2.4710596012453e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29034,0.0457836451509367,0.00250469989617408,0.0408744333544355,0.0506928569474379,3.17173969007996e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,29034,0.0923992168054903,0.00505591005904641,0.0824896330897593,0.102308800521221,3.38603153939655e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,29122,0.0498954689030445,0.00273881064266305,0.0445274000434249,0.0552635377626641,9.56554750417128e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,29470,0.0974422959565609,0.00535031708217971,0.0869556744754887,0.107928917437633,1.04483153709589e-73
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28491,0.104474895017716,0.00574534034164047,0.0932140279481011,0.115735762087332,1.79246748032632e-73
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29095,0.0252341625890169,0.00138812966137528,0.0225134284527214,0.0279548967253125,1.94935038812521e-73
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,24699,0.0252051539972,0.00138978506549125,0.0224811752688371,0.0279291327255628,4.93930660067993e-73
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28664,0.055304982326855,0.00305321003249964,0.0493206906631557,0.0612892739905543,6.34596141067343e-73
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,24669,0.142419832691773,0.00787206844249807,0.126990578544477,0.157849086839069,1.09280909445115e-72
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23848,0.0859873371221808,0.00476493983499693,0.0766480550455868,0.0953266191987748,2.57884292944834e-72
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29132,0.0667318080268792,0.00370434206497081,0.0594712975795364,0.073992318474222,3.70014244107945e-72
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,29470,0.0329151774445015,0.00182742345673638,0.0293334274692982,0.0364969274197049,3.84248495660622e-72
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,24119,0.0802098086400919,0.00445133170751555,0.0714851984933614,0.0889344187868224,4.09150904290807e-72
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29172,0.0532998011994902,0.00296756916753027,0.0474833656311309,0.0591162367678495,9.63886454510685e-72
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,29280,0.0669632785523508,0.00372940213066967,0.0596536503762383,0.0742729067284634,1.0551677764721e-71
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29034,0.0552511212098571,0.0030780208436196,0.0492182003563627,0.0612840420633515,1.16808927203078e-71
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,24579,0.16337902010666,0.00910753521658802,0.145528251082148,0.181229789131173,1.67733798999254e-71
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29145,-0.0426953230694076,0.00238450820197955,-0.0473689591452876,-0.0380216869935277,2.58801860683265e-71
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,24539,0.122203976973836,0.0068291343589759,0.108818873630244,0.135589080317429,3.69211429018158e-71
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,28908,0.0915066646317191,0.00512893239966708,0.0814539571283717,0.101559372135067,8.1126470104806e-71
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24529,0.0864448647111088,0.0048492734395071,0.0769402887696748,0.0959494406525427,1.23287133828463e-70
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,23974,0.152684537340313,0.00858326338352671,0.1358613411086,0.169507733572025,2.45450493961104e-70
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28291,0.107227084588247,0.00603213596814739,0.0954040980906785,0.119050071085816,2.62047299400803e-70
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23848,0.0694272160428103,0.00392810030767422,0.0617281394397688,0.0771262926458517,1.83037502025252e-69
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29247,0.0287225565972355,0.00162932124159689,0.0255290869637056,0.0319160262307654,3.39572468939254e-69
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,24119,0.0335752583555683,0.00190468507528689,0.029842075608006,0.0373084411031306,4.0997362176122e-69
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,29089,0.11235134643622,0.00639764638555245,0.0998119595205376,0.124890733351903,1.10274577790239e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23974,0.0547572880237594,0.00311988418461042,0.048642315021923,0.0608722610255958,1.56795967085756e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,28908,-0.0415758481547295,0.00237146601222171,-0.046223921538684,-0.0369277747707749,1.85761986088548e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24529,0.0697021293858613,0.00398087643476663,0.0618996115737187,0.0775046471980039,3.17086901054629e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,28908,0.107579215376993,0.0061703054737205,0.0954854166485006,0.119673014105485,9.95398987727112e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,29034,0.055515863253959,0.00318467043913812,0.0492739091932483,0.0617578173146697,1.04076943780999e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29507,0.0813396689612405,0.00466798382744538,0.0721904206594475,0.0904889172630334,1.16415646587388e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,29256,0.0651145736451045,0.00373833477366526,0.0577874374887206,0.0724417098014884,1.32146580816135e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29122,0.0774960804005131,0.00445672593793343,0.0687608975621636,0.0862312632388626,2.20812135139707e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,29231,0.039925562818544,0.00229610786273396,0.0354251914075854,0.0444259342295026,2.20940508270107e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24119,0.0471915412127853,0.00271507061237715,0.0418700028125261,0.0525130796130446,2.93989455215008e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,29127,0.0362939989720529,0.00209057075194544,0.0321964802982398,0.040391517645866,3.56417098450945e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28612,0.0662540325015186,0.0038258526282266,0.0587553613501945,0.0737527036528427,7.6234082819491e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29507,-0.0383636585035332,0.00221969384920388,-0.0427142584479728,-0.0340130585590936,1.33866227337266e-66
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,29034,0.137013118944015,0.00793699197121525,0.121456614680433,0.152569623207597,1.93321687917475e-66
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29445,0.0461553528399987,0.00267401709517569,0.0409142793334544,0.051396426346543,1.97684248853793e-66
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29034,0.117184251640124,0.00679442064858386,0.103867187168899,0.130501316111348,2.52011187929824e-66
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28491,0.0814348130030497,0.00472609922955121,0.0721716585131293,0.09069796749297,3.37711428690692e-66
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,29216,-0.0467632632554526,0.00271461438930287,-0.0520839074584863,-0.041442619052419,3.57164407678944e-66
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29122,0.116736533859715,0.00679646412164351,0.103415464181294,0.130057603538137,8.47246242834281e-66
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,24551,0.131008022696991,0.00762935142034427,0.116054493913116,0.145961551480865,1.05001995323558e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,29507,0.072716867596999,0.00423897484155307,0.064408476907555,0.081025258286443,1.21514641900949e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29256,0.108970813270668,0.00636475463572918,0.0964958941846387,0.121445732356697,2.15833574243678e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,24653,0.0314555233053425,0.00183802687236484,0.0278529906355074,0.0350580559751776,2.79618436396871e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,29271,0.0494483283624503,0.00289382317328309,0.0437764349428155,0.0551202217820852,3.80788140166253e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29034,0.0710328366961765,0.00415946592377352,0.0628802834855803,0.0791853899067726,4.55043119967997e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,29409,-0.0549580123406052,0.00322059459821434,-0.0612703777531053,-0.0486456469281051,5.60521075680106e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29034,0.051728225047434,0.00303960106272346,0.045770606964496,0.0576858431303719,1.24223335450257e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29381,-0.0543636850104255,0.00319465085634365,-0.0606252006888591,-0.048102169331992,1.25272817110849e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29034,0.147375893076494,0.0086643151916763,0.130393835300808,0.164357950852179,1.43589798712915e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,23979,0.0717679464782089,0.00422090122639862,0.0634949800744676,0.0800409128819502,1.86434778951235e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24579,0.0561857593256148,0.00330824583319235,0.0497015974925577,0.0626699211586718,2.5331257588679e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29381,0.0789944926100127,0.0046562045905477,0.0698683316125393,0.0881206536074862,2.99737643669722e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,29122,0.0475405295457569,0.00280226170173074,0.0420480966103646,0.0530329624811491,3.03492781606231e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,29122,0.0868721592211641,0.00513896357170882,0.0767997906206148,0.0969445278217134,8.39320222405809e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REN,Renin,29172,0.0892892523130428,0.00530323104834209,0.0788949194582923,0.0996835851677933,2.61451881844042e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,29369,0.0677141535191962,0.00402461329568175,0.05982591145966,0.0756023955787324,3.16812666040657e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29122,-0.0458479750070929,0.00272881362467802,-0.0511964497114618,-0.040499500302724,4.7250275018542e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28491,0.12872279102747,0.00768165401635459,0.113666749155415,0.143778832899525,1.00334885568151e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24579,0.101176906218373,0.00604019015603011,0.0893381335125544,0.113015678924192,1.2482930188488e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,29507,0.051864344932451,0.00310056236657831,0.0457872426939576,0.0579414471709445,1.60823585074867e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,28908,0.0422199630761758,0.00252450061980366,0.0372719418613607,0.047167984290991,1.72274090384389e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,29289,0.0697337066111129,0.00417216354422682,0.0615562660644283,0.0779111471577975,2.01800677307522e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28467,0.0603565655221833,0.00361251056392348,0.0532760448168932,0.0674370862274733,2.2872545185288e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,23974,0.097462829362392,0.00583751291337273,0.0860213040521815,0.108904354672603,3.15403538270703e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,24262,0.0326237203153822,0.00195629209591569,0.0287893878073875,0.0364580528233769,4.32498673608399e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,29507,-0.0317196555457645,0.00190307712349067,-0.0354496867078062,-0.0279896243837228,4.34246666287886e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24653,0.0840599549674457,0.00507201108321483,0.0741188132443447,0.0940010966905468,2.33681060170429e-61
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,29122,-0.0365692874270091,0.00220813008208631,-0.0408972223878982,-0.0322413524661199,2.53772488108878e-61
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,24539,0.123733003368849,0.00747390411918526,0.109084151295246,0.138381855442453,3.15065792752579e-61
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,24577,-0.0220340156938768,0.001333975981805,-0.0246486086182146,-0.019419422769539,5.85126169491735e-61
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,29409,0.0744809887684574,0.00452644011025371,0.0656091661523601,0.0833528113845547,1.44996748694555e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28491,0.0819480492710632,0.00498157000752882,0.0721841720563067,0.0917119264858197,1.58976942368534e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,28882,0.0424404013530336,0.00258264116423799,0.0373784246711271,0.04750237803494,2.09124931345348e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28631,0.0804849233080475,0.00489806425321001,0.0708847173717559,0.0900851292443391,2.13602883538938e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,29122,0.104975281960452,0.00639057410706712,0.0924497567106004,0.117500807210303,2.3084360054718e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29034,0.0773972061815196,0.00472874984647083,0.0681288564824368,0.0866655558806024,6.07357663597906e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29187,-0.0385410592708598,0.00235511273186991,-0.0431570802253248,-0.0339250383163948,6.30798936251188e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,29381,0.0274125441954711,0.00167518771415091,0.0241291762757354,0.0306959121152069,6.38384988995558e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,29122,0.0621151674799726,0.00379729353358062,0.0546724721541545,0.0695578628057906,7.09019038823815e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,24669,0.0854761839561274,0.00523217644607812,0.0752211181218143,0.0957312497904406,1.11533045577647e-59
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29034,-0.0464788874729707,0.00285737467151728,-0.0520793418291445,-0.0408784331167968,3.13233858890337e-59
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29132,0.026527785823279,0.00163474237014618,0.0233236907777925,0.0297318808687655,5.85114293950194e-59
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,28467,0.0583754116331174,0.00359989702708341,0.0513196134600339,0.0654312098062009,7.15913378184159e-59
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,28887,-0.0320345324094834,0.00197689880644365,-0.035909254070113,-0.0281598107488539,8.53108308007629e-59
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29122,0.119780418541169,0.00740188991388558,0.105272714309953,0.134288122772384,1.21067474848126e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,29377,0.0640495352037431,0.00395956292987721,0.0562887918611838,0.0718102785463025,1.337378369652e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28491,0.0721270842271925,0.00445950552658914,0.0633864533950777,0.0808677150593072,1.40911291402105e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29034,0.0358724798935172,0.00221894240874972,0.0315233527723677,0.0402216070146666,1.5672830063695e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24539,0.0916692357891071,0.0056822820168692,0.0805319630360434,0.102806508542171,3.01050814122243e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,24625,-0.0824683949059798,0.00512133149670086,-0.0925062046395135,-0.0724305851724461,4.82003107436854e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29034,-0.0269449224419506,0.00167658460332229,-0.0302310282644623,-0.0236588166194389,7.20953253048916e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,24119,0.0587618172770146,0.00365939416257969,0.0515894047183584,0.0659342298356708,1.00507496590176e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,28860,0.0998818960743441,0.0062302651967847,0.0876705762886461,0.112093215860042,1.36149980624156e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24529,0.0424430806983444,0.00265406148749159,0.0372411201828609,0.0476450412138279,2.84381504936804e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,23848,0.0697473690987775,0.00436438232520653,0.0611931797413727,0.0783015584561823,3.43526969621308e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,24636,-0.0385049747059402,0.00241266428620272,-0.0432337967068976,-0.0337761527049829,4.72915112155363e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29289,0.0644714811351941,0.00404384073308045,0.0565455532983564,0.0723974089720318,5.52792396198299e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,29381,-0.0416040997189966,0.00261109041414746,-0.0467218369307256,-0.0364863625072676,6.41795481561279e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,28168,0.0446315459513541,0.00281094075538454,0.0391221020708004,0.0501409898319078,1.58943347930884e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,24653,0.101440006491634,0.00639015481126055,0.088915303061563,0.113964709921704,1.81623460747765e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,24602,0.048687339576373,0.00306902042732307,0.0426720595388197,0.0547026196139262,2.13908975423346e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24602,0.0693104021879008,0.00437134313129535,0.0607425696505619,0.0778782347252397,2.4457282622515e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,24669,-0.0445690896914378,0.00281232886156967,-0.0500812542601143,-0.0390569251227612,2.76413651732318e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29226,-0.0498342374584564,0.00314650364300475,-0.0560013845987457,-0.0436670903181671,2.92012421312525e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,29040,0.0340313555996763,0.00215070689138178,0.0298159700925681,0.0382467411067846,3.69030301118112e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,29256,0.0914200314839163,0.00577788614638815,0.0800953746369955,0.102744688330837,3.73013744357879e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29381,0.105784466478903,0.00668683463366431,0.0926782705969214,0.118890662360885,3.87656036600451e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29172,0.0958065721124619,0.00606184003374363,0.0839253656463243,0.107687778578599,4.9234091666343e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,29172,0.0290465974184396,0.00183915089333028,0.0254418616675122,0.0326513331693669,5.88873053219309e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,29154,-0.0425741340229118,0.00269979021181044,-0.0478657228380603,-0.0372825452077634,8.59639957750094e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,24699,0.0227960329636752,0.00144534098383802,0.0199631646353527,0.0256289012919978,9.07056827458422e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28491,0.0701165893592836,0.00446731380063742,0.0613606543100342,0.0788725244085329,2.77078124983546e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,23974,0.0932394087631606,0.00596508951248408,0.0815478333186918,0.104930984207629,8.37367576174518e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,29122,0.103543874129882,0.00663952431339511,0.0905304064756274,0.116557341784136,1.30860925444955e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24653,0.0818703396829338,0.00524996361727749,0.0715804109930699,0.0921602683727977,1.44816321559202e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24119,0.0237865627349701,0.00153150435128844,0.0207848142064447,0.0267883112634954,3.88661990152711e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29271,0.0313920586584343,0.00202506893011317,0.0274229235554125,0.0353611937614561,5.53919441637028e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23974,0.0753724276445781,0.00487762202146459,0.0658122884825075,0.0849325668066487,1.3129670737244e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,28908,0.0569252508175815,0.00368859860400745,0.0496955975537269,0.0641549040814361,1.61248072806284e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29122,0.0924864998290584,0.00599651109438644,0.080733338084061,0.104239661574056,1.8556039195009e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29470,0.0417686210745906,0.00270900043195619,0.0364589802279565,0.0470782619212248,1.98993517159444e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,24651,0.0604192834040007,0.00392191728616547,0.0527323255231164,0.0681062412848851,2.66331221976178e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,28487,0.053183716140567,0.00346067283435242,0.0464007973852363,0.0599666348958978,4.38323250866888e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28491,0.0527766284183537,0.00345398609719313,0.0460068156678552,0.0595464411688523,1.68188996103333e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29034,-0.0211170053082462,0.00138212147280752,-0.0238259633949489,-0.0184080472215434,1.69841703336489e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23848,0.0794415153521108,0.00521062196331028,0.0692286963040227,0.089654334400199,3.08520638921708e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29023,-0.0669434424752787,0.00439976427834307,-0.0755669804608311,-0.0583199044897263,4.45393088547917e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,29127,0.0316611773959234,0.00208139441603786,0.0275816443404892,0.0357407104513576,4.70394649125031e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,28467,0.0686257534403661,0.00451194221081349,0.0597823467071717,0.0774691601735606,4.87973599582624e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,29122,0.0944474503085382,0.00621005429210391,0.0822757438960146,0.106619156721062,4.90273224868098e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,24529,0.105650146866678,0.00694424638082097,0.0920394239602694,0.119260869773088,4.9335007129155e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29172,0.0818444997070336,0.00538284211004084,0.0712941291713536,0.0923948702427137,5.21255739944987e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,29172,0.037596660579396,0.00247279525558131,0.0327499818784567,0.0424433392803354,5.25905496899377e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,28756,-0.0292597257005468,0.00192444992557141,-0.0330316475546668,-0.0254878038464269,5.28689906352433e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,29122,0.059324790733471,0.0039127114162322,0.0516558763576559,0.0669937051092861,9.94284398339951e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,29256,-0.0423889195513588,0.00279640865507849,-0.0478698805153127,-0.036907958587405,1.04964626552572e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,29199,-0.039228834328896,0.00259064035984607,-0.0443064894341943,-0.0341511792235977,1.33394535471543e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28631,0.0630966745840638,0.00417536240147789,0.0549129642771672,0.0712803848909605,2.14296127085951e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,29122,0.0859731897374821,0.00569351875483093,0.0748138929780135,0.0971324864969507,2.52770507163269e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELN,Elastin,24653,0.0370575355146499,0.00245781509388698,0.0322402179306314,0.0418748530986684,3.85658603196192e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29280,0.0447323523669198,0.00296945534306204,0.0389122198945182,0.0505524848393214,4.333597232726e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,24119,0.0483310060118759,0.00320886727207006,0.0420416261586186,0.0546203858651332,4.93903809209425e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29271,-0.0215007019094503,0.00142896656589948,-0.0243014763786133,-0.0186999274402874,5.66374693186128e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29034,0.0293230187469209,0.00195211505455379,0.0254968732399955,0.0331491642538463,8.28857910567892e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23979,0.0888855462372646,0.00592268085900963,0.0772770917536057,0.100494000720923,1.11208473320947e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29247,-0.0327408820323322,0.00218479117868938,-0.0370230727425634,-0.028458691322101,1.40146949538321e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,28776,0.0397887434125488,0.0026551598690897,0.034584630069133,0.0449928567559646,1.41933443100809e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,29122,0.0845476093261103,0.00566995772640915,0.0734344921823483,0.0956607264698722,4.24887545874258e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,29122,-0.0357229666993267,0.00239606721866741,-0.0404192584479148,-0.0310266749507385,4.41011150725974e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,24602,0.0551622119704455,0.00369986562591211,0.0479104753436578,0.0624139485972333,4.74966690911408e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24653,0.0621220367298051,0.00416700298084651,0.0539547108873459,0.0702893625722642,4.82727338898326e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,24653,0.0713913778166137,0.00478909289873374,0.0620047557350956,0.0807779998981319,4.90004518048662e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,23974,0.0463724631022519,0.00312214972636497,0.0402530496385766,0.0524918765659272,1.1113783901318e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29064,0.0209649328637511,0.00141215916090643,0.0181971009083745,0.0237327648191277,1.1233736930208e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,29122,0.0339978939763269,0.00229275029444103,0.0295041033992225,0.0384916845534313,1.45578744761138e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,29172,-0.0531930339575038,0.00359594512818199,-0.0602410864087405,-0.0461449815062671,2.47284108919914e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29470,0.03915903821469,0.00265202586586941,0.0339610675175859,0.044357008911794,3.65508704175942e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,29132,0.0459556628239737,0.00312633366485958,0.0398280488408489,0.0520832768070984,9.70696458539356e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,23974,0.081863816390838,0.00557123622167443,0.0709441933963561,0.0927834393853199,1.14713146634516e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),24220,-0.183571749498396,0.0125019635602997,-0.208075598076583,-0.159067900920209,1.33251278176221e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24529,0.0817567664899125,0.00557043486501764,0.0708387141544779,0.092674818825347,1.4570435031826e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24119,0.0852156061210966,0.00581442607858081,0.0738193310070783,0.096611881235115,1.99641106957721e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24539,0.0610347451685866,0.00417578404998324,0.0528502084306194,0.0692192819065537,3.52362646965032e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,23940,0.123547062479891,0.00847598502928825,0.106934131822486,0.140159993137296,6.39665209345045e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28467,0.0285188689984533,0.00195969987292273,0.0246778572475247,0.0323598807493818,8.34411742553062e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,29115,0.0469589028556934,0.00322865312778577,0.0406307427252333,0.0532870629861535,9.32273913141419e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24579,0.0414388833719859,0.00284990170099857,0.0358530760380287,0.0470246907059431,1.05993030870228e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29226,0.0874154514050142,0.0060202845830913,0.0756156936221552,0.0992152091878731,1.32346368405727e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,24699,0.0219031554581113,0.00151033518168565,0.0189428985020074,0.0248634124142152,1.83994394135148e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,29127,0.0376373031331946,0.00260284438974442,0.0325357281292956,0.0427388781370937,3.15833347663061e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29059,0.0196721426460695,0.00136068104636601,0.0170052077951921,0.0223390774969469,3.2769734495543e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,24653,0.0300974304384066,0.00208717467290282,0.026006568079517,0.0341882927972961,6.00162768531031e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28491,0.0611100462726173,0.00424668619539324,0.0527865413296466,0.0694335512155881,8.72159041741654e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29507,-0.0289703794154891,0.00201872727885074,-0.0329270848820365,-0.0250136739489416,1.51122195963506e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,28808,0.0362035061021551,0.0025246293046727,0.0312552326649966,0.0411517795393135,1.77640980583817e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",28992,0.105049578380401,0.00732920706602161,0.0906843325309984,0.119414824229803,1.96228806942665e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29339,0.0305645289753593,0.00213259381431145,0.0263846450993088,0.0347444128514097,1.97961707571891e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29507,0.0498278843974883,0.00348768466634704,0.0429920224514481,0.0566637463435284,3.7714617847719e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29034,0.0843924068980335,0.0059085783238197,0.0728115933833469,0.0959732204127201,4.00311631727577e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,29470,0.0753686344009974,0.0052793468262053,0.065021114621635,0.0857161541803597,4.39348733698563e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,29122,0.0754918427300766,0.00529509531782808,0.0651134559071335,0.0858702295530196,5.79823594078765e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29122,0.103164375940953,0.00724639541649941,0.0889614409246137,0.117367310957291,7.73705991213389e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29122,0.0426973004272626,0.00300078885386837,0.0368157542736806,0.0485788465808446,8.66259358186525e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,29122,0.0907434428875486,0.00639558698370468,0.0782080923994874,0.10327879337561,1.53281996947845e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29120,0.0607525683979602,0.00428265623624065,0.0523585621749286,0.0691465746209919,1.59315318968544e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29122,0.0374245020272796,0.00263966402645039,0.0322507605354369,0.0425982435191224,1.78334063060265e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,24579,0.0626622335325381,0.00441854313535953,0.0540018889872334,0.0713225780778427,1.79959338364493e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,23878,0.0498224265909523,0.00351517061274065,0.0429326921899807,0.056712160991924,2.04247724735732e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24185,0.111849006452208,0.00790934550068925,0.0963466892708569,0.127351323633559,3.19871044056152e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23979,0.0687240377425484,0.00486199881654141,0.0591945200621273,0.0782535554229696,3.51491861923012e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,29132,-0.0286721217841883,0.00203248968573859,-0.032655801568236,-0.0246884420001407,4.84778120679066e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,29409,-0.0335378846169387,0.00238119607439436,-0.0382050289227516,-0.0288707403111257,6.6251596876409e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24579,0.0683167554001401,0.00485011607106918,0.0588105279008445,0.0778229828994357,6.96528310686649e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24475,0.107469838896828,0.00763404801382936,0.0925071047897222,0.122432573003933,7.7945529781298e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,29256,0.0559342166403938,0.00397506069198531,0.0481430976841026,0.063725335596685,7.98766594307815e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,29381,0.0427139933453877,0.0030357595128542,0.0367639047001934,0.0486640819905819,8.08953750516594e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28467,0.0777135129977627,0.00552461806125308,0.0668852615977067,0.0885417643978188,8.59055994081174e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",28986,0.0744177864984379,0.00529126165320714,0.0640469136581519,0.0847886593387239,8.84104618032253e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,28459,0.0388441727152501,0.00276282309659377,0.0334290394459263,0.0442593059845739,9.50128644750062e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,23848,0.0359643244484218,0.00255767688260981,0.0309512777585065,0.040977371138337,9.91074466800292e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29034,-0.0415307874276343,0.00295629533547991,-0.0473251262851749,-0.0357364485700937,1.10641951537915e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,29122,0.0329470296439895,0.00235594752181152,0.028329372501239,0.0375646867867401,2.6926502037534e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29122,0.0558525744299395,0.00399416392990533,0.0480240131273251,0.063681135732554,2.73331517783414e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,29186,0.0455801994172253,0.00325976341555795,0.0391910631227317,0.0519693357117188,2.7649065317333e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24653,0.028913805362241,0.00206801931781245,0.0248604874993286,0.0329671232251534,2.98925353755304e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24539,0.136733462087884,0.0097843953543006,0.117556047193455,0.155910876982313,3.290240636324e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,29256,0.0258684293710152,0.00185313786552513,0.0222362791545859,0.0295005795874444,3.82976940640063e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,28908,0.0520492491626304,0.00373281479311834,0.0447329321681184,0.0593655661571423,4.77512852408328e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,24699,-0.022617698425608,0.0016225517590617,-0.0257978998733689,-0.019437496977847,5.34641704303366e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,23848,0.0658591589691871,0.00474207961740745,0.0565646829190685,0.0751536350193057,1.10485339310146e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNST,Consortin,29172,0.104936455513558,0.00756684279098082,0.0901054436432356,0.11976746738388,1.36330453565005e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,24653,-0.026799760725743,0.00193322982727476,-0.0305888911872015,-0.0230106302642845,1.5536952470202e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28491,0.0644262459495959,0.00465307161193964,0.0553062255901942,0.0735462663089976,1.86166803537389e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24539,0.049555222938646,0.00358059254364121,0.0425372615531093,0.0565731843241828,2.13077018617877e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28631,0.0818968069727644,0.00594251320313685,0.0702494810946162,0.0935441328509127,4.52166569950985e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29381,0.0333660759041111,0.00242303189731088,0.0286169333853818,0.0381152184228404,5.22745638261465e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,28491,0.0606579247684461,0.00440764008314337,0.0520189502054851,0.0692968993314071,5.92271432239031e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24602,0.0940568702773222,0.00683836983183497,0.0806536654069256,0.107460075147719,6.92066513833727e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,29132,0.0359505391808173,0.00261526961856379,0.0308246107284323,0.0410764676332024,7.28710379798891e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29256,-0.0229753248702548,0.0016738459220876,-0.0262560628775465,-0.0196945868629632,9.61882008787774e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28491,0.0487608087482453,0.00355867231242004,0.041785811015902,0.0557358064805886,1.34905943064582e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,29381,0.0581318808945815,0.0042466604814335,0.0498084263509719,0.0664553354381912,1.5992018786387e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24529,0.0462599073577582,0.00337861590159217,0.0396378201906375,0.0528819945248788,1.62591941778228e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,24699,0.0163842878613673,0.00119666966692884,0.0140388153141868,0.0187297604085478,1.6307693247251e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,29034,0.0500853942801666,0.00366154884340196,0.0429087585470988,0.0572620300132344,1.84252977716099e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,23979,0.0695843082682451,0.00508618195943976,0.0596153916277432,0.079553224908747,1.902912313319e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,23979,0.0714695245924729,0.00522436586856782,0.06122976749008,0.0817092816948658,1.92936158470103e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24579,0.0844604749086855,0.00618832947467127,0.0723313491383298,0.0965896006790412,2.94554083327424e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29145,0.0264340816590051,0.00193887112899859,0.0226338942461678,0.0302342690718423,3.40009980874524e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24539,0.0262508040385246,0.00192495565586146,0.0224778909530362,0.0300237171240131,3.43507658179997e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24539,0.0286292869909916,0.00210030677792753,0.0245126857062537,0.0327458882757296,3.73192644858945e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24529,0.108684993433068,0.00798386030091825,0.0930366272432681,0.124333359622868,4.76147671028003e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,29470,0.0392850294661256,0.00288729210477433,0.0336259369407679,0.0449441219914833,4.93122466725762e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,29187,0.0472262977686154,0.00347233427694083,0.0404205225858114,0.0540320729514194,5.32534962542405e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,29042,0.0302418354066042,0.00222563811014286,0.0258795847107242,0.0346040861024842,6.3453299923634e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,24699,0.0339455143326882,0.00249781550203745,0.0290497959486948,0.0388412327166816,6.49098152485996e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29143,0.0472217233481086,0.00348990047821838,0.0403815184108006,0.0540619282854166,1.37153457865456e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,29122,0.0807185492093387,0.00597332036591133,0.0690108412921525,0.0924262571265249,1.74444708825346e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29172,0.0339972055068778,0.00252083088985105,0.0290563769627698,0.0389380340509859,2.49855387797349e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,29470,0.088803696688865,0.00658704236101226,0.0758930936612809,0.101714299716449,2.66264244793911e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29132,0.0432750228131597,0.00321875676134514,0.0369662595609233,0.0495837860653962,4.39056339778133e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29388,0.0768306316846408,0.00571559319111104,0.0656280690300631,0.0880331943392184,4.52054777351873e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,23974,-0.0304885633068719,0.0022690927988516,-0.034935985192621,-0.0260411414211227,5.20559046112308e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,28978,0.0430462160687893,0.00320544075703306,0.0367635521850045,0.0493288799525741,5.41655641531818e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,28403,0.0653470811494798,0.00486765572541992,0.0558064759276568,0.0748876863713029,5.77533030746841e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29256,0.0232691521674822,0.00173425944291508,0.0198700036593687,0.0266683006755958,6.32582426302009e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,24539,0.0978037665393299,0.00729274745653125,0.0835099815245287,0.112097551554131,7.2544824032114e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28467,0.0797863646721308,0.0059533304799074,0.0681178369315123,0.0914548924127493,7.83258482457338e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29145,0.0878766812278883,0.00656116659568138,0.0750167947003528,0.100736567755424,8.72087931115843e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,28612,0.0501044578917332,0.00375138867486233,0.042751736089003,0.0574571796944634,1.4414190359899e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29034,0.0505093995781154,0.00378561235905625,0.0430895993543651,0.0579291998018656,1.7252815234142e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,29507,-0.0152773322797484,0.00114692817504011,-0.017525311502827,-0.0130293530566698,2.31047648738309e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,28491,0.0691065622747164,0.00519047827459904,0.0589332248565023,0.0792798996929305,2.53039002955026e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29280,-0.0281748366618344,0.00211716531685712,-0.0323244806828743,-0.0240251926407944,2.730874060389e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,29326,0.053864176624521,0.00404841636500326,0.0459292805491146,0.0617990726999274,2.83375411052852e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,28860,0.0476322001627105,0.00358141962091975,0.0406126177057077,0.0546517826197132,3.0493445195533e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,28908,0.0362176301128886,0.00272457786103173,0.0308774575052664,0.0415578027205108,3.3396604582013e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,29280,0.052787217864924,0.00397190712554381,0.0450022798988581,0.0605721558309898,3.45379415609304e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,24653,0.0417608237496218,0.0031447091112246,0.0355971938916216,0.0479244536076221,4.17055941381183e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29293,0.0954823330250367,0.00719996038650982,0.0813704106674774,0.109594255382596,5.04988801955199e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,29122,0.077666221789848,0.00586268971735216,0.0661753499438378,0.0891570936358583,6.08591138300866e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,24683,0.0675117193833678,0.00509791144419587,0.0575198129527439,0.0775036258139917,6.77713224855826e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,28631,0.0438084695398356,0.00331482677550744,0.037311409059841,0.0503055300198302,9.28868543877781e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,24529,0.0411454795185867,0.00311257229115231,0.0350448378279282,0.0472461212092453,9.3105965497975e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29132,0.0394577401251415,0.00298620900438621,0.0336047704765445,0.0453107097737384,9.56831761235608e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29317,0.0669086559363319,0.00507120425906106,0.0569690955885722,0.0768482162840916,1.23537597856484e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24653,0.0712528763231892,0.00540359971245019,0.0606618208867868,0.0818439317595915,1.43512230670374e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29034,0.0557535071745874,0.00423416722386036,0.0474545394158211,0.0640524749333537,1.75178475165074e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,29337,0.034253126289933,0.00260501941266888,0.029147288241102,0.039358964338764,2.23235171396925e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24699,-0.0239800625768655,0.00182381995328126,-0.0275547496852967,-0.0204053754684342,2.36171825154466e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,29034,0.0940616317901883,0.00716087736528119,0.0800263121542371,0.108096951426139,2.66940999008624e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28631,0.0402165617744302,0.00306491051309623,0.0342093371687616,0.0462237863800989,3.2144180233145e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,29034,0.050200186717305,0.00382666286043647,0.0426999275108495,0.0577004459237605,3.33496244970498e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,28117,0.0840175370484604,0.00641228879528012,0.0714494510097114,0.0965856230872094,4.14464245872993e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28631,0.0633783580624107,0.0048505974758257,0.0538711870097923,0.0728855291150291,6.64869008729382e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,23432,0.0214041031324396,0.00163799807577046,0.0181936269039296,0.0246145793609497,6.93257180915598e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,29381,0.0539453602076423,0.00413900937450228,0.0458329018336178,0.0620578185816668,1.01203212949481e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24529,0.0658594514529698,0.00505742377735935,0.0559469008493454,0.0757720020565941,1.22722731903999e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,29381,0.0524254389493173,0.0040420512583542,0.0445030184829431,0.0603478594156915,2.30762463184711e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29470,0.0894736652512148,0.00690958772429833,0.0759308733115901,0.10301645719084,3.01966607384266e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,28908,0.0397666359184956,0.00307660492567687,0.033736490264169,0.0457967815728223,4.12309866842175e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24539,0.0772375308479032,0.00597613358918088,0.0655243090131087,0.0889507526826977,4.37008106465695e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28467,0.0553001198949754,0.00428915242004292,0.0468933811516912,0.0637068586382595,6.29416281018707e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,24653,0.0674888480687846,0.00523890938901493,0.0572205856663153,0.0777571104712538,7.50998813113126e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29034,0.0689906807256165,0.00536936210591288,0.0584667309980273,0.0795146304532058,1.10470844967669e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,29381,0.0544634099739243,0.00423949621690462,0.0461539973887913,0.0627728225590573,1.13443169496456e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,29470,0.0337455862947401,0.00262876468920254,0.0285932075039031,0.0388979650855771,1.28274971650414e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,29388,0.0214238003545155,0.00166928591418032,0.018151999962722,0.0246956007463089,1.33296514143603e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,24301,0.0984663441085937,0.0076766211080972,0.0834201667367232,0.113512521480464,1.53713015119225e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,29409,-0.014896439832678,0.00116254926752862,-0.0171750363970341,-0.012617843268322,1.73393248094405e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24579,0.0566191753353409,0.00442302623744424,0.0479500439099502,0.0652883067607317,2.13155800157607e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28467,0.0509859523469346,0.00398568828182479,0.043174003314558,0.0587979013793112,2.29633672222031e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28612,0.0856128328849918,0.00669894835690943,0.0724828941054493,0.0987427716645343,2.6815040181169e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,29042,0.038501305590817,0.00301340987867075,0.0325950222286223,0.0444075889530116,2.79032825888781e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24669,-0.0192716748207531,0.00150843569979217,-0.0222282087923457,-0.0163151408491604,2.93371124806404e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,24119,-0.0463443307984598,0.00363054157227792,-0.0534601922801245,-0.0392284693167951,3.38834809868678e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,24602,0.0936246201321858,0.00733740506747079,0.0792433061999431,0.108005934064429,3.60202964206279e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,29388,0.0236855380804567,0.00185764106806343,0.0200445615870524,0.0273265145738611,3.89477555085388e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,28853,0.0551543076993696,0.00432704527110518,0.0466732989680034,0.0636353164307357,4.1115147937937e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,24669,0.025104487290951,0.00196935881254782,0.0212445440183573,0.0289644305635448,4.2138818005047e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,28853,0.0993170278887174,0.00779527843700126,0.084038282152195,0.11459577362524,4.42417758023788e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29132,0.0454493980869564,0.00357559731579931,0.0384412273479897,0.052457568825923,6.44086603449045e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24618,-0.0131719376726141,0.0010364183177025,-0.015203317575311,-0.0111405577699172,6.87646663974273e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,24579,0.0335666188463871,0.00264884114013969,0.0283748902117133,0.0387583474810609,1.09864354175825e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,24119,0.0619836717537023,0.00490955997165621,0.0523609342092561,0.0716064092981484,2.00269121359399e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29066,0.0598254230746035,0.00474284122345613,0.0505294542766295,0.0691213918725775,2.2069969468073e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29034,0.121166649183745,0.00961144400157936,0.102328218940649,0.14000507942684,2.42172488995739e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,23848,0.0380543973727636,0.00301924965453554,0.0321366680498739,0.0439721266956532,2.62333417493504e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,24579,0.0336040183829313,0.00267281876949044,0.02836529359473,0.0388427431711325,3.86523438676919e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29280,0.0370132684759176,0.00294700751815647,0.0312371337403309,0.0427894032115043,4.36276760613426e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,24185,0.113475524903872,0.00903982726053466,0.0957574634732244,0.13119358633452,4.9683731175599e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29122,0.0574080199360448,0.00458261194499637,0.0484261005238519,0.0663899393482377,6.54816940219346e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,28612,-0.0205052189111472,0.00163887050939021,-0.023717405109552,-0.0172930327127424,7.98786891211387e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,23974,0.0290630736841335,0.00232441579998758,0.0245072187161579,0.0336189286521092,9.25131373507885e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,28908,0.0825568436595921,0.00661339091921338,0.0695945974579339,0.0955190898612503,1.1386190177091e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,24538,0.0513289891431411,0.00411676556732243,0.0432601286311891,0.059397849655093,1.42565278936103e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,29168,0.0496026816612019,0.00398410275666244,0.0417938402581435,0.0574115230642603,1.71844857803158e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,28467,0.0535542404983667,0.00430335885049801,0.0451196571513906,0.0619888238453428,1.84739224344334e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24579,0.0692999476986533,0.0055689804551188,0.0583847460066205,0.0802151493906861,1.93029166398694e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,24539,0.0871870201622738,0.00700782779442244,0.0734516776852058,0.100922362639342,1.99317465179249e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29172,0.0243365499034302,0.00196436618125329,0.0204863921881738,0.0281867076186866,3.67515618898362e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,24344,-0.0938681182356216,0.007576109084423,-0.108717292041091,-0.0790189444301525,3.77877269965881e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,29034,0.0818292354726554,0.00660649647490613,0.0688805023818394,0.0947779685634714,3.81019186185869e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24653,0.0553447995168746,0.00446754222489394,0.0465884167560825,0.0641011822776667,3.85310825931092e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,29271,0.0297178482046455,0.00239969288982848,0.0250144501405817,0.0344212462687093,3.9069507642553e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28431,0.0506397571499676,0.0040891746041109,0.0426249749259102,0.058654539374025,3.93834572245901e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,29172,0.105325857495027,0.00850571489497811,0.0886546563008699,0.121997058689184,3.96182681410961e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,24653,0.0712224367926302,0.00575599756520446,0.0599406815648295,0.082504192020431,4.61636068253343e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,24119,-0.0196887509511506,0.001592556671723,-0.0228101620277276,-0.0165673398745735,5.29246213352635e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29187,0.0263417735683057,0.0021328835724089,0.0221613217663843,0.0305222253702271,5.9343390073067e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24119,0.0676020855339192,0.00547361422324229,0.0568738016563643,0.0783303694114741,6.17229807064762e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,29507,-0.0261792999320503,0.00212222112416564,-0.030338853335415,-0.0220197465286857,7.08433404888976e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28467,0.0439262043378462,0.00356492089307261,0.0369389593874239,0.0509134492882685,8.48299013657183e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29172,0.0546170645453401,0.00443423014602297,0.0459259734591351,0.0633081556315451,8.93880132825368e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,29271,0.0407693722202158,0.00331470914168188,0.0342725423025193,0.0472662021379123,1.10986741532061e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24669,0.0200538333398175,0.00163219611749969,0.0168547289495181,0.0232529377301169,1.35297197909068e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,28908,0.0610690444453443,0.00497869086703771,0.0513108103459504,0.0708272785447382,1.67880450612154e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,29217,0.0242341139879011,0.00198034557590702,0.0203526366591233,0.0281155913166788,2.38445482172131e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,28914,0.0619186809215148,0.00506392582489311,0.0519933863047243,0.0718439755383053,2.69763851139335e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,29359,0.0490248155591934,0.00401539803318273,0.0411546354141552,0.0568949957042315,3.36075010614666e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,28908,-0.0288337188958568,0.0023620663606237,-0.0334633689626793,-0.0242040688290344,3.46329313882026e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23948,0.0683920547835734,0.00560239549208877,0.0574113596190794,0.0793727499480674,3.57604453881933e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24653,0.0624692791814833,0.0051206035700401,0.0524328961842047,0.0725056621787619,3.9192693347755e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29271,0.0883361617351357,0.00727581804025402,0.0740755583762378,0.102596765094034,7.71902208729776e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,28491,0.0831105594673747,0.00684585945202529,0.0696926749414051,0.0965284439933442,7.83408254746522e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,28908,0.048961372516895,0.00403739980269709,0.0410480689036087,0.0568746761301812,9.18406534408577e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,28908,0.0517468152157534,0.00427022792109658,0.0433771684904041,0.0601164619411027,1.02335726233108e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,29122,-0.0367700446912312,0.00304274321635417,-0.0427338213952853,-0.030806267987177,1.53461661090047e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29271,0.105662203712787,0.00874423466910011,0.0885235037613507,0.122800903664223,1.54926583630376e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29132,-0.0338774234441883,0.00280364834754978,-0.0393725742053859,-0.0283822726829908,1.55639294904943e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,29314,0.0572485407859508,0.00475008393581689,0.0479383762717497,0.0665587053001519,2.26756323400653e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,24602,0.0466987867504111,0.00387723210014173,0.0390994118341332,0.0542981616666889,2.57764869277916e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29256,-0.0356215113191544,0.00295911844348584,-0.0414213834683866,-0.0298216391699222,2.69339375552271e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24669,-0.0278085860053379,0.00231100716733546,-0.0323381600533154,-0.0232790119573604,2.95048024919727e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,24539,0.0595541290515159,0.00495545003745514,0.0498414469781039,0.069266811124928,3.54672099999957e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24539,-0.0251876081879296,0.00209689368146529,-0.0292975198036016,-0.0210776965722577,3.8138525221358e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29122,0.0474190548872565,0.00394938604138506,0.0396782582461417,0.0551598515283712,3.92471885848397e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28491,0.0299612236970814,0.0025036993060923,0.0250539730571405,0.0348684743370223,6.36309204417286e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24137,0.0545051466232312,0.00456442810848097,0.0455588675306085,0.0634514257158539,8.91990778833971e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24579,0.0903112909371963,0.00756453135317322,0.0754848094849768,0.105137772389416,9.15605103069149e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29073,-0.0212978727531473,0.00178457801279419,-0.0247956456582239,-0.0178000998480706,9.34274658393755e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29122,-0.0291838635939211,0.00244637099323776,-0.0339787507406671,-0.0243889764471751,9.90960623410859e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,29409,0.0334541034978738,0.00280496089158472,0.0279563801503678,0.0389518268453799,1.02157200958929e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29256,0.079274545747502,0.00665129272747583,0.0662380120016494,0.0923110794933547,1.12633588105121e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,24699,0.0253860195538807,0.0021297732048444,0.0212116640723856,0.0295603750353757,1.15033215800781e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,24529,0.0177750407224817,0.00149371855134646,0.0148473523618426,0.0207027290831208,1.45748852616036e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,29143,0.0640616262913277,0.00539328527623314,0.0534907871499108,0.0746324654327447,1.82965432645933e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24579,0.0332811222966801,0.00280235916792021,0.0277884983275564,0.0387737462658037,1.93283311056192e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,24546,0.0620179903840598,0.0052245101908805,0.051777950409934,0.0722580303581856,2.06459157697031e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,23974,0.0435283453509274,0.003671455580776,0.0363322924126064,0.0507243982892484,2.47046697504394e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,23934,0.0229265304942046,0.00193436513970154,0.0191351748203896,0.0267178861680196,2.58095604631704e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,23979,0.0509558724979067,0.00430319517734658,0.0425216099503074,0.059390135045506,2.93325179972481e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24119,0.0481928558236006,0.0040783488733267,0.0401992920318803,0.0561864196153209,3.92289211916389e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,28908,0.0551449429657364,0.0046681194032516,0.0459954289353633,0.0642944569961095,3.96068519468948e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,24529,0.068681019080365,0.00581487928330286,0.0572838556850914,0.0800781824756386,4.1724984561261e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,29445,-0.0380218935679739,0.00322322156922761,-0.04433940784366,-0.0317043792922877,4.81997363249502e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24539,0.0895198809012486,0.00760110057427638,0.0746217237756669,0.10441803802683,6.23598560295543e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,29013,0.0691450741993437,0.00588333715024585,0.0576137333848618,0.0806764150138256,8.07785804227879e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24529,0.0490815244912259,0.00417576074603826,0.0408970334289909,0.0572660155534609,8.20812298681935e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,23974,0.0373087078878254,0.00317519710805846,0.0310853215560308,0.04353209421962,8.62939777838796e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,28952,0.0189357714129039,0.00161253608354745,0.0157752006891508,0.0220963421366569,9.07393075980386e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,28048,-0.0258597464848701,0.00220225210013153,-0.0301761606011279,-0.0215433323686123,9.17003826989548e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24168,0.0361508275740549,0.00308562663720196,0.0301029993651391,0.0421986557829708,1.28715162188805e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,29132,0.0454333025643701,0.00388083688300185,0.0378268622736864,0.0530397428550537,1.38006639762563e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,29231,0.0211788780319985,0.00180908110611541,0.0176330790640123,0.0247246769999847,1.3810556267757e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,28865,0.0232697309022783,0.00198793170143611,0.0193733847674635,0.0271660770370931,1.40818789510542e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24602,0.0518963534290708,0.00443261065707633,0.0432084365412012,0.0605842703169404,1.40932953581864e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,29381,0.0530429764018481,0.0045381613465236,0.0441481801626618,0.0619377726410343,1.71973147446118e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,29172,0.0554074048319745,0.00474810969302265,0.0461011098336501,0.0647136998302989,2.14683578049788e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,29271,0.0860383495876169,0.00737909508482649,0.071575323221357,0.100501375953877,2.40111464179975e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,24699,0.0339045230462211,0.00291147552922691,0.0281980310089363,0.0396110150835058,2.93273755527411e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28467,0.0546599345169928,0.00469500534415594,0.0454577240424472,0.0638621449915384,2.96230147307141e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,29034,-0.0368314622472351,0.00316608512765054,-0.0430369890974301,-0.03062593539704,3.28064814169541e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,28771,0.0294046038535876,0.00252859153679801,0.0244485644414635,0.0343606432657117,3.45345733655168e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,28860,0.0426619483313695,0.00366998519354484,0.0354687773520216,0.0498551193107174,3.62879197119593e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,29470,0.0281037806042863,0.00242618618758982,0.0233484556766103,0.0328591055319623,5.83024698786891e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,24529,0.032149838906374,0.00277790528688775,0.026705144544074,0.037594533268674,6.76252768450855e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,23979,0.0416003848999226,0.00359640845630465,0.0345514243255655,0.0486493454742797,7.29788934733274e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24602,0.0648741460120288,0.00561183858459754,0.0538749423862177,0.07587334963784,7.87425084211761e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,29172,-0.0250357092379948,0.00216632197560583,-0.0292817003101822,-0.0207897181658074,7.96359045764494e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,29176,-0.0222478986781085,0.00192509675885422,-0.0260210883254628,-0.0184747090307542,7.96454822255245e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28491,0.0450238562202965,0.00390071645715495,0.0373784519642728,0.0526692604763202,9.43514694826722e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,24602,0.0535200112523881,0.00464833029680597,0.0444092838706484,0.0626307386341278,1.34659067425303e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,24683,0.0186113127521898,0.00161777558845991,0.0154404725988084,0.0217821529055713,1.50254121336894e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,29083,0.0666800927451366,0.00581321250113599,0.0552861962429101,0.0780739892473632,2.15919350121404e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,29280,0.0805295719391238,0.00702251387926417,0.066765444735766,0.0942936991424815,2.23519748876966e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,29280,-0.0382936097161483,0.00334347288538352,-0.0448468165715,-0.0317404028607966,2.6284413936701e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23979,0.0615260606365269,0.00538074080435129,0.0509798086599983,0.0720723126130554,3.36747825325119e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29367,0.0503397002096494,0.00440396070817163,0.041707937221633,0.0589714631976658,3.40888081437903e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,23979,0.0379011638965259,0.00331869938527313,0.0313965131013906,0.0444058146916612,3.95343990349443e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24185,0.042690339553746,0.00374308755349479,0.0353538879488962,0.0500267911585958,4.70626482254355e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29470,0.0536140028420386,0.0047150583683731,0.0443724884400273,0.0628555172440499,6.7475935840412e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28612,0.0743506064881783,0.00654178724194315,0.0615287034939698,0.0871725094823869,7.20009942270203e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,23974,0.04362839388,0.00383997898464994,0.0361020350700861,0.0511547526899139,7.74152908156546e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,29122,0.0558668918339423,0.00492079517538048,0.0462221332901965,0.065511650377688,8.25871684422323e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,28853,0.0635843238867794,0.00560357813993747,0.0526013107325019,0.0745673370410568,8.86775936148663e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29271,0.0323249586705174,0.00284933278230141,0.0267402664172066,0.0379096509238281,9.08895305435805e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,28853,0.0505827619854422,0.00446369074275656,0.0418339281296393,0.0593315958412451,1.0522987704536e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29127,0.0590363594664386,0.00521227799935063,0.0488202945877114,0.0692524243451658,1.12052198954479e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24539,0.0661320521409538,0.00583925562585965,0.0546871111142689,0.0775769931676387,1.16366189458321e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,29038,0.0694613995822585,0.00613493080840911,0.0574369351977766,0.0814858639667403,1.17477806359594e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,24119,0.0402969605872654,0.00356008371073231,0.03331919651423,0.0472747246603007,1.25388533527308e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,23940,0.0574029753848007,0.00507818911008575,0.0474497247290326,0.0673562260405688,1.49292919643017e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,28981,0.056110686899652,0.00497246986106317,0.0463646459719682,0.0658567278273358,1.80834553744858e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,28467,0.0275194624781274,0.00244381996429905,0.0227295753481012,0.0323093496081535,2.36303307177393e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,24143,-0.0243768687697021,0.0021662553085629,-0.0286227291744854,-0.0201310083649188,2.64843815459649e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23649,0.0422250440081645,0.003752879595621,0.0348694000007474,0.0495806880155817,2.70695627019242e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,29470,0.0388756459203585,0.00346760913780168,0.0320791320102672,0.0456721598304498,4.12111142638792e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,23940,0.0544134643988413,0.00485362205307998,0.0449003651748045,0.063926563622878,4.26078320684187e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,28491,0.0317495733852412,0.00283451701263348,0.0261939200404796,0.0373052267300029,4.63455926633693e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,23848,0.0489758122618694,0.00437434090820427,0.0404021040817891,0.0575495204419498,5.03122997594984e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,24579,0.059156136855129,0.00528461673705862,0.0487982880504941,0.0695139856597639,5.12766600013759e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24539,0.0370400960786601,0.00330978418454327,0.0305529190769553,0.0435272730803649,5.30077346902557e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29172,0.0573217863777322,0.00512348177704797,0.0472797620947182,0.0673638106607463,5.34583073894914e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29507,0.0318575693764976,0.00285287520751222,0.0262659339697736,0.0374492047832215,6.77249014195699e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,24579,0.0482709582336506,0.00432735961794014,0.0397893333824879,0.0567525830848133,7.95555491001343e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,23979,0.0804072263639705,0.00721207825698161,0.0662715529802865,0.0945428997476545,8.52838073333644e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29187,-0.0186342186701363,0.00167190838613878,-0.0219111591069683,-0.0153572782333043,8.61396132956103e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,28523,0.0301568574549303,0.0027094535719681,0.0248463284538728,0.0354673864559878,1.02458156462279e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24669,-0.0206299441376861,0.00185370213766839,-0.0242632003275161,-0.0169966879478561,1.06052308822697e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23593,0.0257484300959954,0.00231527439267984,0.0212104922863429,0.0302863679056479,1.16702284950548e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,29470,0.0382432293988152,0.00344185909441741,0.0314971855737571,0.0449892732238733,1.26144037775441e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29271,0.0300245943609693,0.00270753213676623,0.0247178313729075,0.0353313573490311,1.61199009979134e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,29367,0.0266369938750198,0.00240431075069126,0.0219245448036649,0.0313494429463746,1.8096988633708e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28612,0.0444149067589026,0.00400982398064392,0.0365556517568405,0.0522741617609647,1.8634684801338e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29226,0.054918996525892,0.00495964393856046,0.0451980944063135,0.0646398986454705,1.92876871826224e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",23843,0.0568511931139813,0.00513502002674306,0.0467865538615649,0.0669158323663977,2.02865190799863e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,24653,0.0359003316582563,0.00324403949468254,0.0295420142486785,0.0422586490678341,2.12659680605783e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24602,0.0601064660239888,0.00543173012899024,0.0494602749711679,0.0707526570768097,2.14498741672687e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24539,0.0310894552724291,0.0028098200899017,0.0255822078962217,0.0365967026486364,2.17541314346067e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,23974,0.0722105117357331,0.00652773281348599,0.0594161554213006,0.0850048680501657,2.24374139513768e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,24602,0.0604608638829815,0.00546908686590434,0.049741453625809,0.071180274140154,2.41762450364263e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",24699,0.0128645206422858,0.00116404200636252,0.0105829983098152,0.0151460429747563,2.50968581671354e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29122,-0.040719267670952,0.00368531011255978,-0.0479424754915692,-0.0334960598503348,2.52166670500204e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29226,0.0401270872028016,0.0036358970138258,0.033000729055703,0.0472534453499001,2.9018677073042e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,29122,-0.0205005644982679,0.00185803676129152,-0.0241423165503993,-0.0168588124461366,2.99832646324996e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,29034,0.0425828003878386,0.00386139623524055,0.0350144637667671,0.0501511370089101,3.19245209819954e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,28491,0.0431338263368379,0.00391522764379301,0.0354599801550036,0.0508076725186722,3.60990609371559e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,28908,0.0443337800421963,0.0040243057317449,0.0364461408079763,0.0522214192764163,3.62050262006615e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29076,0.0498412729672386,0.00452654782587122,0.040969239228531,0.0587133067059462,3.84993610155129e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29132,-0.0337849106592737,0.003068577222017,-0.0397993220144271,-0.0277704993041204,3.88833854198383e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,24669,0.031433600505981,0.00285776386127203,0.0258323833378879,0.0370348176740742,4.47258685341375e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29271,0.0657495442986717,0.00597998508523698,0.0540287735316072,0.0774703150657362,4.58754028919061e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,23848,0.0612420313623033,0.0055693214383352,0.0503261613431663,0.0721579013814403,4.64962995097288e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24539,0.0589082399435314,0.00537077250518182,0.0483815258333751,0.0694349540536878,6.3036625470714e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,29470,0.0321934371109018,0.00293664269293134,0.0264376174327564,0.0379492567890472,6.54159915320535e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24119,0.0517523102641995,0.00472385424590833,0.0424935559422192,0.0610110645861798,7.27313186558031e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28631,0.0458079298313078,0.00418587546313363,0.0376036139235659,0.0540122457390498,8.11014672682784e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24602,0.0554131936273963,0.00507646693323981,0.0454633184382463,0.0653630688165463,1.12256343422458e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24119,0.0175014425049095,0.00160384850879119,0.0143578994276788,0.0206449855821402,1.17042719278942e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29132,-0.0400234073189071,0.00367062029757443,-0.047217823102153,-0.0328289915356612,1.25131164011039e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28612,0.0287205671755205,0.00263937247901224,0.0235473971166565,0.0338937372343845,1.59752434408603e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29034,0.0641991590377696,0.00590537972681843,0.0526246147732055,0.0757737033023337,1.78430212208817e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,23979,0.040787964743141,0.0037517839014089,0.0334344682963795,0.0481414611899024,1.82432948232523e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,24619,0.0338937484454901,0.00311981644553575,0.02777890821224,0.0400085886787402,1.97438238142805e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,28491,0.044646073115613,0.00411517347044212,0.0365803331135464,0.0527118131176796,2.27749815168841e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,28770,-0.0289668885463829,0.00267002901948807,-0.0342001454245795,-0.0237336316681863,2.28051707631313e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,29122,0.0505653914089316,0.00466207569492134,0.0414277230468858,0.0597030597709774,2.34750819986449e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,28467,0.054348779184731,0.00501486452252066,0.0445196447205905,0.0641779136488715,2.58435355845107e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,29034,0.0247895370753008,0.00228895750177875,0.0203031803718144,0.0292758937787871,2.79681235436111e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,29256,-0.0208472780791501,0.00192505967789118,-0.0246203950478168,-0.0170741611104834,2.81368064839311e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,29007,0.0293475594051262,0.00271020585227243,0.0240355559346723,0.0346595628755802,2.8437642071679e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24539,0.077736439162013,0.00718722246839875,0.0636494831239515,0.0918233952000746,3.33328624146771e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29226,0.0576351779849956,0.00533186740585926,0.0471847178695114,0.0680856381004797,3.49154931358157e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,28860,0.0231816754619242,0.00214908623324151,0.0189694664447709,0.0273938844790776,4.47813366564644e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29122,0.0579958701165247,0.00537844501725487,0.0474541178827051,0.0685376223503442,4.65835761329585e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29034,-0.0200370058098317,0.00186103310387766,-0.023684630693432,-0.0163893809262315,5.56596012326729e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,24539,0.0509640664638703,0.00473285959616086,0.0416876616553951,0.0602404712723456,5.59339672058962e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,23998,0.021277907013379,0.00197638383277614,0.0174041947011378,0.0251516193256203,5.73681784155226e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,29122,0.0454528305993821,0.0042243252351889,0.0371731531384118,0.0537325080603523,5.98967547539336e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28612,-0.0161210720611464,0.00150231964812349,-0.0190656185714685,-0.0131765255508244,8.20788344498123e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,24488,0.0326926560438006,0.003047647792792,0.0267192663699283,0.038666045717673,8.7035732371997e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,24669,0.0280029686957344,0.00261458759592041,0.0228783770077304,0.0331275603837384,1.04283502911737e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,23979,0.0514089574053123,0.00481944487481747,0.0419628454506701,0.0608550693599546,1.66587128311491e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29470,0.0414461154215621,0.00388776771321714,0.0338260907036565,0.0490661401394677,1.73814916941e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24579,0.0674534474925761,0.00633151515164505,0.0550436777953518,0.0798632171898004,1.91605257310009e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24602,0.0492101441521047,0.00462070442492711,0.0401535634792476,0.0582667248249618,1.99272370789455e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,29181,0.0788528979732462,0.00741437482799736,0.0643207233103714,0.093385072636121,2.28604535369417e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29122,0.0751677548230329,0.00706992048714009,0.0613107106682383,0.0890247989778275,2.36323144705479e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,23979,0.0238889659527537,0.00224859978020975,0.0194817103835425,0.0282962215219648,2.63930741936838e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,29132,-0.0211970320547134,0.00199851297313832,-0.0251141174820645,-0.0172799466273623,3.1070622090731e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29120,0.0722795997411499,0.00682176435677805,0.0589089416018649,0.0856502578804349,3.49204882099028e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,28467,-0.0549045915892227,0.00519065389052183,-0.0650782732146455,-0.0447309099637999,4.23305979881373e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,29137,0.032111114870717,0.00303680254480161,0.0261589818829059,0.0380632478585282,4.38682315984556e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,28908,0.0713460808891389,0.00674924049011342,0.0581175695285166,0.0845745922497612,4.53324138554709e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28491,0.0677554540987549,0.00641112193422821,0.0551896551076677,0.0803212530898422,4.66542757874545e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,28908,-0.0190336800961557,0.00180117040591692,-0.0225639740917529,-0.0155033861005586,4.70911437486227e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,29445,0.0389029767809049,0.00368285798418533,0.0316845751319017,0.0461213784299082,4.91084191545981e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,23848,0.0493421212579081,0.00467339874888937,0.0401822597100849,0.0585019828057312,5.32002050899301e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24602,0.0562646206596437,0.00533509779302141,0.0458078289853217,0.0667214123339657,6.0140990360261e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29507,-0.0184483948146362,0.00175000880445266,-0.0218784120713634,-0.015018377557909,6.1587180205499e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,23979,0.0438545811971741,0.0041666978180046,0.0356878534738851,0.0520213089204631,7.54374246304833e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29409,-0.0432182937960404,0.00410739158749766,-0.0512687813075358,-0.035167806284545,7.59817344326866e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,23974,0.0717831346945244,0.00682266210100548,0.0584107169765536,0.0851555524124951,7.84818759521024e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,29418,-0.0261810069731257,0.00248966069994345,-0.0310607419450148,-0.0213012720012365,8.11130541203873e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29122,0.0452193589518044,0.00430242957140804,0.0367865969918446,0.0536521209117641,8.62426363024001e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,23979,0.0544725540430546,0.00518359771922843,0.0443127025133668,0.0646324055727423,8.9687059393683e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,29160,-0.0159861693613369,0.00152374974017768,-0.0189727188520852,-0.0129996198705887,1.05218943820685e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,28612,0.0424656522956244,0.00405357713406182,0.0345206411128633,0.0504106634783856,1.23799558277987e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29122,0.0368883229538129,0.00352338185599627,0.0299824945160603,0.0437941513915656,1.32340232177923e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,28289,0.0617586224085177,0.00590434105701913,0.0501861139367602,0.0733311308802752,1.47024578191982e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,29476,-0.0314364734594397,0.00300702939492868,-0.0373302510734999,-0.0255426958453794,1.55166669638148e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28612,0.0533569453604591,0.00510730699799604,0.0433466236443869,0.0633672670765314,1.6779062284338e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29280,0.0335986878100494,0.00321917277744736,0.0272891091662526,0.0399082664538463,1.8615063461669e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24602,0.0684234882463331,0.00655567865965694,0.0555743580734055,0.0812726184192607,1.89367318565807e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,29409,0.0405415152218647,0.00388742546255691,0.0329221613152532,0.0481608691284763,2.02715528196376e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28491,0.0461386355629138,0.00442760277574945,0.0374605341224449,0.0548167370033827,2.21642721859754e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,29172,0.039439794679051,0.00378765932341461,0.0320159824051584,0.0468636069529437,2.40350324466895e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,28908,0.0570106727370274,0.00547867857121,0.0462724627374558,0.067748882736599,2.58296856190549e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,29381,-0.021850350197276,0.00210254674517117,-0.0259713418178115,-0.0177293585767405,2.97243081805806e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23979,-0.0255401900635709,0.00246283930417941,-0.0303673550997626,-0.0207130250273793,3.8288727454157e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,23974,0.0655403540983723,0.006321574406592,0.053150068261452,0.0779306399352926,3.9298094282556e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28491,0.0412699556714531,0.00398738458308083,0.0334546818886147,0.0490852294542916,4.629554001737e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,29381,-0.0211849068154374,0.00204976195614923,-0.0252024402494899,-0.0171673733813849,5.38491774757233e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,29507,0.0402948560995982,0.0038996602914351,0.0326515219283854,0.047938190270811,5.51781257871512e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,29034,0.0977518861503457,0.00946155761869016,0.0792072332177129,0.116296539082978,5.60964994232249e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29507,0.0518465473013511,0.00502162467494706,0.0420041629384549,0.0616889316642473,6.01199132057457e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29122,0.0753504567905882,0.00730291199307863,0.061036749284154,0.0896641642970223,6.45937145946893e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24342,0.0230903809271217,0.00223753895006385,0.0187048045849966,0.0274759572692468,6.47210670658721e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,29085,0.0479264351944079,0.00465261523382547,0.03880730933611,0.0570455610527058,7.69701272173187e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24579,0.045355977081292,0.00441447304857745,0.0367036099060802,0.0540083442565039,1.03159678301473e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,24579,0.0773533819057595,0.0075375820652338,0.0625797210579012,0.0921270427536177,1.16784130319598e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,23974,0.0356587686153957,0.00347718915388413,0.0288434778737828,0.0424740593570086,1.26281912388959e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,24579,0.040007145849609,0.00390378402039702,0.0323557291696308,0.0476585625295871,1.34997290090982e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29132,0.0215810802964234,0.0021069872724021,0.0174513852425153,0.0257107753503315,1.40601284397037e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28491,0.0426420697106866,0.00417384066071193,0.0344613420156913,0.050822797405682,1.84340644180478e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29138,0.0405767759943675,0.00397309644606524,0.0327895069600796,0.0483640450286553,1.9091709098984e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24119,0.0206475077711849,0.00202154586176009,0.0166852778821351,0.0246097376602347,1.93051097968578e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,24669,-0.037121921051124,0.0036353239654059,-0.0442471560233195,-0.0299966860789284,1.97107662263293e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29122,0.0801698884407191,0.00785648945604895,0.0647711691068631,0.095568607774575,2.0854454520284e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,28467,0.0483159228801011,0.0047364591968899,0.0390324628541969,0.0575993829060053,2.16499094730862e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,23974,0.0327965380207414,0.00321971152307834,0.0264859034355078,0.0391071726059749,2.56229513094765e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,24539,0.0490107053823176,0.00482298207616239,0.0395576605130393,0.0584637502515959,3.27538166177982e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,29359,0.0200896871581108,0.00197810461034852,0.0162126021218277,0.0239667721943939,3.41584288636165e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24119,0.0493622700693668,0.00486071364134395,0.0398352713323326,0.0588892688064009,3.50884368070594e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,24550,0.06011178326863,0.00592694930535388,0.0484949626301364,0.0717286039071237,4.00855580037516e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,24602,0.034316459354808,0.0033837405773737,0.0276843278231556,0.0409485908864605,4.02962331273007e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,29256,-0.0195337944166464,0.00192882307980192,-0.0233142876530582,-0.0157533011802346,4.5801179697091e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,24653,0.0457369601593997,0.0045171406270827,0.0368833645303176,0.0545905557884818,4.76003834631191e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24067,0.0609664854819626,0.00602123502307324,0.0491648648367391,0.0727681061271862,4.77044552862915e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,28631,0.037207993505619,0.00368096671577282,0.0299932987427043,0.0444226882685337,5.57407484307585e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,24119,0.0474975755057618,0.00471890252701661,0.0382485265528092,0.0567466244587143,8.75613793198661e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28467,0.0407393004707255,0.00404986559353522,0.0328015639073964,0.0486770370340545,9.1490351413873e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,29122,0.0329161891627176,0.00327411819587068,0.0264989174988111,0.0393334608266241,9.69867819451609e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,29034,-0.0197992005433806,0.00197176611649911,-0.0236638621317189,-0.0159345389550424,1.09634967295712e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,29470,-0.00625740156864843,0.000623246129698319,-0.00747896398285714,-0.00503583915443973,1.10979627926684e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28491,0.0689805634497934,0.0068710733678892,0.0555132596487306,0.0824478672508562,1.12156502444053e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29381,0.0458905382790184,0.00457442577260562,0.0369246637647114,0.0548564127933255,1.20397277228305e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,29256,0.0493362426494377,0.00492000144010305,0.0396930398268357,0.0589794454720396,1.25770909775412e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,24683,0.033266340210091,0.0033187910615741,0.0267615097294058,0.0397711706907763,1.33169659035796e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29127,0.079914520994433,0.00798681024593498,0.0642603729124004,0.0955686690764655,1.56862142321944e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,24653,0.0701298562202362,0.00701348496976872,0.0563834256794895,0.0838762867609829,1.701800437354e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,28859,0.0320146729072934,0.00320491558680636,0.0257330383571529,0.0382963074574338,1.85471142801273e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,29132,0.0628342018704716,0.00629335052499318,0.050499234841485,0.0751691688994583,1.94908143601966e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,29034,-0.0205079384419353,0.00205549582629498,-0.0245367102614735,-0.0164791666223972,2.093687833167e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,28853,-0.0338511970892804,0.00339705709726135,-0.0405094289999126,-0.0271929651786482,2.36919309677535e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,24529,0.0439637145069856,0.00441197071240167,0.0353162519106783,0.0526111771032929,2.41094740552318e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,29256,0.0387159565465426,0.0038888596781644,0.0310937915773404,0.0463381215157449,2.59636720383502e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,28412,0.0320813657647877,0.00322581270687855,0.0257587728593057,0.0384039586702696,2.88873191429604e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,29071,0.0718061042366062,0.00722040463355268,0.057654111154843,0.0859580973183695,2.89218919132872e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,24648,-0.0260759820766645,0.00262248020458876,-0.0312160432776585,-0.0209359208756705,2.98529675419669e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29256,0.0424284673436641,0.00428357836159561,0.0340326537549367,0.0508242809323915,4.30948451083943e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24579,0.0221553569964975,0.00223676301783128,0.0177713014815482,0.0265394125114469,4.37048171693344e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24653,0.0745735719158707,0.00753142565507845,0.0598119776319169,0.0893351661998244,4.52168834916981e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23971,0.0270629623749051,0.0027360527531468,0.0217002989787373,0.0324256257710728,5.02962360272076e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29507,-0.0180670432779453,0.00182733864608662,-0.0216486270242751,-0.0144854595316156,5.14358995351274e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24653,-0.0226992975406823,0.00229699981165835,-0.0272014171715327,-0.018197177909832,5.49026788754583e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,23979,0.0533332396106663,0.0054023310025033,0.0427446708457598,0.0639218083755728,6.07369540051784e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,29132,-0.0166121843345286,0.00168447544322621,-0.019913756203252,-0.0133106124658052,6.61131212328553e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24602,0.0740797798766658,0.00751148378854579,0.0593572716511161,0.0888022881022155,6.69457732261372e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,23940,0.0560631547449683,0.00568618462338835,0.0449182328831272,0.0672080766068095,6.89251561527123e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29172,0.0550917836137771,0.00559215316499517,0.0441311634103866,0.0660524038171676,7.32271415764122e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29381,0.0322173322458208,0.00327272066795103,0.0258027997366368,0.0386318647550048,7.87698482943962e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24579,-0.0468587590029033,0.00476702509486097,-0.0562021281888308,-0.0375153898169758,9.23213587267419e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,23940,0.0554411935769616,0.00564264311603432,0.0443816130695343,0.0665007740843888,9.66516606279323e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,24621,0.0322656823885685,0.00328423599157821,0.0258285798450753,0.0387027849320618,9.73296483003363e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24602,0.0331267537750213,0.00337789008724267,0.0265060892040257,0.039747418346017,1.1567268939611e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24579,0.0287701205509907,0.00293437909061922,0.0230187375333771,0.0345215035686044,1.18497639636918e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,28908,0.055306234640148,0.00565042078864677,0.0442314098944003,0.0663810593858956,1.37479911048248e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,29034,0.0615609244697226,0.00629072020631419,0.0492311128653468,0.0738907360740984,1.40160673377892e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,29507,-0.0201031135361884,0.00205995628506749,-0.0241406278549206,-0.0160655992174561,1.82564991654736e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29122,0.0493862791870404,0.00506711024433709,0.0394547431081397,0.0593178152659411,2.06749289065295e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,29418,0.0470445836101313,0.00482752676148672,0.0375826311576174,0.0565065360626453,2.09380243827777e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28491,0.057863142258456,0.0059382536837019,0.0462241650384002,0.0695021194785117,2.11846948107125e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,23848,0.0455579982979097,0.0046790535306144,0.0363870533779054,0.0547289432179139,2.31721620399521e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28491,0.0529517670728108,0.00544620994962824,0.0422771955715394,0.0636263385740821,2.6142050037381e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,24602,0.0455213385498186,0.00468538711518179,0.0363379798040623,0.0547046972955749,2.83733500016727e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,23974,0.039415491083043,0.00405823266356724,0.0314613550624512,0.0473696271036348,2.93231446331252e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,28680,-0.0204020567380115,0.00210299593478901,-0.024523928770198,-0.0162801847058251,3.21666722389728e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,29381,0.0153075047368402,0.00158112060603035,0.0122085083490208,0.0184065011246597,3.90269833850358e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24602,0.0357830857065356,0.00369617129536773,0.0285385899676149,0.0430275814454563,3.97260369817573e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,29226,0.0587255462044795,0.00606715071691326,0.0468339307993295,0.0706171616096295,3.98756016843148e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,23979,0.0273956557042492,0.00283062843485173,0.0218476239719398,0.0329436874365586,4.09320996499247e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,23940,0.0889894180965484,0.00919498254624685,0.0709672523059045,0.107011583887192,4.10395348609863e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28491,0.0306836478730885,0.0031714749828315,0.0244675569067387,0.0368997388394382,4.16969276220073e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,29256,0.0482957762718939,0.00499271892827649,0.038510047172472,0.0580815053713159,4.22823984746607e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24683,0.0428258771014335,0.00442905646124239,0.0341449264373984,0.0515068277654686,4.45604750171051e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24602,-0.0177827226485315,0.00184057362701704,-0.0213902469574849,-0.0141751983395781,4.80830975799789e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,28908,-0.0285135077879602,0.00295291539385607,-0.0343012219599181,-0.0227257936160023,5.00293405155256e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,24422,0.0633942571027374,0.0065862857338203,0.0504851370644496,0.0763033771410252,6.84559185145649e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,28491,0.0648406662005654,0.00674192494141278,0.0516264933153964,0.0780548390857344,7.27961821012343e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,24579,0.0921016289246407,0.00957735729515408,0.0733300086261387,0.110873249223143,7.43524466184883e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,29271,0.0621682770995145,0.00646580883757198,0.0494952917778734,0.0748412624211556,7.45036825949058e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24602,0.0419595629598498,0.0043656425570903,0.0334029035479528,0.0505162223717468,7.82501600231643e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,29028,0.0308690316330893,0.00321396873400868,0.0245696529144323,0.0371684103517463,8.23514920375498e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29034,0.0224226516721589,0.00233595235546803,0.0178441850554416,0.0270011182888763,8.70285367203222e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,29409,0.0741825783383127,0.00773044397160974,0.0590309081539576,0.0893342485226678,8.93092173980839e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,28455,0.0212740097029937,0.00221900853248146,0.0169247529793301,0.0256232664266574,9.76552268061185e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24119,0.0278305317730212,0.00290335927680543,0.0221399475904826,0.0335211159555599,1.00470797266106e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,28491,0.0315388087031125,0.00329167815069571,0.0250871195277489,0.037990497878476,1.03262318152632e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24539,0.0513177295599135,0.00535831672483852,0.04081542877923,0.061820030340597,1.08807357897919e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,24539,0.039728142450427,0.00414977933939883,0.0315945749452053,0.0478617099556488,1.12710672480228e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23979,0.0250396276621969,0.00261601649889958,0.0199122353243537,0.0301670200000401,1.15019295821622e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28485,0.052563011781608,0.00549867864603526,0.0417856016353789,0.0633404219278371,1.27872413886399e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,29507,-0.0158947915468958,0.0016652023586374,-0.0191585881698251,-0.0126309949239665,1.45865172541128e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,28631,0.0294781025294415,0.00308852244873663,0.0234245985299177,0.0355316065289653,1.47396983844113e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,23974,0.0282036416924012,0.00295465275520793,0.0224125222921937,0.0339947610926088,1.47954472636844e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,24556,0.0649330441106183,0.0068101727777232,0.0515851054662809,0.0782809827549558,1.63769254944849e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,23974,0.0518182475795299,0.00544056169562684,0.0411547466561013,0.0624817485029585,1.81130386746584e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,24602,-0.0309838022713792,0.00325868710451954,-0.0373708289962375,-0.0245967755465209,2.11419216080166e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,29381,0.0421840498212824,0.00443931970054411,0.033482983208216,0.0508851164343489,2.20221621476371e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,24529,0.0240269153538658,0.00253119087556938,0.0190657812377498,0.0289880494699818,2.45811910342054e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29147,0.0643206270545862,0.00678141940391051,0.0510290450229216,0.0776122090862508,2.60594844457044e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23974,0.0296916593764528,0.00313303918426058,0.0235509025753021,0.0358324161776036,2.85281629418534e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24185,0.044283972351092,0.0046826352596282,0.0351060072422207,0.0534619374599633,3.44596043048103e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29507,0.0230223175655659,0.0024482312595255,0.018223784296896,0.0278208508342359,5.63888622592458e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,28773,0.0309604324819994,0.00329541662484837,0.0245014158972966,0.0374194490667022,6.13132767728505e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24539,0.0426105734291004,0.00453588262677343,0.0337202434806244,0.0515009033775763,6.25720161976172e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29281,-0.0159638051724456,0.00169964423842672,-0.019295107879762,-0.0126325024651292,6.27418677277069e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29034,0.0226233317869352,0.00240940988913384,0.0179008884042328,0.0273457751696375,6.45042463978119e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,24155,0.0145840574880398,0.0015549748979171,0.0115363066881222,0.0176318082879573,7.2297505163629e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,23647,0.046695091805135,0.00497983043840875,0.0369346241458539,0.0564555594644162,7.38914079075739e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,28631,0.0521704259590156,0.00556922165239353,0.0412547515203243,0.0630861003977069,7.9448873460735e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28467,0.0421306139316839,0.00449870358336252,0.0333131549082934,0.0509480729550745,8.14375198278592e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,24602,0.0360714960992636,0.00385383593166762,0.0285179776731951,0.0436250145253322,8.64316170111034e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,23940,0.0321230042057815,0.00343406908867893,0.0253922287919708,0.0388537796195922,9.13897569523714e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29172,-0.0513725020329464,0.00549438327518738,-0.0621414932523136,-0.0406035108135791,9.37077305531639e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24529,0.0230907064023201,0.0024712095855709,0.0182471356146011,0.027934277190039,1.00525388599496e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29034,0.0292979664152172,0.00313650627945889,0.0231504141074778,0.0354455187229567,1.02078554568917e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,24579,0.0539294036069408,0.00577390369844704,0.0426125523579846,0.065246254855897,1.04062089083291e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,24699,0.0167005256841824,0.00178881403729961,0.0131944501710751,0.0202066011972896,1.08123667612033e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,24119,0.0202497124626444,0.0021689786314075,0.0159985143450857,0.0245009105802031,1.0835743425325e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24579,0.0205935162003746,0.00220626019555731,0.0162692462170823,0.0249177861836669,1.10177470398827e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,24539,0.0553355354319657,0.0059310664986121,0.043710645094686,0.0669604257692454,1.14792662283067e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,23979,0.0202118193308015,0.00216794695468674,0.0159626432996155,0.0244609953619875,1.22540967343135e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24602,0.0396999078552138,0.00425910633918788,0.0313520594304056,0.0480477562800221,1.24424736353633e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24119,0.0468545150641841,0.00503485765443556,0.0369861940614904,0.0567228360668778,1.43668887180282e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,28491,0.0188229761073333,0.00202306975269665,0.0148577593920479,0.0227881928226187,1.44430652831709e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,24013,-0.022420439719088,0.00240989281268104,-0.0271438296319429,-0.0176970498062332,1.47162177102648e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28491,0.0425279218806715,0.00457444665332613,0.0335620064401523,0.0514938373211907,1.54693508863874e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24683,-0.0172840093599774,0.00185984558308945,-0.0209293067028328,-0.0136387120171221,1.6165064523959e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29122,0.0624845622886196,0.00672578851921481,0.0493020167909586,0.0756671077862806,1.64247434400431e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24119,-0.0267693064622661,0.00288156390151384,-0.0324171717092332,-0.021121441215299,1.67174436468218e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,29317,0.0385962555736368,0.00415891507367746,0.030444782029229,0.0467477291180446,1.80171102252218e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,23974,0.0288785966927644,0.00311270716286582,0.0227776906535474,0.0349795027319814,1.87488134208437e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,23848,0.025687372602807,0.0027714054294595,0.0202554179610664,0.0311193272445477,2.03889290355835e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24602,0.0547521967330998,0.0059079882399781,0.0431725397827428,0.0663318536834569,2.0574978648947e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24602,0.0769791233747767,0.00830991645453853,0.0606916871238811,0.0932665596256722,2.13501267461309e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23979,0.0632560687936372,0.00683046377847576,0.0498683597878247,0.0766437777994497,2.19284398985672e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24653,0.0309706555884702,0.00334661385282515,0.0244112924369329,0.0375300187400075,2.32603604296483e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23979,-0.0136464618562745,0.00147529925730803,-0.0165380484005982,-0.0107548753119507,2.42781286668223e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,24563,0.0199858286496838,0.00216087586935141,0.015750511945755,0.0242211453536125,2.44633715816688e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,23979,0.0282905930012109,0.00305939615777032,0.0222941765319811,0.0342870094704407,2.49306132201602e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,28444,-0.0772504277036826,0.00837835799339112,-0.0936720093707292,-0.060828846036636,3.16331498977274e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28612,0.0314125518818243,0.00340697465130496,0.0247348815652666,0.038090222198382,3.16689842672908e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,23843,0.0257786207622,0.00279864084709411,0.0202932847018955,0.0312639568225044,3.48606867112878e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,24579,0.0458415802896226,0.00497951012653514,0.0360817404416138,0.0556014201376315,3.64595707487089e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,29122,0.0539764925998728,0.00586597616976695,0.0424791793071295,0.065473805892616,3.75477502914122e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,28448,-0.0297297914173258,0.00323671382783824,-0.0360737505198888,-0.0233858323147629,4.37972997979291e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,24579,0.042791046604772,0.00465925476417231,0.0336589072669943,0.0519231859425498,4.46844965409023e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,29256,0.021015967858484,0.00229379710713153,0.0165201255285062,0.0255118101884618,5.41350858292935e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28612,0.0485252445394326,0.0053041293397952,0.038129151033434,0.0589213380454311,6.14124424430757e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,28612,0.0312980439151032,0.0034232860700397,0.0245884032178253,0.038007684612381,6.4840919126053e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,29132,0.0154427194148424,0.00169164919557593,0.0121270869915136,0.0187583518381712,7.36174951827085e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,29080,0.0725300021093373,0.00795369554978809,0.0569407588317526,0.0881192453869219,8.05487702287427e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,29470,0.0347408178169468,0.00381071776982276,0.0272718109880942,0.0422098246457994,8.22991742268543e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,29507,-0.0192060183134735,0.00211014574936328,-0.0233419039822255,-0.0150701326447214,9.43336238274261e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29181,0.0251568321946072,0.00278275739991839,0.0197026276907671,0.0306110366984472,1.65731420422161e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28631,0.0346347954989426,0.00383256479466526,0.0271229685013987,0.0421466224964866,1.70952415584161e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,29069,0.0259202103918184,0.0028695483962402,0.0202958955351877,0.0315445252484492,1.77340870361527e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29256,0.0160239472579126,0.00177420541391065,0.0125465046466477,0.0195013898691775,1.79280744068429e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,29034,0.0567753687894359,0.00629137292772894,0.0444442778510872,0.0691064597277846,1.91691211694192e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,23911,0.05375835257113,0.0059561814781177,0.0420842368740193,0.0654324682682407,1.91784398094219e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28491,0.0281165810623986,0.00311638651950362,0.0220084634841715,0.0342246986406257,1.95693199479372e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24602,0.0426776018450399,0.00474085357100457,0.033385528845871,0.0519696748442089,2.37100788338658e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29226,-0.0515740858187054,0.00573414790948268,-0.0628130157212915,-0.0403351559161194,2.51981268447053e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29132,0.0485283867839138,0.00539838031169779,0.0379475613729862,0.0591092121948415,2.63171643947667e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24119,0.0338152026953191,0.00376232401551511,0.0264410476249095,0.0411893577657287,2.70176492313286e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,28908,0.0591679445714881,0.00658681683303352,0.0462577835787424,0.0720781055642338,2.796611903325e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,29470,0.0396957572145814,0.00443050104556926,0.0310119751652656,0.0483795392638971,3.44439406242218e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24539,0.0404062366755987,0.00450970235821932,0.0315672200534888,0.0492452532977086,3.47725221059433e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,24529,0.0204392954140597,0.00228220065620667,0.0159661821278946,0.0249124087002248,3.60165780794528e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,29507,0.035357159729221,0.0039531984683002,0.0276088907313526,0.0431054287270894,3.96973574895459e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,28631,-0.0250922727546661,0.00280549508378577,-0.0305910431188862,-0.019593502390446,3.97518917517513e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24185,0.0278775539983389,0.00311669583209577,0.0217688301674312,0.0339862778292466,3.99497816233844e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,29409,0.0238429523366415,0.00266741614854131,0.0186148166855006,0.0290710879877825,4.1666215416925e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24539,0.0918347840700901,0.0102886108864233,0.0716691067327005,0.11200046140748,4.7247163516401e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,23979,0.0566287355434684,0.00634506316090674,0.0441924117480912,0.0690650593388456,4.77560479421582e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,29076,0.0424096649185871,0.00475652170095821,0.033086882384709,0.0517324474524652,5.10584246584996e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24435,0.0189529829787332,0.00212612226886355,0.0147857833317606,0.0231201826257057,5.24260401333207e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,29019,0.0488787204062449,0.00548468058987442,0.0381287464500911,0.0596286943623988,5.30528973233594e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,24119,0.0207151395707705,0.00232582361534052,0.0161565252847031,0.0252737538568379,5.62630990284305e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29034,0.0725212940808276,0.00815084926331373,0.0565456295247327,0.0884969586369226,6.04221400580333e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,29034,0.0369668509404867,0.00415924050827349,0.0288147395442707,0.0451189623367028,6.58054092403861e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,29409,0.02390071246912,0.00269007516255661,0.0186281651505091,0.029173259787731,6.76200188837237e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,29122,0.0419859014651441,0.00473195449826114,0.0327112706485523,0.051260532281736,7.52923536686745e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29044,0.0553596769643266,0.00624278257261855,0.0431238231219942,0.0675955308066589,7.87922005702961e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24119,0.0647058378391257,0.00731503865597102,0.0503683620734225,0.0790433136048289,9.71569112185474e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,29132,-0.0159960167132316,0.0018090418463911,-0.0195417387321582,-0.0124502946943051,9.89796363131341e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,29256,-0.0172931023216197,0.00195654841120868,-0.0211279372075888,-0.0134582674356507,1.02264565252925e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,28779,0.0721863896558227,0.00816794119010505,0.0561772249232168,0.0881955543884286,1.03093685718095e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29194,-0.0303941544322848,0.00345241124598414,-0.0371608804744138,-0.0236274283901559,1.39482349713173e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,29188,0.0401766647076058,0.00456433165331201,0.0312305746671143,0.0491227547480974,1.41276272134296e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,29077,0.0291767303089304,0.00331596921418086,0.0226774306491359,0.0356760299687249,1.45712524788164e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,28724,0.0261561197096922,0.00297743851132431,0.0203203402274965,0.0319918991918878,1.65226248929469e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,24190,0.0154554903545341,0.00176029540873978,0.0120053113534042,0.0189056693556641,1.74003434506256e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,29172,0.0786092472298407,0.00895544477077249,0.0610565754791266,0.0961619189805548,1.7559785463378e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29381,0.0416523600754601,0.00474833957082878,0.0323456145166357,0.0509591056342845,1.84844055564885e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,29034,0.0476355196721396,0.00543976539543589,0.0369735794970852,0.0582974598471939,2.11367306464174e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,24119,0.0353869576520838,0.00404510842622349,0.0274585451366857,0.0433153701674818,2.30924745863577e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,24119,-0.0175097456434008,0.00200213679839325,-0.0214339337682516,-0.0135855575185501,2.36198547181295e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24653,0.0555993608606013,0.00636570841329342,0.0431225723705462,0.0680761493506564,2.60684712088787e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,23848,0.0414648075163352,0.00474928991331469,0.0321561992862384,0.050773415746432,2.69307573194757e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29034,0.0633133865490352,0.00725821671226286,0.049087281793,0.0775394913050704,2.85141289426438e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,28988,0.0341983881510935,0.0039261710097898,0.0265030929719055,0.0418936833302815,3.18704515110087e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,29470,0.0212372995632975,0.0024389034642012,0.0164570487734631,0.0260175503531318,3.2592830359211e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,28908,0.0482958126787787,0.00554719767365468,0.0374233052384155,0.0591683201191418,3.30229849502908e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29381,0.0300818936893764,0.00346181031833324,0.0232967454654432,0.0368670419133095,3.82120938310403e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29132,0.034826667045491,0.00400957605549948,0.026967897976712,0.0426854361142699,3.9514370287382e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24602,0.0257586369899819,0.00296702756284299,0.0199432629668096,0.0315740110131542,4.13912961387813e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24529,0.0506006360438887,0.00583528022121793,0.0391634868103016,0.0620377852774759,4.52410449086418e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,29122,0.0292545433313628,0.00338555873848021,0.0226188482039416,0.035890238458784,5.85364503813234e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,24119,0.0328269859356211,0.00380029034820296,0.0253784168531433,0.0402755550180989,6.0681053877652e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,24653,0.0190034692736735,0.00220343509227078,0.0146847364928228,0.0233222020545243,6.82000604044872e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,29256,0.0413953335115884,0.00480373458987393,0.0319800137154355,0.0508106533077413,7.19308324911145e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24586,0.0242440193653615,0.00281417170825256,0.0187282428171865,0.0297597959135365,7.40918664493315e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24304,0.0339690985757029,0.00394311414644552,0.0262405948486697,0.0416976023027362,7.42610176609005e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29172,0.0407448565207388,0.00473377028783954,0.0314666667565733,0.0500230462849043,7.85164367403041e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29280,-0.0166440662033169,0.00193685996587395,-0.0204403117364298,-0.0128478206702039,8.86212646816547e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,28467,0.0372991028761975,0.00434250018248755,0.0287878025185219,0.0458104032338731,9.18855364585956e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,24683,-0.0290445361679171,0.00339047722990774,-0.0356898715385363,-0.022399200797298,1.12812254275047e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,24602,0.045425689415603,0.00530846633864376,0.0350210953918612,0.0558302834393447,1.2227265149318e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29132,0.0229236672007241,0.00268016493968248,0.0176705439189465,0.0281767904825018,1.2562806267597e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,24669,0.0502569994508323,0.00588287202143084,0.0387265702888279,0.0617874286128368,1.38303693861864e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29098,0.0211549054541158,0.00247863205148742,0.0162967866332005,0.0260130242750312,1.4697990225857e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,29226,0.0344046854164539,0.00403166342960617,0.0265026250944258,0.042306745738482,1.48595824071515e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29280,0.0177492053565636,0.00208426915918845,0.0136640378045542,0.021834372908573,1.73256121618707e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,23974,0.0540414331519169,0.00635058487148016,0.0415942868038157,0.066488579500018,1.8448212454851e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23974,0.02908474045933,0.00342605943538307,0.0223696639659792,0.0357998169526808,2.19824366422977e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,24119,0.0689652145899912,0.00812951840093808,0.0530313585241525,0.0848990706558298,2.31275053058567e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29470,0.0201904893886334,0.00238091425273559,0.0155238974532716,0.0248570813239951,2.35280572519329e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24119,0.0250747940353802,0.00295971343370864,0.0192737557053112,0.0308758323654491,2.54727680735873e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,23848,0.0454357546472104,0.00537590767495451,0.0348989756042995,0.0559725336901212,3.03199364884356e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,24361,-0.0248228637311115,0.0029385081232749,-0.0305823396527303,-0.0190633878094927,3.14174237702994e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,23974,-0.0179194085192557,0.00212202305795992,-0.0220785737128571,-0.0137602433256542,3.22449836933176e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29132,0.017641607723511,0.00208953255804332,0.0135461239097461,0.0217370915372759,3.23874915733128e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29089,0.0497706794038517,0.00589985431930297,0.0382069649380178,0.0613343938696855,3.43635786152035e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29034,-0.0388321780493004,0.00460959069697068,-0.0478669758153629,-0.0297973802832378,3.79718131192222e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,23940,0.0248798098885833,0.00295562968326399,0.0190867757093858,0.0306728440677807,4.04940720334684e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,23766,-0.0370131835626816,0.00439905859520944,-0.0456353384092921,-0.028391028716071,4.18701212602415e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPART,Spartin,24119,0.0457385164647648,0.00543841391887857,0.0350792251837628,0.0563978077457669,4.31447009271306e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,28612,0.0213685899251108,0.00255060977248775,0.0163693947710348,0.0263677850791867,5.63467712083388e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23974,0.0329215022997297,0.00393249834094494,0.0252138055514776,0.0406291990479818,5.98853308920474e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,28907,0.0397913414078279,0.00475438757904176,0.030472741752906,0.0491099410627497,6.0495750556622e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,29470,0.0330628507174697,0.00395102564563319,0.0253188404520286,0.0408068609829107,6.10752928468564e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29507,0.0186412781905255,0.0022306036507343,0.0142692950350863,0.0230132613459647,6.70919612183436e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,29271,0.0237067224367659,0.00284034382267601,0.018139648544321,0.0292737963292109,7.3419941881998e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,28853,0.0137593419944498,0.00164988983605602,0.01052555791578,0.0169931260731196,7.78537711191069e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,29122,-0.0249921831549566,0.00299858435155284,-0.0308694084840001,-0.019114957825913,8.11002647918108e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,23940,0.0253654836316941,0.00304913916336162,0.0193891708715053,0.0313417963918829,9.34644021797479e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,24119,0.0325511865091611,0.003921078834976,0.0248658719926081,0.040236501025714,1.08057602692943e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24185,0.0617454883022884,0.00743897903909869,0.047165089385655,0.0763258872189218,1.09251667629055e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28491,0.0300416499924608,0.00362169378508393,0.0229431301736963,0.0371401698112253,1.13400476758564e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,29271,0.0387504604509839,0.00467614913591353,0.0295852081445933,0.0479157127573744,1.21220951059264e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28491,0.0346640067238004,0.00418744507416207,0.0264566143784428,0.0428713990691581,1.30592284928292e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,24529,0.0279903808849478,0.0033813201510169,0.0213629933889547,0.0346177683809409,1.31637090715869e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29066,0.0379200512769077,0.00458200151328721,0.0289393283108647,0.0469007742429506,1.3292030876943e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24119,0.0496071949103463,0.00599808494128923,0.0378509484254194,0.0613634413952732,1.40208930457546e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,29057,0.0396910303016001,0.00480009302422623,0.0302828479741167,0.0490992126290835,1.41020810911261e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25698,-0.0180574879995267,0.00218404747495467,-0.0223382210504378,-0.0137767549486155,1.42859579678742e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,29132,0.0301754914459081,0.0036525464151886,0.0230165004721384,0.0373344824196777,1.49895268122217e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29034,0.0316929220147073,0.00383781664538681,0.0241708013897492,0.0392150426396655,1.54280885544384e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,24683,0.039986100477402,0.00484184874406752,0.0304960769390296,0.0494761240157743,1.54915777039725e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,24539,0.0596245842909499,0.00721995681398495,0.0454734689355394,0.0737756996463604,1.55133871399998e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24529,0.0499903616227571,0.00606710380535159,0.038098838164268,0.0618818850812462,1.81372730719269e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24185,0.0287126868465923,0.00348589399750573,0.021880334611481,0.0355450390817035,1.85710814927353e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,29122,0.03916861880236,0.0047581823725156,0.0298425813522295,0.0484946562524906,1.91977665528285e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,24185,0.0196709520778575,0.00238956848703095,0.0149873978432768,0.0243545063124381,1.93304275813311e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,24119,0.042763569687914,0.00519665933994197,0.0325781173816278,0.0529490219942003,1.98153668993308e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,28491,0.0251599086899921,0.00305847423000075,0.0191652991991906,0.0311545181807936,2.01240014769905e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29132,0.0165091059419395,0.00200711991096323,0.0125751509164516,0.0204430609674274,2.0277651226612e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24529,0.0622659303896545,0.00757282100018705,0.0474232012292879,0.0771086595500211,2.09448253017323e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,28908,0.0577251635546731,0.00703262179240757,0.0439412248415542,0.0715091022677919,2.33779771663661e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24683,0.0154892900086088,0.00188793667857277,0.0117889341186061,0.0191896458986114,2.43047213276964e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,24460,0.0198811900936844,0.00242552014462259,0.0151271706102241,0.0246352095771447,2.59142890426303e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29507,-0.00909974472250862,0.00111035374238734,-0.0112760380575878,-0.00692345138742943,2.59868764122324e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,23974,0.0507471795744586,0.00619399359397543,0.0386069521302667,0.0628874070186504,2.67482094925964e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,23974,0.0330485226175163,0.00403512481644501,0.0251396779772841,0.0409573672577486,2.73660003868894e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24119,-0.016184789887158,0.0019770097287904,-0.0200597289555871,-0.0123098508187288,2.82121475734071e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28467,0.0386477149893141,0.00472241863120512,0.0293917744721521,0.0479036555064761,2.86209461300911e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,24651,0.0211171208864079,0.00258078838440794,0.0160587756529683,0.0261754661198474,2.91489905568138e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24602,0.0654463058369883,0.00800383662673932,0.0497587860485792,0.0811338256253974,3.05253099717605e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,24653,0.0307740950577734,0.00376502971814537,0.0233946368102085,0.0381535533053384,3.13412893255069e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29034,0.0505765975340436,0.00618886187519797,0.0384464282586556,0.0627067668094317,3.15026827699558e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,23979,0.052834748759688,0.00647256252613488,0.0401485262084637,0.0655209713109124,3.43081812609353e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29409,0.0307942536238186,0.00377308267756402,0.0233990115757931,0.0381894956718441,3.43800816175256e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29172,-0.0226389543139369,0.00277450545473652,-0.0280769850052205,-0.0172009236226533,3.49429018927159e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24529,0.0165531707969435,0.00202885641441552,0.0125766122246891,0.0205297293691979,3.54260468640045e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24579,0.0305226245103167,0.00374183855247246,0.0231886209474707,0.0378566280731628,3.59375316110857e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,23243,0.0706596861262319,0.00866859351140535,0.0536692428438774,0.0876501294085864,3.78276936828981e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29470,-0.016285379345687,0.00200080815433259,-0.0202069633281789,-0.0123637953631952,4.12752980561016e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,28908,0.0188687366882058,0.00231915485252765,0.0143231931772516,0.02341428019916,4.24656123283439e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,23979,0.0173990619101066,0.00214089154842982,0.0132029144751842,0.0215952093450291,4.61060545916504e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,29122,0.0225398273030222,0.00277773826568355,0.0170954603022824,0.0279841943037619,5.07029976498396e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23974,0.0204404571200415,0.00252093783506666,0.0154994189633108,0.0253814952767721,5.3780708019596e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,28239,0.0433893296829612,0.0053590480075459,0.0328855955881713,0.0538930637777512,5.88398856711823e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,23948,0.0323585826305114,0.00400277309291163,0.0245131473684046,0.0402040178926182,6.55969718695422e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29256,0.0408053315967305,0.00506635423482939,0.0308752772964649,0.0507353858969961,8.30309558703903e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29271,0.0619283551447346,0.00769725664736675,0.0468417321158957,0.0770149781735734,8.91108095978673e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,24539,0.0438119952790619,0.00544529636544761,0.0331392144027846,0.0544847761553392,8.95029904523075e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23974,0.0198496912840328,0.00246926363235785,0.0150099345646114,0.0246894480034542,9.49528113352276e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,29034,-0.0432275117497077,0.00538494715619935,-0.0537820081758585,-0.032673015323557,1.0323390015727e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,29172,0.0239616485888407,0.0029862438224912,0.018108610696758,0.0298146864809235,1.0616224932692e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24653,0.0226073048408868,0.00281839079356718,0.0170832588854951,0.0281313507962784,1.0920768486408e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,29507,0.0237918186214901,0.00297034169623657,0.0179699488968664,0.0296136883461138,1.19104969778448e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,28908,-0.0642070934436491,0.00802500510544108,-0.0799361034503136,-0.0484780834369846,1.28126869224233e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24471,-0.0152431440390511,0.0019052193701422,-0.0189773740045298,-0.0115089140735723,1.29133237167479e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29172,-0.0178225487507449,0.00223037255865225,-0.0221940789657033,-0.0134510185357865,1.38934982859197e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,24067,0.0577664235192165,0.00723391728530275,0.0435879456400231,0.0719449013984099,1.46180676252818e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,23979,0.030599360657991,0.00383378222047543,0.0230851475058592,0.0381135738101228,1.50995919877135e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24579,0.0546000126870835,0.00685058482500132,0.0411728664300809,0.0680271589440861,1.65360158190029e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,29127,0.0215596092697531,0.00270733551485395,0.0162532316606394,0.0268659868788669,1.73427939011323e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29271,0.0153732328465229,0.0019308411649688,0.011588784163184,0.0191576815298617,1.7546544304256e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,23848,0.0373767965578674,0.00469429723219926,0.0281759739827569,0.046577619132978,1.76545222355487e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,24579,0.0518158463803801,0.00650968994665376,0.0390568540849387,0.0645748386758215,1.79716659980746e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,29327,-0.0141624509079025,0.00177946809892553,-0.0176502083817965,-0.0106746934340084,1.79930491936004e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,29327,0.0388202341267532,0.0048813431610173,0.0292528015311593,0.0483876667223471,1.88898342635184e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23470,0.0276497812067417,0.00347668355008472,0.0208354814485757,0.0344640809649078,1.903430107653e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,29132,-0.013384725958812,0.00168665157742215,-0.0166905630505595,-0.0100788888670646,2.16819135961869e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,23940,0.0381998140667922,0.00481459202209755,0.028763213703481,0.0476364144301034,2.21130362411865e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29093,-0.0308455153209138,0.00390326991610518,-0.03849592435648,-0.0231951062853477,2.83016632778877e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,23848,0.0266077625137721,0.00336797379015655,0.0200065338850652,0.0332089911424789,2.90359505448153e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29122,0.0337564446328642,0.00428011883965369,0.025367411707143,0.0421454775585854,3.20831846917739e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29314,-0.0111907470582141,0.00141951653057588,-0.0139729994581429,-0.00840849465828538,3.29354662954301e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,29132,0.014791642428623,0.0018785039800797,0.0111097746276668,0.0184735102295792,3.5490675628455e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,24510,0.0522242125776572,0.00663326031235326,0.0392230223654449,0.0652254027898696,3.60270645702613e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24653,0.0166743494891197,0.00211968673160199,0.0125197634951798,0.0208289354830596,3.7983496835491e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29256,-0.0159347630796254,0.00202782160952532,-0.019909293434295,-0.0119602327249557,4.03428857652867e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,29172,-0.0205199849787596,0.00261273419177565,-0.0256409439946398,-0.0153990259628793,4.17301395268921e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,24185,0.0300094884690059,0.00382139149617842,0.0225195611364962,0.0374994158015156,4.22915875820985e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,23974,0.0311658816699601,0.00396959118148037,0.0233854829542586,0.0389462803856617,4.29406988754481e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,23979,0.0404791676260648,0.00516076825392925,0.0303640618483634,0.0505942734037661,4.55875498854333e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,23979,-0.0234913928445809,0.00299683990950884,-0.0293651990672182,-0.0176175866219436,4.74012432752323e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,29256,0.0343038202789641,0.004385557471347,0.025708127635124,0.0428995129228042,5.37357542850362e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,24699,-0.0166877598872709,0.00213518685314726,-0.0208727261194395,-0.0125027936551022,5.68760279132822e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24539,0.0263109308869101,0.00336670539666086,0.0197121883094548,0.0329096734643654,5.71428234909158e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,29122,0.0427064217713152,0.00547281667977645,0.0319797010789534,0.053433142463677,6.228699824423e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24529,0.0374410262888891,0.00480795536982841,0.0280174337640255,0.0468646188137528,7.11509579672647e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,29143,0.017350672243397,0.00223143206139412,0.0129770654030645,0.0217242790837295,7.75741303115171e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,24579,0.0252397567009859,0.00324730236765093,0.01887504406039,0.0316044693415817,7.99372584959214e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28631,0.0234903842962952,0.00302576166575535,0.0175598914314147,0.0294208771611757,8.53922289549103e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,23144,0.0133114100231168,0.00171622506021915,0.0099476089050873,0.0166752111411464,9.1103686148846e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24539,0.0164213922629719,0.00212057086209663,0.0122650733732625,0.0205777111526813,1.00163815365735e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,28975,0.0326362933385993,0.004217277376481,0.0243704296806966,0.0409021569965021,1.03689064216357e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29145,0.0210356132761026,0.0027200262529314,0.0157043618203571,0.0263668647318481,1.07905934800014e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,24579,0.0455811055767527,0.00589840664747252,0.0340202285477065,0.0571419826057988,1.13686368694818e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29271,0.0702365901484577,0.00909070975043285,0.0524187990376094,0.0880543812593061,1.14346243573271e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,23974,0.0189897919760137,0.00245925852232553,0.0141696452722557,0.0238099386797718,1.19214540894441e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,23940,0.0266705956195391,0.00345712380958408,0.0198946329527544,0.0334465582863239,1.26009217216657e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,29172,0.0288480067503348,0.00374220850203535,0.0215132780863455,0.0361827354143241,1.31018430606575e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,29409,0.0232285378726193,0.00301481352235809,0.0173195033687974,0.0291375723764411,1.35164469991771e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,28979,0.0164091019134978,0.0021348429453603,0.0122248097405916,0.020593394086404,1.56201218389099e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24539,0.0488880607127579,0.00636008903828317,0.0364222861977229,0.0613538352277929,1.56633060189122e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24579,0.0160553673180461,0.00209055884514676,0.0119578719815584,0.0201528626545337,1.65085621043315e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,29009,0.0423807810906993,0.00552631608251542,0.0315492015689691,0.0532123606124296,1.78897789942256e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24579,-0.0165466819612556,0.00216016830502619,-0.0207806118391069,-0.0123127520834042,1.92924372936775e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29293,0.0175551197765161,0.00229295184858748,0.0130609341532847,0.0220493053997476,1.97524681262726e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,24491,0.0473500892910469,0.00619341667973942,0.0352109925987576,0.0594891859833362,2.1622377175698e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24065,0.0292304320838456,0.00382444683271765,0.021734516291719,0.0367263478759722,2.2005021054831e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24119,0.0216990412525384,0.00284058775926974,0.0161314892443697,0.0272665932607071,2.27173375220804e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,24579,0.0118781601831528,0.00155750571084748,0.00882544898989176,0.0149308713764139,2.50136970097796e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29260,0.0597343397116535,0.00784040709103165,0.0443671418132315,0.0751015376100755,2.63815984229911e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24539,0.0475342883031586,0.00624552550631255,0.035293058310786,0.0597755182955312,2.81903606834025e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29172,0.0443798678208075,0.0058316896328328,0.0329497561404552,0.0558099795011598,2.82094017376103e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29145,0.0277054195677346,0.00364209131986589,0.0205669205807975,0.0348439185546718,2.88964356685968e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,24669,-0.0167576215015516,0.00220343154388066,-0.0210763473275576,-0.0124388956755455,2.94518856821872e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,29507,0.0468676899411225,0.00616495379661422,0.0347843804997586,0.0589509993824864,2.99599639201142e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,29311,0.0315058422144497,0.00414435822879256,0.0233829000860162,0.0396287843428831,3.00059714825081e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28467,0.027303048380508,0.00359731101955969,0.020252318782171,0.034353777978845,3.30071835772309e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29381,0.0300944096425501,0.00397499762665473,0.0223034142943068,0.0378854049907934,3.8144136296897e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28612,0.0183829334879093,0.00242981088984504,0.013620504143813,0.0231453628320055,3.97729835880528e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24529,0.0272807219421273,0.00360620200661104,0.0202125660091696,0.0343488778750849,4.01649093809966e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,29172,0.0348550791104103,0.00462356361816913,0.0257928944187988,0.0439172638020218,4.88931696370761e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24522,0.0227899183353317,0.00302461339666111,0.0168616760778759,0.0287181605927875,5.05908230134741e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,29122,0.0309470274135286,0.00411158935737857,0.0228883122730666,0.0390057425539906,5.35102170936699e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24539,0.0463114642745217,0.0061537870065836,0.0342500417416178,0.0583728868074255,5.42469999724178e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29381,-0.0145462201364298,0.00193311088541993,-0.0183351174718528,-0.0107573228010067,5.43233414307863e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23848,0.01477338956784,0.00196454110344657,0.0109228890050847,0.0186238901305953,5.66995415218147e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24539,0.0308378711781995,0.00410097480650344,0.0227999605574528,0.0388757817989463,5.68072275058637e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,24683,0.012860024784674,0.00171263862297017,0.00950325308365248,0.0162167964856955,6.16473327993407e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,24653,0.0290542975431386,0.00387754790475262,0.0214543036498234,0.0366542914364537,6.96030085333835e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28238,0.0640224311516665,0.00855349542884065,0.0472575801111388,0.0807872821921942,7.36655069541549e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23974,0.0229534208528745,0.00306856424824822,0.016939034926308,0.028967806779441,7.6768830295183e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,24579,0.0523064438084839,0.00699713431955032,0.0385920605421653,0.0660208270748025,7.95348835777327e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29034,0.0295404919309046,0.00395699254319545,0.0217847865462415,0.0372961973155677,8.53839953305948e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29423,0.0170597474422228,0.00228522761904226,0.0125807013088999,0.0215387935755456,8.54569275014154e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,28631,0.0345330295179552,0.00462872237741943,0.0254607336582131,0.0436053253776973,8.8576947541426e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23974,0.0418787672061939,0.00561947576061433,0.0308645947153898,0.052892939696998,9.47355371477447e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24602,0.0201455364804782,0.0027043091375198,0.0148450905709393,0.025445982390017,9.68365968136884e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,23979,0.042295537235346,0.00567958837722783,0.0311635440159794,0.0534275304547125,9.87550938861366e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28491,0.0174773476110431,0.00234755826924292,0.012876133403327,0.0220785618187592,9.97592061228977e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24579,0.0194393552032111,0.00261225226434496,0.014319340765095,0.0245593696413273,1.02730825140517e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29226,0.0265741722585214,0.00357138793996641,0.0195742518961873,0.0335740926208556,1.02789546510995e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,28908,0.0270838803878437,0.00364750399277849,0.0199347725619979,0.0342329882136896,1.15612400884963e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28491,0.0204550526084625,0.00277176983875837,0.0150223837244961,0.0258877214924289,1.62882449648749e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,29132,-0.0163262227336926,0.00221297589561994,-0.0206636554891077,-0.0119887899782776,1.65596187329457e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,29100,0.0312600457742139,0.00424013498361284,0.0229493812063328,0.0395707103420951,1.72024132834796e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,24579,0.0366444278301743,0.00497153126672665,0.02690022654739,0.0463886291129585,1.74893248058329e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29215,0.0615660832009123,0.00836542647640194,0.0451698473071645,0.0779623190946601,1.89340436001277e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29100,-0.0090705367213016,0.00123468187041864,-0.0114905131873221,-0.00665056025528106,2.088757802872e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28612,0.0275081390519731,0.00374577292332675,0.0201664241222526,0.0348498539816935,2.13181085966513e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,24683,0.047095925454189,0.00641711797440453,0.0345183742243561,0.0596734766840219,2.21667025438115e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,23974,-0.0135976971270262,0.00185385436468158,-0.0172312516818021,-0.00996414257225028,2.29063013840751e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29256,0.042954849428005,0.00585727523174342,0.0314745899737879,0.0544351088822221,2.2988193967302e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24119,0.0425587108146983,0.00580576119593969,0.0311794188706565,0.0539380027587401,2.3664491093131e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,29172,-0.0360341692134786,0.00491664204177152,-0.0456707876153507,-0.0263975508116064,2.37857954726898e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDK,Midkine,29146,0.0260869075639571,0.00356172826136998,0.0191059201716719,0.0330678949562422,2.46504056868883e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24602,0.0302804422771913,0.00413494789774992,0.0221759443976014,0.0383849401567811,2.4984368743156e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,28631,0.0473612821187485,0.00646966573386288,0.0346807372803772,0.0600418269571197,2.53525053025008e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24653,-0.018239081013895,0.00249276133048352,-0.0231248932216427,-0.0133532688061473,2.61682959862936e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23924,0.0142480864287511,0.00194747279206581,0.0104310397563021,0.0180651331012001,2.63142841213386e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,29146,-0.0326771158671194,0.00446821581753101,-0.0414348188694802,-0.0239194128647586,2.67500838849343e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,29381,-0.0149344133160873,0.00204338393114945,-0.0189394458211402,-0.0109293808110343,2.76679878399102e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,23974,0.0441534892075379,0.00606027785396923,0.0322753446137582,0.0560316338013176,3.29850008389376e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,29132,0.0373865254942162,0.00513335543598852,0.0273251488396787,0.0474479021487537,3.34607982260299e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,24035,0.0335694699243077,0.00461322345823053,0.0245275519461759,0.0426113879024396,3.52342587221094e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,24529,0.0208078565590525,0.00286182297746596,0.0151986835232192,0.0264170295948858,3.67965508677474e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24185,0.0287332853482042,0.00395717618125199,0.0209772200329503,0.0364893506634581,3.95687891266995e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28491,0.0430998929987205,0.00593763850223256,0.0314621215343447,0.0547376644630964,4.00648009717412e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,24529,0.0201369216004709,0.00277521409310493,0.0146975019779852,0.0255763412229565,4.10591251620757e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29127,0.0244674857067098,0.00338093724074824,0.0178408487148433,0.0310941226985764,4.70422534510573e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28612,0.0209825224441693,0.00289983397344542,0.0152988478562162,0.0266661970321223,4.74549072010682e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,23974,0.0460211482714404,0.00637006091569148,0.0335358288766851,0.0585064676661957,5.1760316422123e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,24683,-0.0304503248527276,0.00421572052414085,-0.0387131370800437,-0.0221875126254115,5.2312041820417e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24602,0.0432222477311915,0.00599177172791734,0.0314783751444735,0.0549661203179095,5.60690871195356e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,24119,0.05485648776676,0.00760770292479773,0.0399453900341564,0.0697675854993635,5.73274069060944e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29034,0.0301885147430716,0.00418982764620707,0.0219764525565057,0.0384005769296375,5.93743635242054e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,29172,0.0195627348081773,0.00271529505615387,0.0142407564981157,0.0248847131182389,5.96065447816047e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,24467,0.023537305086511,0.00326930821063304,0.0171294609936702,0.0299451491793518,6.21906086770719e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,29104,0.0457538534015428,0.00635815200551782,0.0332918754707279,0.0582158313323578,6.34610866797233e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,29226,-0.0158499392451412,0.0022031395164808,-0.0201680926974436,-0.0115317857928388,6.43155967513039e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24669,0.0254633545817294,0.00353922458520308,0.0185264743947314,0.0324002347687274,6.44273510470647e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,24683,0.0359196309089904,0.00499816334853655,0.0261232307458587,0.045716031072122,6.83299290052001e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28515,0.024269181676615,0.00337963422716472,0.0176450985913722,0.0308932647618579,7.08936750173423e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,28908,-0.0255160399685245,0.00355688241643967,-0.0324875295047463,-0.0185445504323028,7.47483713423037e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28491,0.0259859484393561,0.00362284468700182,0.0188851728528326,0.0330867240258797,7.52706816297819e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29122,0.0189045534683648,0.00263798116645659,0.0137341103821098,0.0240749965546197,7.888633205707e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24653,0.0451675265319448,0.0063027518472744,0.032814132911287,0.0575209201526027,7.92098037656235e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,24119,0.0347344604896926,0.00485106252300515,0.0252263779446025,0.0442425430347827,8.28843870465006e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24529,0.0219325854732917,0.00306521479008952,0.0159247644847163,0.0279404064618672,8.58265587892466e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24602,0.0397781675129346,0.00556072904576032,0.0288791385832444,0.0506771964426248,8.7019477192664e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,29234,0.0149087534106693,0.00208631392109397,0.0108195781253251,0.0189979286960135,9.14501195342269e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,24535,0.016131546921402,0.00225800958799973,0.0117058481289226,0.0205572457138815,9.30878486324482e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,23940,0.0228053580970448,0.0031954454261773,0.0165422850617373,0.0290684311323523,9.82303488724631e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,23848,0.0343303049812292,0.00481134843596468,0.0249000620467385,0.04376054791572,9.93557182608508e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,23979,0.0587713569780264,0.00826182523060102,0.0425781795260484,0.0749645344300044,1.16228558485803e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23979,0.0240161645733704,0.00337612516212219,0.0173989592556109,0.0306333698911299,1.1629195679886e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,23979,0.0305287856455522,0.00429706890676852,0.0221065305882859,0.0389510407028185,1.2408190039892e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24416,0.0301032738200347,0.00425362617749005,0.0217661665121542,0.0384403811279152,1.51199124164305e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,29187,-0.0164936438607249,0.00233183140396897,-0.0210640334125041,-0.0119232543089457,1.54747270940069e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,29132,0.0123813462049221,0.00175100859917764,0.0089493693505339,0.0158133230593103,1.57311234205648e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24602,0.0235476789879638,0.00333183116022847,0.0170172899139159,0.0300780680620116,1.61973152990169e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,24539,0.028169352862562,0.00398900791386273,0.020350897351391,0.0359878083737329,1.68811238064869e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",28853,0.0361461733159387,0.00511986695537222,0.0261112340834091,0.0461811125484682,1.70289753939693e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,23979,0.0449075900520964,0.00636735394080889,0.032427576328111,0.0573876037760818,1.80133414941023e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29077,-0.0237407506969135,0.00337032044991524,-0.0303465787787474,-0.0171349226150797,1.9086638493469e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,29172,-0.0168240208528812,0.00239020414031159,-0.0215088209678919,-0.0121392207378704,1.98276581171962e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",28853,0.0473223048073206,0.00672391552790744,0.034143430372622,0.0605011792420192,1.99505895644675e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,29132,0.0373453077488745,0.00531077504129645,0.0269361886679335,0.0477544268298156,2.08100694186896e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,24602,0.0285643617687463,0.00406351625308338,0.0205998699127028,0.0365288536247897,2.12736818027242e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24539,-0.0347851068368231,0.00495044437801246,-0.0444879778177275,-0.0250822358559187,2.17062127110076e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,28491,0.0188196063608043,0.00268066519702266,0.0135655025746398,0.0240737101469687,2.2603134497393e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29409,-0.0283355739724672,0.00403994900766824,-0.036253874027497,-0.0204172739174374,2.36869514472683e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28491,0.0374532102876066,0.00534092090741049,0.026985005309082,0.0479214152661311,2.39317667581499e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24602,0.0240227756594793,0.00342981599053672,0.0173003363180274,0.0307452150009313,2.54978859839602e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,23940,0.0238126300005227,0.00339978518681905,0.0171490510343574,0.0304762089666881,2.55054781728062e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,28631,0.0238123831586768,0.00340267620172432,0.0171431378032972,0.0304816285140565,2.65105070500668e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,29226,0.02806699780606,0.00401481316927858,0.020197963994274,0.035936031617846,2.79072607539883e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24579,0.0188182390447903,0.00269562931111182,0.0135348055950111,0.0241016724945694,3.00502014710929e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,28491,0.0256645290405529,0.00367731899181559,0.0184569838165944,0.0328720742645115,3.03489953367591e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24602,0.0328933558958382,0.00471488159081459,0.0236521879778416,0.0421345238138348,3.10303251025665e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,23843,0.0314302176509634,0.00450986406365272,0.0225908840862041,0.0402695512157228,3.27016915020094e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,28331,0.0546238448144636,0.00784019353333419,0.0392570654891286,0.0699906241397986,3.30484758871863e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,23756,0.0274944426001481,0.00395123489388038,0.0197500222081425,0.0352388629921536,3.52997833182978e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29122,0.0211420903583349,0.00303912087101791,0.0151854134511398,0.02709876726553,3.55832640853596e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23935,0.0175296726518464,0.00252147082952244,0.0125875898259824,0.0224717554777103,3.68978377482013e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24470,0.0243420607517888,0.00350142113018187,0.0174792753366324,0.0312048461669453,3.69060689465741e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,24579,0.0330905088604277,0.00476493815378745,0.0237512300790043,0.0424297876418511,3.89037600259385e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,28739,0.0333486333006948,0.00481363166397622,0.0239139152393014,0.0427833513620881,4.35958893610714e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,29132,-0.0221124473732766,0.00320188524842668,-0.0283881424601929,-0.0158367522863603,5.08488162501224e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,28902,-0.016305278731764,0.00236150656163206,-0.0209338315925629,-0.0116767258709652,5.13828271248123e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24539,0.0500855498303566,0.00725654894283673,0.0358627139023966,0.0643083857583166,5.24811526274075e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,28908,0.0184245641765441,0.00267257441358778,0.0131863183259121,0.0236628100271762,5.53833412941511e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29056,0.032206646428687,0.00467235560727346,0.0230488294384311,0.041364463418943,5.57354999503843e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,28853,0.0365061747199968,0.00529965259088063,0.0261188556418707,0.0468934937981228,5.75774688979662e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28491,0.0325505870140694,0.0047274343728211,0.02328481564334,0.0418163583847987,5.8793812233155e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28467,0.0539644299631036,0.0078520945887572,0.0385743245691395,0.0693545353570677,6.43343977508422e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29256,-0.0117029214651138,0.00170349115308453,-0.0150417641251595,-0.00836407880506812,6.55041408369367e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C3,Complement C3,23519,0.0223798356228232,0.0032681840109928,0.0159741949612773,0.0287854762843691,7.68480785870218e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,24669,0.0399297460763396,0.00583148555803371,0.0285000343825935,0.0513594577700857,7.70404500381899e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24185,0.0353877416682483,0.00517618774863112,0.0252424136809313,0.0455330696555653,8.30007560660932e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,23848,0.0338212234643542,0.00494784932532149,0.0241234387867241,0.0435190081419843,8.36676043501484e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,29280,-0.027898364096182,0.00409054397497774,-0.0359158302871383,-0.0198808979052256,9.26752072913828e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,24579,0.0218060017325157,0.00320203695442622,0.0155300093018403,0.028081994163191,9.98209381945474e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28467,0.0352972627472512,0.00518423362977581,0.0251361648328906,0.0454583606616118,1.00525425725645e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28612,0.0528669626002444,0.00778097641956759,0.0376162488178919,0.0681176763825968,1.10906055743729e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,23848,0.0171675895260629,0.00252674426551928,0.0122151707656451,0.0221200082864807,1.11363462881143e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29122,0.047554257796308,0.00700271923717281,0.0338289280914493,0.0612795875011667,1.13634236001926e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,24635,-0.0170865592788832,0.00252122599116587,-0.0220281622215683,-0.012144956336198,1.25393225932584e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28491,0.027503768719478,0.00405951095208292,0.0195471272533955,0.0354604101855606,1.26701837611332e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24602,0.0224929067265109,0.00331997373254423,0.0159857582107242,0.0290000552422976,1.27191693270235e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,29188,0.0441984364251494,0.00652543263345354,0.0314085884635804,0.0569882843867183,1.28303399911436e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29256,0.012769479146361,0.00188689342840454,0.0090711680266881,0.0164677902660339,1.33533674219812e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29122,0.0174115035006839,0.0025728969066375,0.0123686255636744,0.0224543814376934,1.33716399765951e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28612,0.0167617362949911,0.00247743306816495,0.0119059674813878,0.0216175051085944,1.35160086975621e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,23979,0.024420062704178,0.00361088287797944,0.0173427322633383,0.0314973931450177,1.38361352077477e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAX,Protein max,28467,0.0498759238156394,0.00738273495508279,0.0354057633036771,0.0643460843276017,1.4483340127603e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24529,0.0448140296369515,0.00663498031528464,0.0318094682189936,0.0578185910549094,1.46830592948038e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,23843,0.0471449132218928,0.00698794982144096,0.0334485315718685,0.0608412948719171,1.54815803551192e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29132,-0.0169691220818994,0.00251777384647617,-0.0219039588209927,-0.0120342853428061,1.61636421030056e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24653,0.0464176651609287,0.00689449357119676,0.0329044577613831,0.0599308725604744,1.70353519726243e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29034,0.00988262542477902,0.00147136932597217,0.00699874154587356,0.0127665093036845,1.89422834610075e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,24699,0.0125908862856578,0.00187521077116983,0.00891547317416492,0.0162662993971507,1.92958911624559e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24653,0.0119380800077955,0.00177986453704497,0.00844954551518737,0.0154266145004037,2.02553932094631e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,28415,0.0425816621966934,0.00634999428856722,0.0301356733911017,0.0550276510022852,2.04087651091728e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,29061,0.0313359381899268,0.00467320281950104,0.0221764606637048,0.0404954157161489,2.0446072046197e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24653,0.041739866523468,0.00622675443365841,0.0295354278334975,0.0539443052134384,2.08150114322254e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,28415,0.0334603033209153,0.00500033267125893,0.0236596512852478,0.0432609553565828,2.24821620909888e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24119,0.0559188214389059,0.0083618155675358,0.0395296629265357,0.0723079799512761,2.32135668509305e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,24567,-0.0222203624975185,0.00332345116794754,-0.0287343267866957,-0.0157063982083414,2.3438417618831e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24539,0.022135245842117,0.00331520751460913,0.0156374391134831,0.0286330525707509,2.49294460379754e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,28861,0.024133765317883,0.00361539608030555,0.0170475890004841,0.0312199416352819,2.51238464051259e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,23848,0.032471678002805,0.00487187190220125,0.0229228090744905,0.0420205469311194,2.70197234673119e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,28908,0.0159556527033564,0.00240018225811798,0.0112512954774452,0.0206600099292676,3.03038850489375e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,29034,0.0383719099069544,0.00577794798256967,0.0270471318611179,0.049696687952791,3.16852454126136e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,23848,0.0311248936877085,0.00469064562421598,0.0219312282642451,0.0403185591111718,3.30286906505409e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28612,0.0410121884261857,0.0061848127842085,0.0288899553691371,0.0531344214832344,3.39097741457813e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,23979,0.0112112909215883,0.00169112447381879,0.00789668695290346,0.0145258948902731,3.44011218774958e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,28491,0.0269527436126773,0.00406986832326705,0.0189758016990739,0.0349296855262807,3.59431832083664e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29381,-0.0211245845669248,0.00319455678494189,-0.0273859158654109,-0.0148632532684387,3.83891846212471e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24539,0.0354058496001462,0.00535504624850114,0.0249099589530839,0.0459017402472084,3.87791265839397e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,28727,0.0134796163231263,0.00204645506232286,0.00946856440097344,0.0174906682452791,4.57128024761784e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29507,0.0102640659618968,0.00155912023525173,0.00720819030080341,0.0133199416229902,4.68018813890771e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,23979,0.0239083219278122,0.00364157244334456,0.0167708399388569,0.0310458039167676,5.29604943610702e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,29034,0.014018130394817,0.00214127651048152,0.00982122843427323,0.0182150323553608,5.98340691899777e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,28965,-0.0131520565095869,0.00201235968473046,-0.0170962814916586,-0.00920783152751524,6.43903193941086e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,29470,0.0355175281896212,0.00544227326947851,0.0248506725814433,0.0461843837977991,6.85400768591805e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,28467,0.0281333493688769,0.00431304020431967,0.0196797905684104,0.0365869081693435,7.01368332768074e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,23940,0.028622767509887,0.00438829557237885,0.0200217081880245,0.0372238268317496,7.05138348833039e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,23979,0.0354201217223895,0.00543256872744649,0.0247722870165944,0.0460679564281847,7.17265642151604e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28631,-0.0180270063421855,0.0027671206919544,-0.0234505628984161,-0.0126034497859549,7.40353861951217e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29231,-0.0124649702567495,0.00191584436894341,-0.0162200252198786,-0.00870991529362041,7.82932831605597e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,24602,0.0349147483292511,0.00537407812191221,0.0243815552103032,0.045447941448199,8.35702358465903e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24635,0.0218801980082993,0.00337206695561737,0.0152709467752893,0.0284894492413094,8.82485055055455e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,24567,0.0117295776898916,0.00181331432547055,0.00817548161196936,0.0152836737678139,1.00787119965733e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,29280,-0.0136892281599851,0.00211808476834332,-0.017840674305938,-0.00953778201403218,1.04245699313639e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,24185,0.023990980966851,0.00371974346614008,0.0167002837732164,0.0312816781604855,1.14240745273806e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,28612,0.0381545888583626,0.00591633475887587,0.0265585727309659,0.0497506049857593,1.14367934857176e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29122,-0.0211599289971229,0.0032831659955835,-0.0275949343484666,-0.0147249236457792,1.17425301910559e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24602,0.0399977920477217,0.0062135267639947,0.0278192795902921,0.0521763045051513,1.23931490048376e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,23848,0.0267665455212087,0.0041588291528299,0.0186152403816621,0.0349178506607553,1.24931979364989e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24539,0.0239231929064174,0.00371781023671583,0.0166362848424544,0.0312101009703804,1.25956817279034e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,24669,-0.0225424436514742,0.00350532053582923,-0.0294128719016995,-0.0156720154012489,1.29155516215434e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28467,0.0172712868825676,0.00269101219239163,0.0119969029854799,0.0225456707796551,1.40121827256587e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,24653,0.0323741297397461,0.00504540432607602,0.0224851372606371,0.0422631222188551,1.4192255210601e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23979,0.0460193190150662,0.00719073882220189,0.0319254709235505,0.0601131671065819,1.58453733312781e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,29129,-0.0264462778022621,0.00413292387291677,-0.0345468085931789,-0.0183457470113452,1.58849941842562e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29122,0.0366376475469837,0.00573321168933342,0.0254005526358902,0.0478747424580772,1.67928307513537e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,23979,0.0130985893676031,0.00205350647042685,0.00907371668556649,0.0171234620496397,1.81922571995548e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,28829,-0.0279382759547312,0.00438314200411516,-0.036529234282797,-0.0193473176266655,1.86908902694382e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,29327,0.0323567807637704,0.00507851887638576,0.0224028837660543,0.0423106777614865,1.90209798049839e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,29372,0.0417416420676971,0.00655250568190029,0.0288987309311725,0.0545845532042217,1.91410514978918e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24185,0.0338219639699176,0.00531388227342864,0.0234067547139974,0.0442371732258377,1.9901252493914e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,28712,0.0333875328021557,0.00526262454374403,0.0230727886964174,0.043702276907894,2.26807092085245e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29280,-0.0152801321229017,0.00241342381444603,-0.0200104427992159,-0.0105498214465874,2.46613412887949e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,24119,0.0381422988418907,0.00602556648494194,0.0263321885314045,0.0499524091523769,2.49353970226581e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,29381,-0.0102732122435051,0.0016234811280629,-0.0134552352545084,-0.00709118923250182,2.52116393926776e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,29172,0.030214205948459,0.00478991045616001,0.0208259814543854,0.0396024304425327,2.86929625684701e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,29089,0.038827406655808,0.00615845986684278,0.0267568253167962,0.0508979879948199,2.92846065681279e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,29271,0.0338662689943797,0.00539203993599368,0.0232978707198321,0.0444346672689273,3.41590314058055e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,28860,-0.0140917739125606,0.00225194175728024,-0.0185055797568298,-0.00967796806829128,3.96411945221291e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24579,0.0291697621423288,0.00466293891019046,0.0200304018783555,0.0383091224063021,4.02364995571047e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,24669,-0.0105918898602233,0.00169450083640752,-0.0139131114995821,-0.0072706682208646,4.15194681510444e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,29034,-0.00923773905911495,0.00147828557575847,-0.0121351787876016,-0.00634029933062834,4.18947199552227e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,23848,0.0264908186585199,0.00424068072981493,0.0181790844280827,0.0348025528889572,4.2594334966099e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,29132,0.0120437549986839,0.00192860880551635,0.00826368173987185,0.0158238282574959,4.30229865203373e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29145,-0.0173149928592169,0.00277373741662273,-0.0227515181957975,-0.0118784675226364,4.36627435540357e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,23940,0.0299908950444295,0.00480437767686407,0.020574314797776,0.0394074752910831,4.38115894238898e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29219,0.0214704467488076,0.00344355964672238,0.0147210698412318,0.0282198236563835,4.58081929454376e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28491,0.0229506797020551,0.00368302148466628,0.0157319575921092,0.030169401812001,4.68512129281654e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24539,-0.0220515161534937,0.00353881372150472,-0.028987591047643,-0.0151154412593445,4.70014797237311e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,28467,0.0227545191758087,0.00365352097335877,0.0155936180680256,0.0299154202835919,4.78704396849679e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,24529,0.030897445381855,0.00496530007364413,0.0211654572375125,0.0406294335261975,4.96661374161929e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,23843,0.0333730892756744,0.00536881439782479,0.0228502130559378,0.043895965495411,5.18114614269074e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,28467,0.0202164008746279,0.00327176281278227,0.0138037457615747,0.0266290559876812,6.5360495897195e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,24119,-0.0225298663894164,0.00364804747207817,-0.0296800394346896,-0.0153796933441432,6.68516762468333e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24653,0.0319246091950803,0.00517151177554382,0.0217884461150144,0.0420607722751462,6.7979668688204e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BSG,Basigin,29445,0.00886631964802036,0.00143834151353869,0.00604717028148454,0.0116854690145562,7.17296669245225e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,28908,0.0128467265486565,0.00208466970888247,0.0087607739192469,0.0169326791780662,7.25618689823853e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,23979,0.0245062285398236,0.00397742269301572,0.0167104800615127,0.0323019770181344,7.32836094904534e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28491,0.018877622027455,0.00306911882735403,0.0128621491258411,0.0248930949290689,7.81045249668763e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24185,0.0292939164453174,0.00476558608262849,0.0199533677233656,0.0386344651672693,8.02124808644639e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,23756,0.0220325390267123,0.00358534011725529,0.015005272396892,0.0290598056565327,8.11468284455435e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29085,0.017626015496917,0.00287355252402478,0.0119938525498284,0.0232581784440055,8.68683212716014e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,28908,0.0100214367282803,0.0016338533566005,0.00681908414934331,0.0132237893072173,8.70146800369039e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28491,0.0244775555518641,0.00399253241901138,0.0166521920106018,0.0323029190931265,8.85670951909512e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,23979,0.0139764557572531,0.00228050750577069,0.00950666104594257,0.0184462504685637,9.00043350761242e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,28882,0.0204238542070444,0.00334195802608857,0.0138736164759108,0.026974091938178,1.00059328246226e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,23940,0.0262766854059698,0.00430155390359089,0.0178456397549316,0.0347077310570079,1.02027318510388e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,29132,0.05185884187242,0.00849827333465412,0.0352022261364979,0.068515457608342,1.05884272503859e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23974,0.0144436302880129,0.00237060912547666,0.00979723640207867,0.0190900241739472,1.12649096683393e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,29381,0.022399836166813,0.00367942160039203,0.0151881698300446,0.0296115025035814,1.15840473057491e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,29034,0.0319503890887132,0.00525488834370894,0.0216508079350437,0.0422499702423827,1.21584768585062e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,24683,-0.0104823754019669,0.00172578566074538,-0.0138649152970278,-0.00709983550690593,1.26608694606518e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,23854,0.0175547941955733,0.00289283268009219,0.0118848421425926,0.023224746248554,1.31159477988004e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,29122,0.0157624440930991,0.00259936268521941,0.0106676932300691,0.0208571949561291,1.34440029605231e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,23782,0.0234864040921816,0.00387390167121209,0.0158935568166059,0.0310792513677573,1.35850847264079e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24579,0.0202886824318075,0.00335504351641106,0.0137127971396419,0.0268645677239732,1.49494723057938e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,23848,0.0503467401259514,0.00833528330598369,0.0340095848462234,0.0666838954056794,1.56207744885878e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24653,0.0261855904451654,0.00433740049689617,0.0176842854712489,0.0346868954190819,1.59090546688892e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,29256,0.0237036807190691,0.00393291853557488,0.0159951603893423,0.0314122010487958,1.69033155680734e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24669,-0.0153083180613786,0.00254194885145101,-0.0202905378102226,-0.0103260983125346,1.74414685461483e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29172,0.0134857040303994,0.00224279633501523,0.00908982321376958,0.0178815848470293,1.84401662511335e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,29132,0.0273820398098492,0.00455789671649639,0.0184485622455163,0.0363155173741821,1.90517106324088e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,23843,0.0230724709573717,0.00384231543675122,0.0155415327013393,0.0306034092134041,1.94299321053096e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28467,0.0268786960740053,0.0044820574843974,0.0180938634045864,0.0356635287434242,2.03474883575695e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,24529,-0.047120572619838,0.00785769159905412,-0.0625216481539841,-0.031719497085692,2.04129486959568e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,29470,0.0195093747592141,0.00325428065682185,0.0131309846718433,0.0258877648465849,2.05865389105583e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAT,Catalase,24326,0.0225096962826312,0.00375753534821268,0.0151449270001343,0.029874465565128,2.12074793737756e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29034,0.0393560456196644,0.00660079272612024,0.0264184918764688,0.0522935993628601,2.51551961759948e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24119,0.0365743261650842,0.00613956765177677,0.0245407735676017,0.0486078787625666,2.60234770974587e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,24117,-0.00893979010781138,0.00150200870088794,-0.0118837271615517,-0.00599585305407103,2.68728288494704e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,23940,0.0284830011155937,0.00479052608670335,0.0190935699856552,0.0378724322455323,2.79106703268008e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24699,-0.0107927328295917,0.00181648591256063,-0.0143530452182105,-0.00723242044097285,2.86132941498951e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24119,0.025214447708407,0.00424541794109443,0.0168934285438619,0.033535466872952,2.90316822857561e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,24699,0.0135805560612906,0.00228970195418266,0.00909274023109258,0.0180683718914886,3.04832884517386e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23979,0.0176416614186186,0.00297461723839592,0.0118114116313626,0.0234719112058746,3.05719970391047e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24653,0.0211076511957109,0.00356109426361857,0.0141279064390185,0.0280873959524033,3.1206529821148e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,29217,-0.0116695753588234,0.00196983499468433,-0.0155304519484046,-0.00780869876924209,3.17452202870758e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29132,0.0114725380762318,0.00193757833007922,0.00767488454927649,0.015270191603187,3.23435362270528e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29172,0.0277500998279081,0.00468884473732856,0.0185599641427442,0.0369402355130721,3.28871419423758e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,23848,0.0511822270341008,0.00865079856307657,0.0342266618504707,0.0681377922177309,3.3340820374337e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,24372,0.0412391968887287,0.00697568113070423,0.0275668618725484,0.054911531904909,3.42788135078965e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,28467,0.0153913434550023,0.00260518746423351,0.0102851760251046,0.0204975108848999,3.50306694046546e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,28491,0.0333593979105898,0.00564795720248651,0.0222894017937162,0.0444293940274633,3.53515929604063e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24653,0.0134289574109181,0.00227742229952818,0.00896520970384288,0.0178927051179933,3.75996000131653e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29507,-0.0113382092590148,0.00192451844130769,-0.0151102654039778,-0.00756615311405168,3.86966455312339e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29256,0.0138506986053314,0.00235160967863962,0.00924154363519773,0.018459853575465,3.90698866704615e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29271,0.0106349577800235,0.00180794471653457,0.00709138613561573,0.0141785294244312,4.08884713699761e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29082,0.0123657660606498,0.00210305278157645,0.00824378260875996,0.0164877495125396,4.14965718322013e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29271,0.0359405697624246,0.00613198652405835,0.0239218761752703,0.047959263349579,4.64561958122189e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,29172,-0.0108019435024554,0.00184541638772992,-0.014418959622406,-0.00718492738250477,4.86801057212052e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,28908,-0.0148124334149393,0.00253477654965588,-0.0197805954522648,-0.0098442713776138,5.160628786372e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,23979,0.0214474104654865,0.00368516703746099,0.014224483072063,0.02867033785891,5.96223915480727e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29256,-0.0184508066177324,0.00317154546621852,-0.0246670357315207,-0.0122345775039441,6.03173498036581e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29119,-0.00908903569008516,0.001563257006062,-0.0121530194219667,-0.00602505195820365,6.15728494811427e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29132,0.017225849753687,0.00296468069155565,0.0114150755982379,0.023036623909136,6.29888015327902e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24602,0.0405124716925977,0.00698848448704666,0.0268150420979862,0.0542099012872091,6.83235097055164e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,29473,0.00956153913008568,0.00165118756252311,0.00632521150754039,0.012797866752631,7.08031254705666e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29165,-0.0158205392625179,0.00273776124709486,-0.0211865513068238,-0.0104545272182119,7.60724950400075e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,24669,0.0102522060685612,0.00177656421260492,0.00677014021185556,0.0137342719252669,7.98382325233043e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,24119,0.0385428297248021,0.00667948961945291,0.0254510300706743,0.0516346293789298,8.00872467393669e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,23979,0.0128544685495281,0.00222782196679675,0.00848793749460646,0.0172209996044497,8.02613160754115e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,28450,0.0444037453536618,0.00769738602830117,0.0293168687381915,0.0594906219691321,8.07232190056122e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,23922,0.0236858926377205,0.0041094904263617,0.0156312914020516,0.0317404938733894,8.32982526100247e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29271,0.0109005479566626,0.00189231576131521,0.00719160906448476,0.0146094868488404,8.47410639299895e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",28908,0.0234462950632353,0.00407683850702083,0.0154556915894744,0.0314368985369961,8.95592311129172e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29156,0.0381233469973762,0.00664570061726408,0.0250977737875386,0.0511489202072138,9.75841282178982e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24185,0.0141370240638788,0.00246526875521756,0.00930509730365242,0.0189689508241053,9.89799711875356e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29205,-0.0142865732640898,0.00249340059087043,-0.0191736384221959,-0.00939950810598377,1.01564437799525e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,24493,0.0114386390508455,0.00199684954300843,0.007524813946549,0.015352464155142,1.02604620719202e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24669,0.0244178757944194,0.00426868303514029,0.0160512570455445,0.0327844945432944,1.07606578584412e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,29062,-0.0252715228529567,0.00442380978247772,-0.033942190026613,-0.0166008556793004,1.12338976997703e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,23979,0.0119988143391582,0.00210249400851064,0.00787792608247737,0.0161197025958391,1.16379735524357e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23974,0.0145091290874411,0.00254264541159461,0.00952554408071561,0.0194927140941665,1.16811478853632e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,28540,0.0176454462255137,0.00309274077387216,0.0115836743087242,0.0237072181423031,1.17190904641471e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24579,0.00895045155904997,0.00157149231362287,0.00587032662434914,0.0120305764937508,1.24407256215256e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,29034,-0.00605011201437235,0.00106329401356401,-0.00813416828095781,-0.0039660557477869,1.2828330847829e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24602,0.0157370772198877,0.00276859138075988,0.0103106381135983,0.0211635163261771,1.32955826694207e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,24272,0.0131118644797385,0.00230685113181117,0.00859043626138863,0.0176332926980884,1.33183054737767e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,29122,-0.0196944588999499,0.00346641462033868,-0.0264886315558137,-0.0129002862440861,1.34786104973448e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,24185,0.0296959118266696,0.00522775265390818,0.0194495166250095,0.0399423070283296,1.35895039885557e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,24119,-0.00858486677854486,0.00151848350849992,-0.0115610944552047,-0.00560863910188501,1.58916964921195e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,28467,0.0283187145620809,0.00500956983836873,0.0184999576788782,0.0381374714452836,1.59250459539268e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24529,0.0235730079219032,0.00417455887052494,0.0153908725356743,0.0317551433081321,1.6524500128349e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28412,0.0262430630440346,0.0046551034563851,0.0171190602695198,0.0353670658185494,1.74190584679839e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,28566,0.0197561006834201,0.00350660351341457,0.0128831577971275,0.0266290435697126,1.77763977818195e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,28973,-0.00887717498887982,0.00157908869338082,-0.0119721888279062,-0.00578216114985341,1.90817944432968e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28612,0.0365859560218065,0.00650821492266018,0.0238298547733925,0.0493420572702204,1.91064912975361e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,24529,0.0166572497902455,0.00296789139022999,0.0108401826653947,0.0224743169150963,2.01594348482581e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,23979,0.020574321173141,0.00366629481102867,0.0133883833435248,0.0277602590027572,2.02505737047259e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,29470,0.0239807674213765,0.00428190439691682,0.0155882348034196,0.0323733000393335,2.15649568349827e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24602,0.0267472906865632,0.00477697785360048,0.0173844140935063,0.0361101672796202,2.17631572820156e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29172,0.0225509218283849,0.00403426276548953,0.0146437668080254,0.0304580768487443,2.29296747571332e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29409,0.0245338741286599,0.00439201995826623,0.015925515010458,0.0331422332468617,2.34397160117278e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,29122,0.0251938285533257,0.004514045679696,0.0163462990211215,0.0340413580855299,2.40978207698006e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28491,0.0230476083279233,0.0041310037084034,0.0149508410594526,0.031144375596394,2.43850995673824e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,28543,0.0346898258607587,0.0062555185879384,0.0224290094283994,0.0469506422931179,2.95751177112247e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,29111,0.0368651246945639,0.00665862210957864,0.0238142253597898,0.049916024029338,3.11326687461629e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,29409,-0.0177504220189682,0.00320927460218057,-0.0240406002392421,-0.0114602437986943,3.21161039922674e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,28415,0.0238754644905475,0.0043240353082789,0.0154003552863208,0.0323505736947741,3.38921236761722e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,29172,0.0334372636476695,0.00606840470098022,0.0215431904337483,0.0453313368615908,3.61744894379171e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29049,0.0103852545401841,0.001892345635429,0.00667625709474325,0.0140942519856249,4.09829406056383e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24653,0.0273679893252587,0.00498843933866197,0.0175906482214813,0.0371453304290362,4.14516637563637e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,24669,0.0209400166765239,0.00381998499701607,0.0134528460823724,0.0284271872706754,4.25382140716834e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29034,0.00779352935881757,0.0014234852662198,0.00500349823702675,0.0105835604806084,4.41225449028528e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,23940,-0.0123004777472556,0.00224655576725509,-0.0167037270510756,-0.00789722844343567,4.41259635143955e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,29381,0.0250516729968625,0.00458831376890868,0.0160585780098015,0.0340447679839235,4.80294615053708e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,29089,-0.0270707991084749,0.00495861395057555,-0.0367896824516029,-0.0173519157653468,4.81791370462362e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,29359,0.0198188208788945,0.00363395815733938,0.0126962628905093,0.0269413788672797,4.97068771309712e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,23940,-0.0120131052862262,0.00220276224692135,-0.0163305192901921,-0.00769569128226036,4.98332739410425e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24185,0.02710143209149,0.00497469014779566,0.0173510394018106,0.0368518247811695,5.14758446355239e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28631,0.0249998979654977,0.00460457333993308,0.0159749342192289,0.0340248617117666,5.70153116674977e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,23974,0.0189041442061712,0.00348564949494088,0.0120722711960871,0.0257360172162554,5.90345839977474e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,29381,0.0466052160249176,0.00860432736368179,0.0297407343921013,0.0634696976577339,6.12587324678997e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29022,0.0167490311032239,0.00309795859710558,0.010677032252897,0.0228210299535508,6.47846354044769e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,24699,-0.0104076895938481,0.00192542557998194,-0.0141815237306127,-0.00663385545708347,6.5264162959661e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29312,0.0311758864379418,0.00576814833863508,0.019870315694217,0.0424814571816665,6.53741927853414e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29271,0.0451631765441017,0.00836324020184236,0.0287712257484906,0.0615551273397127,6.70844708201417e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,29381,0.029800667025759,0.00551873858592928,0.0189839393973376,0.0406173946541804,6.71929213888447e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,23979,-0.0245028996102878,0.00454505396039362,-0.0334112053726593,-0.0155945938479163,7.06841253631159e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,29132,-0.0302625886930468,0.00561399555293925,-0.0412660199768077,-0.0192591574092859,7.07833681959436e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,23940,0.0235095677177973,0.00436410218558283,0.0149559274340549,0.0320632080015396,7.2305619200275e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,24020,0.0162037555041631,0.00301389854998282,0.0102965143461968,0.0221109966621294,7.67227500610089e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,28467,0.0168420384050068,0.00313289612044381,0.010701562008937,0.0229825148010767,7.6813717294008e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,29172,-0.0144469322697514,0.00269073355696887,-0.0197207700414103,-0.00917309449809237,7.97160090141462e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29089,0.0411444394872546,0.00767536431446808,0.0261007254308971,0.056188153543612,8.3584483476344e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,28612,0.0197121464711792,0.00368464501159732,0.0124902422484484,0.0269340506939099,8.87232632458878e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,24447,0.018171964066227,0.00339882621186782,0.0115102646909661,0.0248336634414879,9.04551922429524e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24602,0.0248979504694515,0.00465806484715076,0.015768143369036,0.034027757569867,9.11580467734632e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,29122,0.0351777985325567,0.00659145361921133,0.0222585494389025,0.0480970476262109,9.52661045593857e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23848,0.0137660355321445,0.00257945256791488,0.00871030849903129,0.0188217625652576,9.54625650700302e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,23974,0.0192279590217536,0.00360516606957608,0.0121618335253845,0.0262940845181227,9.72394349827217e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29172,-0.0105916635704476,0.00198803731611473,-0.0144882167100325,-0.00669511043086273,1.0020209561172e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24498,0.0152919467698519,0.00287777521568099,0.00965150734711713,0.0209323861925866,1.08295793581344e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,28467,0.0271602199689126,0.00511291454240408,0.0171389074658006,0.0371815324720246,1.09193746916255e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28467,0.0273510953278213,0.00514973877630926,0.0172576073262551,0.0374445833293874,1.09745976018043e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24653,0.0106178350479682,0.00200040441472967,0.00669704239509808,0.0145386277008384,1.11888705926863e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,29122,-0.0224027816699503,0.00423482229795919,-0.0307030333739504,-0.0141025299659503,1.23108831954447e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_E,,29122,0.0107507136001705,0.00203413877593612,0.00676380159933567,0.0147376256010053,1.26510661362025e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29507,-0.0152702111749012,0.00289030679567728,-0.0209352124944287,-0.00960520985537375,1.27812549492972e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,23974,-0.0161263559954704,0.00305334650301354,-0.0221109151413769,-0.0101417968495638,1.29223706205558e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,29122,0.0192882442983101,0.00365336325083712,0.0121276523266694,0.0264488362699509,1.30404192774814e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,28491,0.0178807683770257,0.003390540702182,0.011235308600749,0.0245262281533025,1.34659620232569e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28612,-0.0117608234285628,0.00223112764983875,-0.0161338336222467,-0.00738781323487883,1.36482830299716e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,28467,0.0303558394925685,0.0057664001203289,0.0190536952567239,0.0416579837284132,1.41774207341873e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28612,0.0191841578281441,0.00365210413094357,0.0120260337314947,0.0263422819247935,1.50789228912656e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24119,0.0462778533227975,0.00883259839047859,0.0289659604774594,0.0635897461681355,1.62420113779676e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,24551,0.0237740320229806,0.0045409528217089,0.0148737644924312,0.03267429955353,1.65918547126712e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,29470,-0.0145247680000284,0.00277722637344354,-0.0199681316919778,-0.00908140430807907,1.70709078263834e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24602,0.0465014586038921,0.00889267064102298,0.0290718241474871,0.0639310930602972,1.7164726578463e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,28467,0.0112035318370599,0.002144924800067,0.0069994792289286,0.0154075844451912,1.77022433739447e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,24653,0.0101051807372316,0.00193479203412457,0.00631298835034746,0.0138973731241158,1.77595405801536e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,28631,0.0416175181780361,0.00796867064647994,0.0259989237109355,0.0572361126451368,1.77620518178404e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,24683,-0.0529826285210338,0.0101470322682242,-0.0728708117667533,-0.0330944452753144,1.78927594178276e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24060,-0.0179017731751144,0.00343254444414326,-0.0246295602856352,-0.0111739860645936,1.85031972105968e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,29145,0.00961500805030462,0.00184556799681301,0.00599769477655112,0.0132323213240581,1.90347694333889e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28467,0.0150688113049451,0.00289801034705502,0.00938871102471729,0.020748911585173,2.00979848026085e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29507,-0.0115105655099725,0.00221514375541096,-0.015852247270578,-0.00716888374936707,2.04638924798962e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,28631,0.0299117798491514,0.0057640449137431,0.0186142518182149,0.0412093078800879,2.12441853729946e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24579,0.0170072495209733,0.00327733618793173,0.0105836705926272,0.0234308284493195,2.12704597185192e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24539,-0.019974032222099,0.00384971404252023,-0.0275194717454386,-0.0124285926987593,2.13743279704752e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29060,-0.0216319484847419,0.00417709497356729,-0.0298190546329338,-0.0134448423365501,2.2491867693284e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,29367,0.0219229605213498,0.00424113202595975,0.0136103417504687,0.0302355792922309,2.36726660011911e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29132,-0.00880402094434453,0.00170349957875293,-0.0121428801187003,-0.00546516176998879,2.37922303826092e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,28716,0.00809349696512789,0.00156977088682964,0.00501674602694179,0.011170247903314,2.5416214489465e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,23979,0.0222893828982472,0.00432673663069329,0.0138089791020884,0.0307697866944061,2.60393453284953e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,29120,-0.0239696256913477,0.00465410501752097,-0.0330916715256888,-0.0148475798570066,2.61886418788864e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,23940,0.0162291898611944,0.00315238541182221,0.0100505144540228,0.0224078652683659,2.65043132452435e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,23756,0.0130359789199724,0.00253636395535966,0.00806470556746752,0.0180072522724774,2.77456721283534e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,24539,0.0129552610220885,0.00252166054603325,0.00801280635186335,0.0178977156923137,2.80412937584627e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,28149,0.0216386686297473,0.00421315990183811,0.0133808752221446,0.02989646203735,2.82560570174344e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,24669,0.0168924182252049,0.00328909037124098,0.0104458010975726,0.0233390353528373,2.82942211087561e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,28580,0.0148348682906589,0.00288864154212286,0.00917313086809812,0.0204966057132197,2.83110709208255e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,29034,0.0151024468829149,0.00294230632281557,0.0093355264901964,0.0208693672756334,2.87210859839643e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24119,0.0133361365992796,0.00259934693612164,0.00824141660448122,0.0184308565940781,2.91101320264118e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,23974,0.043152453822313,0.00844049009054211,0.0266090932448505,0.0596958143997755,3.20277747836614e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,23974,-0.0153757174936444,0.0030128955381043,-0.0212809927483288,-0.00947044223895997,3.36325541748654e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24498,0.0251314444408003,0.004932316436719,0.015464104224831,0.0347987846567695,3.50845779037861e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,28491,0.0218719455750264,0.00429468536438683,0.0134543622608283,0.0302895288892246,3.55073765448922e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,28863,0.0208322067196359,0.0040943082031439,0.0128073626414739,0.028857050797798,3.63954952373188e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29034,0.02474888772921,0.00486913632423582,0.0152053805337078,0.0342923949247122,3.74201734599923e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,29271,0.0236526632525401,0.00465761372175637,0.0145237403578976,0.0327815861471826,3.83204203642817e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,24119,-0.0115721093207242,0.00227913740209698,-0.0160392186288343,-0.00710500001261411,3.85467188135912e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,24602,0.0105984813504133,0.00208876447540908,0.00650450297861146,0.014692459722215,3.92284361280664e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24185,0.0267356446036835,0.00527667043179992,0.0163933705573557,0.0370779186500114,4.07613888981722e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28612,0.0218297239982558,0.00433068358262159,0.0133415841763175,0.0303178638201941,4.66633182137045e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24579,0.0375570972135323,0.00745182741565225,0.0229515154788539,0.0521626789482107,4.68872480334318e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,23848,0.014090791604137,0.0027980400548385,0.00860663309665353,0.0195749501116205,4.78950227563624e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,23974,0.0225913382776065,0.0044872239245079,0.013796379385571,0.031386297169642,4.82339337293859e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,24119,0.039693680535503,0.0078845506591666,0.0242399612435364,0.0551473998274695,4.82895832628746e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29409,-0.0115489581722204,0.00230630218161986,-0.0160693104481953,-0.00702860589624543,5.54416108194369e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24539,0.034455293566424,0.00689634779566576,0.0209384518869191,0.0479721352459289,5.88834032345658e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,29409,-0.0220167134941783,0.00441109326311867,-0.0306624562898909,-0.0133709706984657,6.03432862941975e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29034,0.0187632400904044,0.00375972838150076,0.0113941724626629,0.0261323077181458,6.05449597315972e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,29122,0.0109246867585563,0.00219029423101934,0.00663171006575837,0.0152176634513542,6.14309975722078e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",23979,0.0224404835112073,0.00450574770986258,0.0136092179998766,0.0312717490225379,6.38895919304668e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24602,-0.0162993531167115,0.00327296820682603,-0.0227143708020905,-0.00988433543133246,6.40175370440164e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28491,-0.0106561790946459,0.00214233288967647,-0.0148551515584118,-0.00645720663088002,6.59325065460076e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,24539,0.0148965863629651,0.00300494784896841,0.00900688857898703,0.0207862841469432,7.19366452454015e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,23848,0.0177495258364161,0.00359191800744046,0.0107093665418328,0.0247896851309994,7.8042181428497e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29034,-0.0116172683730195,0.00235290856803758,-0.0162289691663732,-0.00700556757966583,7.96069655835646e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28491,0.0260991018744746,0.00528781347534835,0.0157349874627918,0.0364632162861573,8.03113533626331e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,23848,-0.0124674055533585,0.00252829356729399,-0.0174228609452547,-0.00751195016146225,8.22946743205613e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24602,0.0132642245578104,0.00269525993398423,0.00798151508720131,0.0185469340284195,8.65202199823059e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29271,0.00927408397065047,0.00188622577083236,0.00557708145981905,0.0129710864814819,8.84730030988771e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24669,0.021128316988094,0.00430267554959651,0.0126950729108849,0.0295615610653032,9.14221569199296e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,28491,0.0230685562904204,0.00471171986056477,0.0138335853637135,0.0323035272171274,9.83446953221639e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,23974,0.0184581957556035,0.00377449085109873,0.01106019368745,0.025856197823757,1.01361204337103e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,23848,0.0154734177517895,0.00316506458525355,0.00926989116469253,0.0216769443388865,1.02103968773073e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCN,Decorin,28612,-0.00784046209232955,0.00160501797985348,-0.0109862973328424,-0.00469462685181673,1.04004080442933e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,23848,0.0157341858079639,0.00322229716193693,0.00941848337056755,0.0220498882453603,1.0520831075766e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23979,0.0170288865922761,0.0034902479341368,0.010188000641368,0.0238697725431842,1.07314381163471e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29172,0.0214503259094011,0.0044068924262377,0.0128128167539752,0.030087835064827,1.13638256001253e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24539,0.032727917858233,0.006728563310155,0.0195399337703292,0.0459159019461368,1.15733486944606e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,24579,-0.014332198361433,0.00295114528124785,-0.0201164431126788,-0.00854795361018721,1.20221380231081e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24529,0.0188180065642292,0.0038761953554064,0.0112206636676327,0.0264153494608258,1.21272925524953e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,24579,0.0198426006827381,0.00409480283500931,0.0118167871261198,0.0278684142393563,1.26870512954655e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24529,0.0165569408719964,0.00342597170615332,0.0098420363279359,0.0232718454160569,1.35458884382765e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29122,0.0507930619054299,0.0105158756273414,0.0301819456758407,0.0714041781350191,1.37135970490943e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29409,0.0109015576545332,0.0022587145026539,0.00647447722933154,0.0153286380797348,1.39689923615272e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,29381,0.0101671371944568,0.0021074101236273,0.00603661335214733,0.0142976610367663,1.41079487181701e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29172,-0.00870174130040092,0.00180375154486854,-0.0122370943283433,-0.00516638827245858,1.41243090531993e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,29018,0.00969234891484775,0.00200942523346483,0.00575387545725669,0.0136308223724388,1.41816257662777e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,29042,0.0166482431171785,0.00345452131461597,0.00987738134053119,0.0234191048938258,1.44817832987502e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,24653,-0.0117385549803719,0.00243712128958553,-0.0165153127079596,-0.0069617972527843,1.46917303355172e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27646,0.0135104754465192,0.00280590582692772,0.00801090002574091,0.0190100508672976,1.47967867251339e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCT,Secretin,23940,0.0159031255284926,0.00330575107293731,0.00942385342553546,0.0223823976314497,1.51284044226656e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24529,0.0174753827024527,0.00363926707622735,0.010342419233047,0.0246083461718583,1.58097235105155e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23848,-0.00691624701465102,0.00144187269574961,-0.00974231749832026,-0.00409017653098179,1.62266379995108e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,28399,0.0254404211851446,0.00531509945904482,0.0150228262454168,0.0358580161248725,1.70616903979857e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24529,0.0114569781918657,0.00239912292149049,0.00675469726574438,0.0161592591179871,1.8030886501842e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29187,0.00889792490324398,0.00186983587953498,0.00523304657935543,0.0125628032271325,1.95808866725836e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,28612,0.0149088035141788,0.00313492970224591,0.00876434129777685,0.0210532657305808,1.98717287713836e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",23979,0.0291185409218095,0.00612973381819432,0.0171042626381486,0.0411328192054704,2.04213971411375e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24669,0.0139343708957195,0.00293571227876078,0.00818037482934835,0.0196883669620906,2.08123094560684e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,29122,-0.0154057639036259,0.00324609416695777,-0.0217681084708631,-0.0090434193363887,2.08526714287355e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29034,0.0129621847392691,0.00273658071860775,0.00759848653079795,0.0183258829477403,2.18322517057048e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29122,-0.0202223884687174,0.00427041670694513,-0.0285924052143298,-0.0118523717231049,2.19587212532157e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,28358,0.0233930293664423,0.00494633944300442,0.0136982040581537,0.033087854674731,2.26309853414536e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28357,0.0190983346825798,0.00403840909620154,0.0111830528540248,0.0270136165111349,2.26520541224377e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,23603,0.026887306323803,0.0056852600959514,0.0157441965357382,0.0380304161118677,2.26596601307334e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,28612,0.0155827996555351,0.00329640050572674,0.00912185466431069,0.0220437446467595,2.2870140602102e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28491,0.0155542086428405,0.00329139377706408,0.00910307683979486,0.0220053404458861,2.30394772299383e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,29271,0.0118282832902977,0.00250940082432066,0.00690985767462925,0.0167467089059662,2.44511299961685e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,28491,0.0240246422704761,0.00509926039717337,0.0140300918920163,0.0340191926489359,2.47184571202796e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,28582,0.0183049561670505,0.00389185046589677,0.0106769292538928,0.0259329830802082,2.57051189007084e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,24567,0.0103653632224542,0.00220408685620597,0.00604535298429047,0.0146853734606179,2.58021861083726e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29271,-0.00939091403477046,0.00200224059097112,-0.0133153055930738,-0.00546652247646708,2.74166320918221e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,28467,0.0224071832366488,0.0047790594216502,0.0130402267702144,0.0317741397030832,2.7633123243336e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29034,0.0177722637006084,0.0037993150567591,0.0103256061893606,0.0252189212118563,2.91339383291094e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29122,0.0300204422636075,0.00642614737950724,0.0174251933997733,0.0426156911274417,3.00185703708643e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,28908,0.0133701520850779,0.00286623306291089,0.00775233528177253,0.0189879688883832,3.10432308156868e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,28561,0.0195150710557873,0.00418578440960862,0.0113109336129544,0.0277192084986202,3.14221945561566e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24261,0.018262542616377,0.00392686893581331,0.0105658795021829,0.0259592057305711,3.32614746739431e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29445,0.0167478763737073,0.00360199399150138,0.00968796815036461,0.02380778459705,3.34002026951946e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,28814,-0.00836645415629674,0.00180157831629842,-0.0118975476562416,-0.00483536065635184,3.43305334921673e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,29172,0.00791572608168333,0.00170588939831926,0.00457218286097758,0.0112592693023891,3.49527038851913e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,29359,-0.0100322238782072,0.00216842467616555,-0.0142823362434917,-0.00578211151292276,3.73478494711107e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,23843,-0.0094211607745629,0.00203721740323357,-0.0134141068849007,-0.0054282146642251,3.77430882101247e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28491,0.0171439506194554,0.00371151319580267,0.00986938475568219,0.0244185164832287,3.870429167159e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,28908,0.0153359470423169,0.00332114509180342,0.00882650266238218,0.0218453914222516,3.89745754030314e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,29226,-0.00883748098645772,0.00191595450486753,-0.0125927518159981,-0.00508221015691736,3.99399681413772e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28631,0.0216271690602334,0.0046905385276972,0.0124337135459469,0.0308206245745199,4.02841418084436e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28612,-0.0110088875239523,0.00240319063158239,-0.0157191411618538,-0.00629863388605081,4.64828444239115e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,24669,-0.0107311217343531,0.0023430348718349,-0.0153234700831495,-0.00613877338555664,4.67228205175236e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,28908,-0.0112380792886918,0.00245479205004171,-0.0160494717067736,-0.0064266868706101,4.71359394874876e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,24529,0.0124686933145812,0.00272977895302252,0.00711832656665701,0.0178190600625053,4.9560685607847e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,24699,-0.0101383736024973,0.00222310157894451,-0.0144956526972285,-0.00578109450776604,5.12860120006955e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29172,-0.00908775727840115,0.00199722375552923,-0.0130023158392384,-0.00517319871756385,5.38122773224767e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,29172,0.0215355566105066,0.00474146369860519,0.0122422877612404,0.0308288254597728,5.59556817135633e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,24699,-0.00721083802027922,0.00158858563330136,-0.0103244658615499,-0.00409721017900855,5.67463112761205e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,28962,0.00831701836938358,0.00183296670028897,0.0047244036368172,0.01190963310195,5.71637208618538e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,24653,0.0208193079071888,0.00459604187344264,0.0118110658352413,0.0298275499791364,5.93068106554292e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29034,0.0103294121502881,0.0022855902481119,0.00584965526398877,0.0148091690365874,6.22706723680067e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,23974,0.0138458047230432,0.00306411207897779,0.00784014504824673,0.0198514643978397,6.25176024004413e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,24539,0.0141538652653738,0.0031364637506602,0.0080063963140798,0.0203013342166678,6.43100383554163e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,28047,0.00997064354345164,0.00220979712084249,0.00563944118660035,0.0143018459003029,6.44745116579793e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,24653,0.0167365154982485,0.00371023907008458,0.00946444692088273,0.0240085840756143,6.48512200993943e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LXN,Latexin,28809,-0.0212530101908991,0.00471353919052246,-0.0304915470043231,-0.012014473377475,6.54127248903455e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29122,0.0383210302611528,0.00850252599341544,0.0216560793140586,0.0549859812082471,6.60012440744202e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24529,0.0117153191202015,0.00260293939690615,0.00661355790226542,0.0168170803381375,6.80083407064588e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,23848,0.0176595900634037,0.00392453528605231,0.00996750090274117,0.0253516792240662,6.83416645985609e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,29143,0.0296006136417875,0.00658705383333869,0.0166899881284437,0.0425112391551313,7.0246895198434e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,28491,0.0234075216476708,0.00521362766524611,0.0131888114237885,0.0336262318715532,7.1609789511491e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24669,0.00882920352154066,0.00197048875506104,0.00496704556162103,0.0126913614814603,7.4726894452198e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,29016,-0.0134511394995167,0.00300362786596215,-0.0193382501168025,-0.00756402888223086,7.55274930404124e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24284,-0.00255693109783758,0.000571577537369117,-0.00367722307108105,-0.00143663912459411,7.73120544682045e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,29172,0.0239335389136301,0.00535097908679247,0.0134456199035168,0.0344214579237433,7.75150316036551e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,28807,-0.00923525812251546,0.0020688381051919,-0.0132901808086916,-0.00518033543633932,8.07551117945042e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,29132,0.0143339501680134,0.00321608447435186,0.00803042459828372,0.020637475737743,8.34412063926358e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,23979,0.0133724869375372,0.00300269629056001,0.00748720220803958,0.0192577716670348,8.48661416446906e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29034,-0.0121394306681403,0.00273850915023629,-0.0175069086026034,-0.00677195273367713,9.33314984329617e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24539,0.0152375422511358,0.00344519234333002,0.00848496525820901,0.0219901192440627,9.78296619353244e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,23848,0.0191035023544049,0.00433790901023884,0.0106012006943367,0.027605804014473,1.06809093549952e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,29409,0.0065290443417407,0.00148520018353269,0.00361805198201663,0.00944003670146476,1.10614479823281e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29122,0.0370623928539092,0.00843388133583579,0.020531985435671,0.0535928002721473,1.11438468984519e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29409,-0.0185011651433354,0.00421750902778853,-0.026767482837801,-0.0102348474488699,1.15455839569594e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",24185,0.014169714356375,0.00323118053657604,0.00783660050468592,0.020502828208064,1.16312063592263e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,28298,-0.0215226249149322,0.00491154955999082,-0.0311492620525142,-0.0118959877773502,1.17994144905389e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,29470,0.0268929766570921,0.00614579212439901,0.01484722409327,0.0389387292209141,1.21383665908496e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,29381,0.00818078449490757,0.00187091264992276,0.00451379570105895,0.0118477732887562,1.23187806369845e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24539,0.0361884392675781,0.00828640151248381,0.0199470923031099,0.0524297862320464,1.26360320217945e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,29409,-0.0136626276296398,0.00313054068157885,-0.0197984873655343,-0.00752676789374522,1.27963405409307e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,28467,0.0150571095760292,0.00345663356738917,0.00828210778394639,0.0218321113681119,1.32921359248458e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,23940,0.0183002254063119,0.00420419014315805,0.0100600127257221,0.0265404380869016,1.3493387566271e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,24648,0.0069048143843888,0.00158654686494934,0.0037951825290881,0.0100144462396895,1.35380892782573e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29132,-0.0103431380646499,0.00237679844819182,-0.0150016630231059,-0.00568461310619393,1.35539349376212e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,24579,0.0295548362869011,0.00680520581498389,0.0162166328895327,0.0428930396842696,1.41129100100379e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,24579,0.0117244760244214,0.00269974524622782,0.00643297534181486,0.0170159767070279,1.41235963525963e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28631,0.0218975988184348,0.00505086989947278,0.0119978938154681,0.0317973038214014,1.45984327788127e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24581,0.00608209774987466,0.00140378068565187,0.00333068760599699,0.00883350789375232,1.47906106941625e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,24579,0.00850536258910408,0.00196956339899539,0.00464501832707312,0.012365706851135,1.57780093082164e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",23848,-0.0145410546379577,0.00337033358562888,-0.0211469084657903,-0.00793520081012514,1.60662028123761e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,24602,-0.0107628515677015,0.00249528176634642,-0.0156536038297405,-0.00587209930566252,1.6147612089409e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,23974,0.0190047363991649,0.00442815385297791,0.0103255548473282,0.0276839179510016,1.77928401156424e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24185,0.0115150070656099,0.00268885371047161,0.00624485379308554,0.0167851603381342,1.85520624539712e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,29483,0.0101527723027414,0.00237311682552446,0.0055014633247135,0.0148040812807694,1.88967117705951e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,23848,-0.0124772113298061,0.00291809768196829,-0.0181966827864639,-0.00675773987314822,1.91189883007793e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,24388,0.0131053440795577,0.0030781687041089,0.00707213341950429,0.0191385547396112,2.07486512081268e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28412,0.0126836268720371,0.00298053730184767,0.0068417737604157,0.0185254799836586,2.09266147602739e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24539,0.015121377666871,0.00356411233396776,0.0081357174922942,0.0221070378414478,2.21679256044289e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29122,-0.0122852236465584,0.00289743755452896,-0.0179642012534352,-0.00660624603968163,2.24178269869154e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,24529,0.0242284515102116,0.00572233115156503,0.0130126824531442,0.0354442205672791,2.30388608489182e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,23848,0.0296265104287188,0.00700486983301588,0.0158969655560077,0.0433560553014299,2.35172284597988e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24119,0.00956695186993506,0.00226598614495016,0.00512561902583274,0.0140082847140374,2.43050876868079e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24539,0.0148350575131754,0.00351909074844868,0.00793763964621597,0.0217324753801348,2.50013402510477e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,28612,0.0167868490207821,0.00398526787594058,0.00897572398393862,0.0245979740576257,2.53640033639907e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,23756,0.0107911023278128,0.00257088945017021,0.00575215900547919,0.0158300456501464,2.70955151417735e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,23974,0.0119292720847438,0.00284968476756029,0.0063438899403256,0.0175146542291619,2.84709825209962e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,29089,0.0118121606966248,0.0028221171063928,0.00628081116809491,0.0173435102251547,2.85290545664643e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29121,0.0215877991091216,0.00516477202745338,0.011464845935313,0.0317107522829302,2.92596082220979e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,24699,0.00911889672999286,0.0021831031390894,0.00484001457737763,0.0133977788826081,2.96348623642915e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29122,-0.013727917178272,0.00328916733367325,-0.0201746851522715,-0.00728114920427241,3.00594546412646e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,24539,0.0102045969904726,0.00244671349087862,0.00540903854835053,0.0150001554325947,3.04660303794335e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29153,0.0169017055203774,0.0040734260084654,0.00891779054378518,0.0248856204969696,3.34496905536563e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,29256,-0.00866030081093244,0.00209653140306595,-0.0127695023609417,-0.00455109926092319,3.62545693425512e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,24529,0.0196422682964121,0.00475964606802658,0.01031336200308,0.0289711745897442,3.69006546817435e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,23756,0.0222766410296877,0.00540046630002774,0.0116917270816334,0.0328615549777421,3.72081289032621e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,28853,0.0100880392161399,0.00244777593858337,0.00529039837651652,0.0148856800557633,3.77778897574323e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24119,0.0198752757349879,0.00482332239698853,0.0104215638368904,0.0293289876330854,3.79048823104433e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24185,0.0202551576456051,0.0049160648198382,0.0106196705987222,0.029890644692488,3.79808035693449e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,29271,-0.00605828076488458,0.00147321928524778,-0.00894579056397023,-0.00317077096579893,3.92851022855851e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,29409,0.00717720804662638,0.00174534353459025,0.00375633471882949,0.0105980813744233,3.92965004305655e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,29034,0.0246816013088114,0.00600482008552961,0.0129121539411734,0.0364510486764495,3.96233883257305e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24539,0.0235311991183182,0.00576121195389279,0.0122392236886884,0.0348231745479481,4.43276283670781e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,28811,0.0298821070935148,0.00732812957935695,0.0155189731179752,0.0442452410690544,4.56003929948702e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28631,0.0108150913592181,0.0026536512222271,0.00561393496365301,0.0160162477547833,4.60293031125361e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,28908,-0.00810909576710598,0.00200243381597025,-0.0120338660464077,-0.00418432548780429,5.14346591659692e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24579,-0.0170568534754621,0.00421563008064187,-0.0253194884335202,-0.00879421851740405,5.22376036561259e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29172,-0.0295321906259821,0.00731259102965712,-0.04386486904411,-0.0151995122078541,5.39224791008974e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,28467,0.010177104361938,0.00252046609276007,0.00523699082012822,0.0151172179037477,5.40991868618343e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,24602,0.00780430096738245,0.00193306151734481,0.00401550039338663,0.0115931015413783,5.42394731235292e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,28631,0.0199332408004458,0.00493907064800562,0.0102526623303548,0.0296138192705368,5.45514149144249e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,23848,-0.00890829634909085,0.00221199171626198,-0.0132438001129643,-0.00457279258521738,5.66019988135619e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24529,0.0127616109430357,0.00316897235279877,0.0065504251315501,0.0189727967545213,5.6650926004561e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,29132,-0.013750830407963,0.00343506037964535,-0.0204835487520678,-0.00701811206385807,6.26772950156258e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,23974,0.0114466981061099,0.00286313310345329,0.00583495722334145,0.0170584389888783,6.4081518829889e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,23756,0.0173016450863344,0.00432838010456801,0.00881802008138109,0.0257852700912877,6.42744712666743e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,28363,-0.025180029558786,0.00631598614750894,-0.0375593624079035,-0.0128006967096685,6.71625261238529e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,28969,0.00767111881515529,0.00192632956899049,0.00389551285993392,0.0114467247703767,6.84336597532076e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23979,0.0148517632364756,0.00373054183419341,0.0075399012414565,0.0221636252314947,6.87912619534142e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,23811,0.0275533635766595,0.0069246602332861,0.0139810295194187,0.0411256976339002,6.94048261757698e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,24653,0.0272496507088896,0.00688525747081519,0.0137545460660918,0.0407447553516873,7.58931832213734e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,29034,0.00821442292292887,0.00207995611126708,0.00413770894484539,0.0122911369010124,7.85568631557753e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23756,0.0185713615305448,0.00470295369260559,0.00935357229303786,0.0277891507680518,7.87468875395345e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24653,0.0194022767097444,0.00491843186017559,0.00976215026380023,0.0290424031556886,8.00845826398377e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,23756,0.0117386845214449,0.00298283654316677,0.00589232489683805,0.0175850441460518,8.32913406742278e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,28612,0.0106274717462673,0.00270299188740026,0.00532960764696283,0.0159253358455718,8.45305428584565e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29361,0.0116363983879508,0.00296714817043162,0.00582078797390484,0.0174520088019968,8.81098690067862e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24602,-0.0116420798101805,0.00297563614805466,-0.0174743266603676,-0.00580983295999332,9.1603544732689e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,23843,-0.0173566698013336,0.0044364456725156,-0.0260521033194642,-0.008661236283203,9.1678063193401e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,28908,0.0160999218544956,0.00411845099594203,0.00802775790244923,0.024172085806542,9.28067007621183e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29122,0.0226125750411695,0.00578574713224295,0.0112725106619733,0.0339526394203656,9.31488508985742e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24602,-0.0123472084893295,0.00315928188561926,-0.0185394009851432,-0.00615501599351572,9.32228148084616e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24119,0.0174192918968931,0.00447111508985529,0.00865590632077671,0.0261826774730095,9.80740543588951e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,23848,0.0171761334806839,0.00441009653449583,0.00853234427307206,0.0258199226882957,9.85764793680238e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,24081,0.0158143070858351,0.00406266757390426,0.00785147864098279,0.0237771355306875,9.94462310219878e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,29034,0.0201193170017972,0.0051728320139812,0.00998056625439404,0.0302580677492003,0.000100707931407727
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29470,0.0184673478916925,0.00475695499525331,0.00914371610099603,0.027790979682389,0.000103750552112594
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,29122,0.0152105714076265,0.00391914893640673,0.00752903949226929,0.0228921033229837,0.000104218313798412
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,23848,0.0164275212467078,0.00423822634453109,0.0081205976114269,0.0247344448819888,0.000106456010706877
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,29181,0.0175350829507695,0.00452442947889175,0.0086672011721417,0.0264029647293973,0.000106575209369335
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,28491,0.00965392513308418,0.00249169822890786,0.00477019660442478,0.0145376536617436,0.000107111125903029
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23848,0.0180658674562185,0.00466702450740523,0.00891849942170424,0.0272132354907327,0.000108696293692502
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,29172,-0.0123106207673463,0.00318381642011608,-0.0185509009507738,-0.00607034058391875,0.000110591751196762
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,23848,0.010437541891723,0.00270186260806117,0.00514189117992311,0.0157331926035229,0.000112257261919222
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,29346,-0.0116007429443595,0.00301331049793293,-0.0175068315203081,-0.00569465436841099,0.000118448965445381
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,28631,-0.0166408741873486,0.00432317738231486,-0.0251143018566857,-0.00816744651801143,0.000118750508518557
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24699,-0.00523582207547914,0.00136425524540663,-0.00790976235647614,-0.00256188179448213,0.000124419852954745
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,23843,0.011837893233473,0.00308536726996219,0.00579057338434713,0.0178852130825989,0.000124976487351508
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29086,0.00657556393767113,0.00171401578042138,0.00321609300804523,0.00993503486729703,0.000125140276839547
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24467,0.0119461743356631,0.00311911649476117,0.00583270600593117,0.0180596426653949,0.000128470034042875
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,23843,-0.00893311399403265,0.00234218252190634,-0.0135237917369691,-0.00434243625109622,0.000137073074352959
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,24185,-0.00913645084412299,0.00239644431098829,-0.01383348169366,-0.00443941999458593,0.000137907979845337
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,24602,0.0160066694793572,0.00420023975482355,0.00777419955990299,0.0242391393988113,0.000138802217324583
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24529,0.0106896538072849,0.00281192681773199,0.0051782772445302,0.0162010303700396,0.000144147213328029
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29409,0.00896438069124617,0.00235823778632789,0.00434223463004351,0.0135865267524488,0.000144226496220781
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,28491,0.0116736130243085,0.00307107992937424,0.00565429636273495,0.017692929685882,0.00014433024671685
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28491,0.0125178494412267,0.00329845955880265,0.00605286870597349,0.0189828301764799,0.000147913727636805
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,24185,-0.0111350845949724,0.00293706857569691,-0.0168917390033383,-0.00537843018660642,0.000150270943891207
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29256,-0.00726973746491251,0.00191853195110033,-0.0110300600890692,-0.00350941484075586,0.000151424572030889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29271,-0.0112800478922376,0.00298457995417862,-0.0171298246024277,-0.00543027118204748,0.000157491750268289
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24583,0.0172709839690803,0.00457060356166376,0.00831260098821929,0.0262293669499412,0.000158015211035169
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,29122,-0.0155066899954991,0.00410798813312811,-0.0235583467364302,-0.00745503325456804,0.000160476372013832
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29473,0.0072767505018943,0.00192837995531356,0.00349712578947972,0.0110563752143089,0.000161285524804235
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,23848,-0.00734352003526275,0.00194749472126869,-0.0111606096889494,-0.00352643038157613,0.000163149147556446
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,28847,-0.00743609530435226,0.00197519217542166,-0.0113074719681787,-0.0035647186405258,0.00016704966150882
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24669,-0.010492863219779,0.00279077143553377,-0.0159627752334251,-0.00502295120613277,0.000170412319520222
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,21429,0.0278395538366051,0.00740796028371574,0.0133199516805222,0.0423591559926879,0.000171690664199577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,23848,-0.0146620086301879,0.0039202514933432,-0.0223457015571406,-0.00697831570323526,0.000184400902038467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,24349,0.0168461401008964,0.00451887566390401,0.00798914379964455,0.0257031364021483,0.000193481335381236
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,28467,0.0134236466034121,0.00360554931174866,0.00635676995238477,0.0204905232544395,0.000197208559522965
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24539,0.0140386882979265,0.00377639216784095,0.0066369596489582,0.0214404169468947,0.000201661920207855
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24185,0.0152058602972905,0.0040965333086614,0.00717665501231417,0.0232350655822669,0.000206183089104808
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29409,-0.00674348469224442,0.00181679411067344,-0.0103044011491644,-0.00318256823532449,0.000206211265704698
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,28467,0.0111241154901664,0.00300289870106014,0.00523843403608855,0.0170097969442443,0.000212242976575885
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23848,-0.00676617241644136,0.00182667688630007,-0.0103464591135895,-0.00318588571929321,0.000212631335079121
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,23974,0.010383337868134,0.00280620253510429,0.0048831808993296,0.0158834948369384,0.000215963854343632
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24669,-0.00687184033360032,0.00185894543061007,-0.0105153733775961,-0.00322830728960457,0.000218950414475273
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,23848,-0.0109281461599271,0.00295813968747217,-0.0167260999473725,-0.00513019237248161,0.000221018326519651
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24579,0.0181500499302467,0.00493057520220389,0.00848612253392711,0.0278139773265664,0.000232706530093235
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,23756,-0.00784845299453927,0.00213314075974362,-0.0120294088836368,-0.00366749710544176,0.000234396938290674
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,24579,-0.0102186748644009,0.00278328492816641,-0.0156739133236071,-0.00476343640519479,0.000241694891832174
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28631,0.00911803173165054,0.00249226721434486,0.00423318799153462,0.0140028754717665,0.000254122345034172
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29470,0.0188224526160584,0.00514560699588798,0.00873706290411795,0.0289078423279988,0.000254668293120529
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,24699,0.0136718193118842,0.00373780434034992,0.0063457228047984,0.0209979158189701,0.000255003805098704
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,29205,0.00971947509114285,0.00266146048578542,0.00450301253900342,0.0149359376432823,0.000260728729513261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24529,0.00735924271146784,0.00201515673739883,0.00340953550616614,0.0113089499167695,0.000260802675734596
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,28823,0.0076627580808343,0.0021053067748857,0.00353635680205833,0.0117891593596103,0.000273396327664173
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29317,-0.00878428455422819,0.00241384269531648,-0.0135154162370485,-0.00405315287140788,0.000274031905058255
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,29132,-0.00860193515650404,0.00236538738852408,-0.0132380944380112,-0.00396577587499684,0.000276751620474519
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29122,-0.01431619255553,0.00393848645886328,-0.022035626014902,-0.00659675909615794,0.000278515769583351
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29033,-0.00875162134744556,0.00241016411934942,-0.0134755430213704,-0.0040276996735207,0.000282667555623262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,29507,-0.00438531704597511,0.0012081972567277,-0.0067533836691614,-0.00201725042278882,0.000284300194385192
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23848,-0.0129889836046975,0.00358635770264488,-0.0200182447018814,-0.00595972250751353,0.000293194745486268
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24185,-0.00721551537161827,0.00199441739842202,-0.0111245734725254,-0.00330645727071112,0.000297658666112838
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,29038,0.0182800016910952,0.00505422649270328,0.00837371776539679,0.0281862856167937,0.000298801597611466
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29132,0.00926255395297579,0.00256418106693795,0.0042367590617774,0.0142883488441742,0.000304020593007046
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29271,0.00668485485155912,0.00185159036191014,0.00305573774221525,0.010313971960903,0.000306316785163094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,23940,-0.00937827906905527,0.00259792503317191,-0.0144702121340722,-0.00428634600403834,0.000306927062454535
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23843,-0.0155800809586962,0.00432560452253726,-0.0240582658228692,-0.00710189609452319,0.000316630506268488
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24579,0.00935973810530265,0.00260079997269205,0.00426217015882624,0.0144573060517791,0.000320327222352381
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28612,0.0136117806856849,0.00379172681725905,0.00617999612385716,0.0210435652475126,0.000331404946165129
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,29172,0.00862550230004853,0.00240364805309709,0.00391435211597822,0.0133366524841188,0.000333124884151837
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23711,0.0221850560058654,0.00618740907531096,0.010057734218256,0.0343123777934749,0.00033708813519861
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",23848,0.0158531273074099,0.00442414193504674,0.00718180911471831,0.0245244455001015,0.000339927695874758
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,24119,0.0086558511476755,0.0024175038785836,0.00391754354565164,0.0133941587496994,0.000343623055655244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,29507,-0.00489475122733779,0.00137135558607214,-0.00758260817603919,-0.00220689427863639,0.000358532766967128
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29122,-0.00882381911001802,0.00247331792659059,-0.0136715222461356,-0.00397611597390046,0.000360838755641046
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24669,0.0156100744728532,0.0043920173053198,0.00700172055442637,0.02421842839128,0.000379850483880561
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23848,-0.00932607696103454,0.00262403191101272,-0.0144691795066195,-0.00418297441544961,0.000380005483509687
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,23843,-0.0107241247265591,0.00302057385213341,-0.0166444494767406,-0.00480379997637762,0.000385445696226253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24185,0.0110056715062955,0.00310263140613287,0.0049245139502751,0.0170868290623159,0.00039007755448213
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,23848,-0.00894891139072962,0.00252644652876936,-0.0139007465871176,-0.00399707619434168,0.000397721708203937
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,24453,-0.00698487396184354,0.00197394786612081,-0.0108538117794403,-0.00311593614424677,0.000403107751991792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,29132,-0.0100758706885997,0.00285268607699906,-0.0156671353995179,-0.00448460597768156,0.000412966577960187
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24539,0.00985168532602709,0.0027892649259176,0.0043847260712286,0.0153186445808256,0.000413185566936445
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,29317,0.0152381725837931,0.00432140290714863,0.00676822288578179,0.0237081222818044,0.000422196795539904
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,28908,-0.0172713423543038,0.0049014445455399,-0.026878173663562,-0.00766451104504557,0.000426182942340762
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,23848,0.00895866162939334,0.00255462059130057,0.00395160527044422,0.0139657179883425,0.000454285081742715
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,29085,0.00636258935647732,0.00181724221376568,0.0028007946174966,0.00992438409545805,0.000463803946355545
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29100,0.0113278965141965,0.00323604663688099,0.00498524510590977,0.0176705479224832,0.000465019221899162
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,23940,0.0124977212733143,0.0035801818634291,0.00548056482099325,0.0195148777256353,0.000482432661622422
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,24602,0.0169093623685252,0.00484414959352568,0.00741482916521491,0.0264038955718356,0.000482642323576256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,24119,0.0105062212027818,0.00301062143679595,0.00460540318666173,0.0164070392189019,0.000484393071190816
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29507,-0.00554020491057833,0.00159598318821421,-0.00866833195947818,-0.00241207786167848,0.000518603217194917
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,24292,0.0150135027096983,0.00432890375088369,0.00652885135796629,0.0234981540614304,0.000524865502206338
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,23843,-0.0116396983619049,0.00335824290578314,-0.0182218544572398,-0.00505754226656991,0.000529176869971881
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29361,-0.00840676437960751,0.00242637879022314,-0.0131624668084449,-0.00365106195077016,0.00053150803309544
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,23979,0.00990216480510264,0.00285872728474495,0.00429905932700254,0.0155052702832027,0.00053345973863114
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,29271,-0.015658039173645,0.0045217834407968,-0.0245207347176067,-0.00679534362968323,0.000535346331366869
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,23843,-0.0187665850420118,0.00542780623635755,-0.0294050852652726,-0.00812808481875099,0.000546184137423373
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29023,-0.00632383786600827,0.00183077217301682,-0.00991215132512123,-0.00273552440689531,0.000552733322759385
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24251,0.00329309345608697,0.000954477760209272,0.0014223170460768,0.00516386986609714,0.00056122435610151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,28612,0.028122280099279,0.0081779844727445,0.0120934305326998,0.0441511296658582,0.000585176889353333
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,24529,0.0149325956832741,0.00434698894590865,0.00641249734929311,0.023452694017255,0.000593187988888606
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29507,0.00557725680778992,0.00162393331498653,0.00239434751041631,0.00876016610516352,0.00059465634582678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,28811,0.0137857161941717,0.00401493366893602,0.00591644620305708,0.0216549861852863,0.000596438578783443
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,28631,-0.012129011205625,0.00353693618362865,-0.0190614061255371,-0.0051966162857128,0.000606121794220944
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29317,0.0170935141714013,0.00498798339689086,0.00731706671349523,0.0268699616293074,0.000611264402680697
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,24539,0.00738751530860627,0.00216043673617091,0.00315305930571129,0.0116219713115013,0.000628488917894872
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,23756,0.00706645448013897,0.00206743352172245,0.00301428477756297,0.011118624182715,0.000631926971314481
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28412,0.0115160855480789,0.00337237352812779,0.00490623343294841,0.0181259376632093,0.000639108226784585
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23848,-0.00902937898092484,0.00264565488534342,-0.0142148625561979,-0.00384389540565174,0.000643802746054549
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,23756,-0.0084134614696465,0.00246944648894295,-0.0132535765879747,-0.00357334635131833,0.000657844375222678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,28906,0.0108897308861101,0.00319727956542792,0.00462306293787142,0.0171563988343489,0.000660272598532737
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PI3,Elafin,28710,0.013147686224375,0.00386753922944382,0.00556730933466515,0.0207280631140849,0.000676018777579461
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,23843,-0.00674555031128917,0.00198459667418094,-0.0106353597926838,-0.00285574082989454,0.000677551689033227
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,23848,-0.00961837892318769,0.00283443214015837,-0.0151738659178981,-0.00406289192847728,0.000691415806981116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,24529,0.0121736983193972,0.00359110697971113,0.00513512863916334,0.019212267999631,0.000700137522723316
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,28631,0.0134286300605124,0.00396248044698048,0.00566216838443063,0.0211950917365941,0.000702565836230302
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,24539,0.0269665652312315,0.00796618708122343,0.0113528385520335,0.0425802919104294,0.000712564844636292
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,23843,-0.021563089127182,0.00637137390375506,-0.0340509819785419,-0.00907519627582211,0.000714566630300418
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,28908,0.0247784416395133,0.00733517955008267,0.0104014897213512,0.0391553935576753,0.000731040029815138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,24539,0.0162900619319481,0.00483301746495016,0.00681734770064581,0.0257627761632504,0.000751263712907278
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,29252,-0.00911614909797898,0.00270481659061273,-0.0144175896155799,-0.00381470858037803,0.000751728216541937
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24185,0.0206815188969275,0.00613658053198087,0.00865382105424501,0.03270921673961,0.000752304576970157
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29145,-0.0059361810934875,0.00176380184065437,-0.00939323270117006,-0.00247912948580494,0.000764870495923738
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,24067,-0.00723557963076708,0.00215305893794015,-0.0114555751491298,-0.00301558411240439,0.000778930501106292
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28631,0.0100313452520418,0.00298546781343818,0.00417982833770296,0.0158828621663806,0.000780278857999916
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29079,0.00679830853121712,0.00202393890926884,0.00283138826905018,0.0107652287933841,0.000783398790972087
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,23848,-0.00806695529228218,0.00240754182846049,-0.0127857372760647,-0.00334817330849962,0.000807321260660652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28556,0.0123334426342764,0.00368095935967074,0.00511876228932176,0.019548122979231,0.000807396053815888
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23940,-0.014863376349185,0.00444260150523661,-0.0235708752994488,-0.00615587739892129,0.000822170793594973
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29172,0.0114973758995914,0.0034401394253144,0.00475470262597515,0.0182400491732076,0.000832441144288716
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,29122,0.00796257000181989,0.0023841554935455,0.00328962523447072,0.0126355147691691,0.000839481492438566
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,23843,-0.0138875759119688,0.00416551518691938,-0.0220519856783308,-0.00572316614560678,0.000857557659586136
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28491,0.0118062103618777,0.00354593370940122,0.0048561802914513,0.0187562404323041,0.000871103483209746
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,28642,-0.00967170393372406,0.00290687803112052,-0.0153691848747203,-0.00397422299272784,0.000878404148809882
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28467,0.00894413698814042,0.00269966509650894,0.0036527933989829,0.0142354805772979,0.000923981466015469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,24185,0.0068101454566378,0.0020653944693444,0.00276197229672278,0.0108583186165528,0.00097773400675659
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,23843,-0.0222404932088427,0.00675321148168695,-0.0354767877129491,-0.00900419870473628,0.00099155573339501
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,24065,0.0262729834147002,0.0079826967656904,0.010626897753947,0.0419190690754534,0.00099889821765264
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24579,0.00648430222133382,0.00198083404242662,0.00260186749817765,0.01036673694449,0.00106363180745109
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,28990,0.00707590182811492,0.00216263591326598,0.0028371354381136,0.0113146682181162,0.00106956902273862
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29122,0.0109420522142688,0.00334782170605508,0.00438032167040085,0.0175037827581368,0.00108279141313477
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24185,0.0166540235537249,0.00510079148444741,0.00665647224420794,0.0266515748632418,0.00109620910971901
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28467,0.0193096762020091,0.00592481232689779,0.00769704404128941,0.0309223083627287,0.00111889413076539
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29172,0.00802592841607387,0.00246709767068791,0.00319041698152558,0.0128614398506222,0.00114248443747584
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24602,0.00686765543791085,0.00211619714640287,0.00271990903096121,0.0110154018448605,0.0011749143494852
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,23848,-0.0164498203183463,0.0050884873920279,-0.026423255606721,-0.00647638502997159,0.00122770429341745
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23848,-0.0133687679436484,0.0041423998091474,-0.0214878715695773,-0.00524966431771955,0.00125133105419938
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28491,0.0107271928846518,0.00332639302913344,0.00420746254755022,0.0172469232217533,0.00126170970049048
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24579,0.0127067785162772,0.00394337057489126,0.00497777218949028,0.020435784843064,0.00127325413849606
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24683,0.0164534501739283,0.00510861800605347,0.00644055888206353,0.0264663414657931,0.00128032757388178
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,29507,-0.0092406051303435,0.00287397215841562,-0.0148735905608381,-0.00360761969984889,0.0013046085433294
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24119,0.0201113991826464,0.00626216568642143,0.00783755443726038,0.0323852439280324,0.00132183863860341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24653,0.0120548476809393,0.00375724129849881,0.00469065473588161,0.0194190406259969,0.00133632251055404
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,24119,0.0172934520418338,0.00539139402134631,0.00672631975999503,0.0278605843236725,0.00134020909240578
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29132,0.00845445255967187,0.00263861759671177,0.00328276207011679,0.0136261430492269,0.00135620970783401
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,28908,0.0136828533210377,0.00427724207221257,0.00529945885950104,0.0220662477825743,0.00138058880226213
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,23848,-0.00908985624036143,0.00284378647040568,-0.0146636777223566,-0.0035160347583663,0.0013933939523512
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,28272,-0.014990431525693,0.00469195950057887,-0.0241866721468276,-0.00579419090455844,0.00140023562374739
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,29280,0.00691033146564577,0.0021666341943043,0.00266372844480935,0.0111569344864822,0.00142703063432972
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,29381,0.00809276599048535,0.0025384939334539,0.00311731788091572,0.013068214100055,0.00143401441458457
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24579,0.0535397741617001,0.0168326873155777,0.0205477070231679,0.0865318413002324,0.0014710085918433
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2,Complement C2,29231,0.00520717720616345,0.00163754693634502,0.00199758521092721,0.00841676920139969,0.00147497750727202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,29172,-0.0171612857176489,0.00540323410426344,-0.0277516245620053,-0.00657094687329259,0.00149417858640109
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,28999,0.0147981304514525,0.00466869126476725,0.00564749557250866,0.0239487653303963,0.00152779835016338
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,28148,0.0079793426076191,0.00252045608256774,0.00303924868578633,0.0129194365294519,0.00154804527043215
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,28729,-0.0380813050460061,0.0120565115804642,-0.0617120677437159,-0.0144505423482964,0.00158710854187824
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,23843,-0.0119501006990399,0.00378345603545191,-0.0193656745285257,-0.00453452686955419,0.00158773378105756
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29470,-0.0056347534061916,0.00178476736600557,-0.00913289744356252,-0.00213660936882067,0.0015948761192407
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,23843,0.0188300726382182,0.00596667257669008,0.00713539438790564,0.0305247508885308,0.00160216574951852
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29145,0.00652670933483539,0.00206984942657424,0.00246980445874987,0.0105836142109209,0.0016163891371143
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29507,-0.006005046623256,0.00191019777510378,-0.00974903426245942,-0.00226105898405258,0.00167004311340561
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,28491,0.0167870708170077,0.00534384664226099,0.0063131313981762,0.0272610102358393,0.00168323938895714
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28491,-0.00832553771797496,0.00265102161550293,-0.0135215400843607,-0.00312953535158921,0.00168831262865266
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,24602,0.0171068086663971,0.00545026734556105,0.00642428466909746,0.0277893326636968,0.00169893883574629
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,23848,-0.0103123755683541,0.00329314622262717,-0.0167669421647033,-0.00385780897200481,0.00174146221288526
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,29172,-0.00881257650649799,0.00282313347502753,-0.0143459181175519,-0.00327923489544404,0.00180072197651028
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24602,0.00704686072088178,0.00225842667362062,0.00262034444058536,0.0114733770011782,0.00180905300660734
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,24539,0.00742062797857686,0.00237952883885796,0.00275675145441526,0.0120845045027385,0.0018196705809062
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,28446,0.0189756442430061,0.00608555848590178,0.00704794961063859,0.0309033388753736,0.00182175808382611
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,29132,-0.00429487962630924,0.00137875534630977,-0.00699724010507638,-0.00159251914754209,0.00184097798301023
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERVV_1,,23848,-0.010118246677121,0.00325395329485832,-0.0164959951350434,-0.00374049821919873,0.00187609713506437
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29470,-0.00800230954129994,0.00257532048834812,-0.0130499376984623,-0.00295468138413763,0.0018898020763172
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,28467,-0.00712111753687308,0.00230061821947593,-0.0116303292470459,-0.00261190582670026,0.00196800718503712
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24653,0.00742629711534602,0.00240429942295436,0.00271387024635548,0.0121387239843366,0.00201219181490349
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,24119,0.00779196022011205,0.00254092985948587,0.00281173769551975,0.0127721827447044,0.00216763863194372
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,23940,0.00675451841642306,0.00220497946539422,0.00243275866425038,0.0110762781685957,0.00219152111093018
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,28884,0.0209335722547591,0.00686957626888926,0.0074692027677362,0.0343979417417821,0.00231125498381053
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,23843,-0.0075490778148951,0.00247894738529468,-0.0124078146900727,-0.00269034093971753,0.00232721037821942
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,28927,-0.0105887215574189,0.00348149834610714,-0.0174124583157889,-0.00376498479904894,0.00235670871894736
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29187,0.00722454188820174,0.0023763516999051,0.00256689255638775,0.0118821912200157,0.00236644701796384
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,28631,-0.00615292547953378,0.00202473929254334,-0.0101214144929187,-0.00218443646614884,0.00237679187557791
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,24539,0.0128601240591972,0.00423548464592028,0.00455857415319346,0.021161673965201,0.00239766903940705
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29034,-0.0048434851423392,0.00161184703624165,-0.00800270533337283,-0.00168426495130557,0.00265870064858861
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,28612,0.0161360553636904,0.00537104283331998,0.00560881141038319,0.0266632993169975,0.00266450642490926
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,23974,0.00816116699184849,0.00271649449944609,0.00283683777293416,0.0134854962107628,0.00266466949708645
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23940,0.0113868123632221,0.00379260580052305,0.00395330499419693,0.0188203197322473,0.00268161421048899
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,23843,-0.0072332930822427,0.00241586564726279,-0.0119683897508778,-0.00249819641360763,0.00275556963027383
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24539,-0.00719437655753315,0.002403290372472,-0.0119048256875783,-0.00248392742748802,0.00276024578710095
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23974,-0.00621570303932378,0.00208097602474883,-0.0102944160478315,-0.00213699003081607,0.00282091156371744
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29507,-0.00728527398104674,0.00244038870649182,-0.0120684358457707,-0.00250211211632277,0.00283539698826087
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,23848,-0.00687419134871719,0.00230280182574684,-0.011387682927181,-0.00236069977025339,0.00283733999878154
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29145,0.0618083175537338,0.0207073271285549,0.0212219563817662,0.102394678725701,0.00283950554320956
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",23940,0.00820357416721462,0.00275173896405662,0.00281016579766363,0.0135969825367656,0.00287379403664073
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28436,-0.00596283522209922,0.00200917120281405,-0.00990081077961475,-0.00202485966458369,0.0030018107947893
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,28037,-0.00995983231917301,0.00336228066245821,-0.0165499024175911,-0.00336976222075491,0.00305680672491815
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,29075,0.00597663785694864,0.00202622749824722,0.00200523196038409,0.00994804375351319,0.00318399825034341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,24119,-0.00916360229031546,0.00311056200665916,-0.0152603038233674,-0.00306690075726351,0.00322258208313028
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,28860,-0.00693173850354346,0.00235784896367025,-0.0115531224723371,-0.00231035453474977,0.00328624289973638
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28631,-0.00771540858618926,0.00262697688008722,-0.0128642832711602,-0.00256653390121831,0.00331677256109547
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24648,-0.00386418783995595,0.00131981810164789,-0.00645103131918581,-0.0012773443607261,0.00341661567998238
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,23979,-0.00780402973602386,0.00267718422006502,-0.0130513108073513,-0.00255674866469643,0.00356001693909734
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,23756,-0.008445821561996,0.00290204961606389,-0.0141338388094812,-0.00275780431451079,0.00361422717920897
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,23922,0.00890989505371218,0.00306724228692399,0.00289810017134115,0.0149216899360832,0.00367759511185589
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28412,0.00954842144593026,0.00330053211958315,0.00307937849154728,0.0160174644003132,0.00381877875112436
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,29172,0.00731208559486015,0.00252876170988203,0.00235571264349138,0.0122684585462289,0.00383608216817242
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,29023,0.00693187286705036,0.00239764777751619,0.00223248322311864,0.0116312625109821,0.00384163822882814
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,29034,0.00886698451951338,0.00306900535925645,0.00285173401537073,0.014882235023656,0.00386503468303445
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,23756,-0.00620752168342589,0.00215466571808051,-0.0104306664908637,-0.00198437687598809,0.0039681159618351
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28612,-0.00675626699378286,0.0023488353679141,-0.0113599843148945,-0.00215254967267123,0.00402495108703291
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,23974,-0.00809695563648598,0.0028171135897076,-0.0136184982723129,-0.00257541300065908,0.00405405133595448
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24539,0.0161826306007038,0.00563571928889044,0.00513662079447857,0.0272286404069291,0.00408956072571281
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",28467,0.0109203508622828,0.0038071242000213,0.00345838743024103,0.0183823142943245,0.00412858374222138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29409,0.00785829416569846,0.00274171228751124,0.00248453808217643,0.0132320502492205,0.00415727312328546
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24579,-0.00738900224085134,0.0025780809618427,-0.012442040926063,-0.00233596355563964,0.00415933996389356
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,28631,-0.00985208435322282,0.00344395152506112,-0.0166022293423426,-0.00310193936410301,0.00423023630653232
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,27294,-0.00982072590635887,0.00344068980929748,-0.0165644779325819,-0.00307697388013581,0.00431656555314137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28491,0.0104935661518793,0.00368044243314031,0.00327989898292434,0.0177072333208343,0.00435900182711044
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29359,0.0133232318723694,0.00468856699343828,0.0041336405652304,0.0225128231795085,0.00449127000691758
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23974,0.00891301395870866,0.00313714394388627,0.00276421182869156,0.0150618160887258,0.00449927932641858
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,23979,0.0190924936112214,0.00674126488863179,0.0058796144295031,0.0323053727929397,0.00462699752076319
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,23974,0.00649601433628726,0.00229504640127361,0.00199772338979099,0.0109943052827835,0.00465212383529792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,23940,0.00668944664407079,0.00236607152386813,0.00205194645728926,0.0113269468308523,0.00469904240353054
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24529,0.0107950700619129,0.00381962266170819,0.00330860964496487,0.018281530478861,0.00471399217353928
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,28491,-0.0109693357717352,0.00388327835338953,-0.0185805613443786,-0.00335811019909171,0.00473486842256098
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,23756,-0.00520013566193585,0.00184290248791629,-0.00881222453825178,-0.00158804678561993,0.00478080767525138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24529,0.0103997385091569,0.00368648418839022,0.00317422949991207,0.0176252475184017,0.00479059217287333
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,23974,-0.00530866605182218,0.00188280392469159,-0.00899896174421769,-0.00161837035942667,0.00481300032831074
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,24185,-0.00568085403574208,0.0020156476073102,-0.00963152334607007,-0.0017301847254141,0.00483063635778007
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,28631,0.00977615624566752,0.00347181527809561,0.00297139830060012,0.0165809141907349,0.00486796669481356
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,29145,-0.00705822036692951,0.00251022131192573,-0.0119782541383039,-0.00213818659555508,0.00492992610066024
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,29015,0.0116827741768396,0.00415994134848342,0.00352928913381208,0.0198362592198671,0.00498218055042033
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,23843,-0.00968936428179542,0.00347698693470974,-0.0165042586738265,-0.00287446988976432,0.00532877458551933
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24539,-0.00913641677177173,0.00327886127917565,-0.015562984878956,-0.00270984866458745,0.00533280822269662
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,24285,-0.00670223904339013,0.00240726630337741,-0.0114204809980099,-0.00198399708877041,0.0053706405145376
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29507,-0.0120968162637467,0.00434529111233312,-0.0206135868439196,-0.0035800456835738,0.00537452990850187
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,23940,0.0128113537559195,0.00460584015108531,0.00378390705979229,0.0218388004520467,0.00541430855743804
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,23979,0.0142976281660014,0.0051488594288338,0.00420586368548713,0.0243893926465156,0.00549305358949073
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,29213,-0.0107099848721633,0.00387050260611067,-0.0182961699801402,-0.00312379976418635,0.00565967080584969
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23848,0.00788062113595645,0.0028544604718738,0.00228587861108379,0.0134753636608291,0.00577024109569366
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,24699,0.00502205729216915,0.00181930398855097,0.00145622147460925,0.00858789310972905,0.00577683114744322
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,23848,-0.0129242940311158,0.00469488759398394,-0.0221262737153244,-0.00372231434690731,0.00591247122862194
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,28565,0.00739343009369844,0.00268636857426783,0.00212814768813348,0.0126587124992634,0.00592332788234405
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29226,0.012442374391033,0.00453427490785083,0.00355519557164539,0.0213295532104206,0.00607193611614539
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,23979,0.00572827688370284,0.00208749044601759,0.00163679560950837,0.00981975815789731,0.00607226948385292
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,23974,-0.00547488121304164,0.00199670414470537,-0.00938842133666416,-0.00156134108941911,0.00611192559386456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,23848,-0.0104481083992143,0.00381865891199774,-0.0179326798667299,-0.00296353693169873,0.00622243042799695
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,23974,-0.00844784350604661,0.00308869945323785,-0.0145016944343928,-0.00239399257770041,0.00624107708769638
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23848,0.0164472629542207,0.00603603075536873,0.00461664267369803,0.0282778832347435,0.00643781275522856
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,23974,-0.0111207396229523,0.00408747344802626,-0.0191321875810838,-0.00310929166482086,0.00651932412528579
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,29122,0.0129303750010224,0.00477044131859935,0.00358031001656764,0.0222804399854771,0.0067217232848466
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,23940,0.00932128002548292,0.00343930744069783,0.00258023744171516,0.0160623226092507,0.00672865003137006
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,24579,-0.00580254565277926,0.00214468224303347,-0.0100061228491249,-0.00159896845643365,0.00682383660025742
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,28467,0.0105788551215906,0.00391311862329413,0.00290914261993407,0.0182485676232471,0.00686679822927769
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23979,0.00872194142062869,0.00323171807679199,0.00238777399011638,0.015056108851141,0.00696270613352747
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24579,-0.00761270068097065,0.00282768149570534,-0.0131549564125531,-0.00207044494938818,0.00710292247174697
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,23756,-0.0107730296440148,0.00400893172000759,-0.0186305358152297,-0.00291552347279988,0.00720916957741425
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,27817,0.00528266143657504,0.00197467723155594,0.0014122940627254,0.00915302881042468,0.00747278455682573
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,24683,-0.00422840369608072,0.00158449760070796,-0.00733401899346833,-0.00112278839869312,0.00762159917679028
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28612,0.00510186518203225,0.00191323651501823,0.00135192161259651,0.00885180875146798,0.00766624936937119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29079,0.00430075355080378,0.00161382259316313,0.00113766126820404,0.00746384583340353,0.00770427191849415
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23848,-0.00814396781372074,0.00306113017621972,-0.0141437829591114,-0.00214415266833008,0.00780897658491469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,24185,-0.00733274600385197,0.00275739815215885,-0.0127372463820833,-0.00192824562562062,0.00783550614541851
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28631,0.0117066273524066,0.00441834817335428,0.00304666493263226,0.020366589772181,0.00806437112379586
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,24185,-0.00687747488093218,0.00260138024541185,-0.0119761801619394,-0.00177876959992495,0.00820390490706591
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,28491,-0.0151117957924453,0.00572497690286326,-0.0263327505220573,-0.00389084106283334,0.00830428712083239
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,24579,-0.0140197577311796,0.00531135393663184,-0.024430011446978,-0.00360950401538119,0.00830606016867184
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23848,0.00852405123440341,0.00322936962140119,0.00219448677645708,0.0148536156923498,0.00830725888778995
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24579,0.0086197277495538,0.00326746435847244,0.00221549760694782,0.0150239578921598,0.00834373349677137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,24602,-0.00957656109918718,0.00363223596520226,-0.0166957435909836,-0.00245737860739076,0.00838072072370384
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,28805,0.00735175790468968,0.00279332859415249,0.00187683386015079,0.0128266819492286,0.00849544528905764
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23843,-0.0106294126000349,0.00404117060862635,-0.0185501069929425,-0.00270871820712722,0.0085369269984454
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,23848,0.0081763649934129,0.00311195089747434,0.0020769412343632,0.0142757887524626,0.00860931658801603
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28467,0.00876723791492305,0.00334736021389671,0.0022064118956855,0.0153280639341606,0.00881959707158589
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,24683,0.00482692122760609,0.00184439382691137,0.0012119093268598,0.00844193312835238,0.00887403485800903
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,29470,0.00494932316812726,0.00189694845530376,0.0012313041957319,0.00866734214052263,0.00908272865188989
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29445,0.00696784488871399,0.00267082424287383,0.00173302937268129,0.0122026604047467,0.0090886514597304
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23365,0.0198359508772778,0.00760899577130885,0.00492231916551246,0.0347495825890431,0.00914220054817111
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23848,-0.00578310376579707,0.00222445716716924,-0.0101430398134488,-0.00142316771814535,0.00933405094743792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,23979,0.00605172130771269,0.0023361154702287,0.00147293498606444,0.0106305076293609,0.00958929571266734
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23940,0.00695406669311773,0.00268624431694758,0.00168902783190046,0.012219105554335,0.00963778884116662
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,24602,0.00808496219361014,0.00313240242364088,0.00194545344327402,0.0142244709439463,0.00985508658251703
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,23848,-0.00697184483972302,0.00270154215887984,-0.0122668674711275,-0.00167682220831853,0.00986620934198881
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,23942,-0.0126593127804096,0.00490666181075869,-0.0222763699294966,-0.00304225563132259,0.0098852060893868
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RETN,Resistin,29054,0.00760511560868042,0.00294778661684233,0.00182745383966946,0.0133827773776914,0.00988658531533113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,23940,-0.00783494296294713,0.00304053886788543,-0.0137943991440026,-0.00187548678189169,0.00997711561491652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,29256,0.00750282509940292,0.00291586750368215,0.00178772479218591,0.0132179254066199,0.0100840267592657
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,23756,-0.00616704110750513,0.00239913821150103,-0.0108693520020472,-0.00146473021296311,0.0101605318469147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,29507,-0.00473445021339007,0.00184419870069559,-0.00834907966675342,-0.00111982076002672,0.0102568567590593
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28491,0.00830317803857442,0.00323652923376363,0.0019595807403977,0.0146467753367511,0.0103090578513976
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23843,-0.00592020408427905,0.00231325735679289,-0.0104541885035931,-0.00138621966496498,0.0104959429078171
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24579,0.00598258744881767,0.0023387032129521,0.00139872915143155,0.0105664457462038,0.0105311645147395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28612,-0.00560586907458407,0.00219627812027226,-0.0099105741903177,-0.00130116395885044,0.0107022694474242
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,28631,0.00519543604511271,0.002035874039276,0.00120512292813174,0.00918574916209368,0.0107175308403097
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,23848,-0.00617398602219754,0.00242895108129725,-0.0109347301415401,-0.00141324190285493,0.0110335868712377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29034,0.0129931379206043,0.00511261001413878,0.00297242229289225,0.0230138535483163,0.0110464141371334
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28491,0.00709412688740225,0.00279265370377081,0.00162052562801145,0.012567728146793,0.0110815887652869
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,23843,-0.00897164636963282,0.00353246603986146,-0.0158952798077613,-0.00204801293150435,0.0110988795360377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,23848,-0.00904271429543554,0.00356916466509624,-0.0160382770390242,-0.00204715155184691,0.0112971996210752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28491,-0.00571239630845156,0.00225641914987719,-0.0101349778422109,-0.00128981477469226,0.0113590212134207
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24539,0.00503859656418877,0.00199049000927642,0.00113723614600699,0.00893995698237056,0.0113691276489484
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,28894,-0.0226133685511524,0.00895116364644463,-0.0401576492981839,-0.00506908780412095,0.0115322374087075
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28491,0.00722806252406798,0.00286634360170817,0.00161002906471996,0.012846095983416,0.0116842904080588
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23974,0.00497427993875949,0.00197582145549947,0.00110166988598053,0.00884688999153845,0.0118230266851647
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,23756,-0.00839464426079194,0.00333442804983258,-0.0149301232384638,-0.00185916528312008,0.0118233932507052
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,23974,-0.00855682320494323,0.00340756265496824,-0.015235646008681,-0.00187800040120547,0.0120411597586915
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24535,0.00657127078157455,0.00262536664038676,0.0014255521664165,0.0117169893967326,0.0123212963741055
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,23756,0.0152344283211814,0.00610613406550077,0.00326640555279987,0.0272024510895629,0.0126046391915695
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,23974,0.0065747587514127,0.00263763073285234,0.00140500251502211,0.0117445149878033,0.0126851479335966
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,24529,0.00898236486521774,0.00361264177493049,0.00190158698635398,0.0160631427440815,0.012911968986792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,24185,-0.006035675901562,0.00243099309888147,-0.0108004223753697,-0.00127092942775432,0.0130420639650099
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29256,0.0170359566304779,0.00690652785507803,0.00349916203452498,0.0305727512264309,0.0136442163849455
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,23843,-0.0163942190668936,0.0066517938422083,-0.0294317349976219,-0.00335670313616533,0.0137224334936612
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,24529,-0.00725404303646441,0.00294970587014587,-0.0130354665419503,-0.0014726195309785,0.013929896498277
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,28467,0.00668072758019634,0.00272773707103025,0.00133436292097705,0.0120270922394156,0.0143240511551754
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,23940,-0.00650857231518493,0.00265825588425326,-0.0117187538483213,-0.00129839078204855,0.0143548758583264
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,24683,0.00907926031981775,0.00371237137307022,0.00180301242860011,0.0163555082110354,0.0144649952175473
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23940,-0.0134048519693009,0.00548456504263264,-0.0241545994528609,-0.00265510448574091,0.0145283751818069
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23979,0.00483714752127259,0.00197928982071749,0.000957739472666305,0.00871655556987887,0.0145374037145203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28467,0.0116965329513824,0.00478733315727544,0.00231335996312254,0.0210797059396422,0.0145626866959093
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,23848,-0.00608076724835216,0.00249131627314157,-0.0109637471437096,-0.00119778735299469,0.0146626079469825
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23979,0.00776558685763441,0.00318656556963835,0.00151991834114326,0.0140112553741256,0.0148178488123457
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,28631,-0.00578193379893391,0.00238165884808319,-0.010449985141177,-0.00111388245669086,0.0152013727667294
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28631,0.00538757545098144,0.00222009970730679,0.00103618002466014,0.00973897087730274,0.015241857363822
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24185,-0.00605225100735832,0.00249706253097494,-0.0109464935680692,-0.00115800844664744,0.015368538753763
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23848,-0.0147236295157891,0.00609931207513719,-0.026678281183058,-0.0027689778485202,0.0157867293789774
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,23756,-0.0044243889512708,0.0018339159491619,-0.00801886421162814,-0.000829913690913472,0.0158494864687533
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,23843,-0.0100156548598582,0.00416176788335033,-0.0181727199112248,-0.00185858980849152,0.0161099457804952
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28467,-0.00676228148069551,0.00281076315787872,-0.0122713772701378,-0.00125318569125321,0.0161411166962717
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",28823,-0.00688848657331479,0.00286482789278711,-0.0125035492431775,-0.00127342390345205,0.0162007540622907
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24529,0.011281868090905,0.00469230806076924,0.00208494429179728,0.0204787918900127,0.0162094056942037
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,28549,0.0123195389843169,0.00514444745432284,0.00223642197384416,0.0224026559947897,0.0166392263683041
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,24110,-0.00546507221717332,0.00228260009830437,-0.00993896840984988,-0.000991176024496747,0.0166628447456207
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23979,-0.00678891467747676,0.00283667700648182,-0.0123488016101811,-0.0012290277447724,0.016706903221431
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23979,0.00621103990373686,0.00259871492510582,0.00111755865052945,0.0113045211569443,0.016854086517823
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23974,-0.00594562328021876,0.00248927232206563,-0.0108245970314674,-0.00106664952897013,0.016925069768108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,28187,-0.00440694476147084,0.00184594081776586,-0.00802498876429194,-0.00078890075864975,0.0169759297394477
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',23848,0.00724253695735176,0.00303448047620771,0.00129495522398465,0.0131901186907189,0.017005939299717
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28467,0.00826879837735836,0.00346959322341311,0.00146839565946865,0.0150692010952481,0.0171685313740563
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,23974,0.00653355542087994,0.00274319872543893,0.00115688591901964,0.0119102249227402,0.0172393415584472
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",23848,0.0066774359750576,0.00280832589659044,0.00117311721774034,0.0121817547323749,0.0174274949028461
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,28908,0.00592221200315495,0.00249087166394004,0.00104010354183248,0.0108043204644774,0.0174337872601688
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,24602,0.00427055270569941,0.00179626953644638,0.000749864414264511,0.00779124099713431,0.0174400998169248
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FST,Follistatin,29226,-0.00838038337354054,0.00353999825500726,-0.0153187799533548,-0.00144198679372632,0.0179228900903204
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28612,0.00951056687023692,0.00402989463050971,0.00161197339443788,0.017409160346036,0.0182814222952266
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,24683,-0.0105512746009406,0.00447461772551762,-0.0193215253429551,-0.00178102385892607,0.0183800586183092
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,24669,-0.00783791515293931,0.00333268900814446,-0.0143699856089025,-0.00130584469697616,0.0186891756522722
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,23756,0.00926228172446642,0.00394731964308743,0.00152553522401506,0.0169990282249178,0.018960179315068
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,23843,-0.00682926108861166,0.0029112471127812,-0.0125353054296628,-0.00112321674756051,0.0189934364921565
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,28826,-0.00563493169609031,0.00240897554454619,-0.0103565237634009,-0.000913339628779774,0.0193349714392412
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,23843,-0.00924137469503827,0.00396049450678439,-0.0170039439283357,-0.00147880546174086,0.0196360065978941
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,29172,-0.00582458646438227,0.00249960113407154,-0.0107238046871625,-0.000925368241602046,0.0198020336684175
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,29132,-0.00938508575154338,0.00403224636713708,-0.0172882886311321,-0.00148188287195471,0.0199450603756822
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23848,-0.00858513104428812,0.00370894847165198,-0.015854670048726,-0.00131559203985024,0.0206373962768811
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,24579,-0.00606781795447699,0.00262859962557691,-0.0112198732206077,-0.000915762688346249,0.020986037103148
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,28631,0.00770042681569004,0.0033420268318268,0.00115005422530952,0.0142507994060706,0.0212231034418178
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,28860,0.00645675914993825,0.0028093796859282,0.00095037496551897,0.0119631433343575,0.0215526109928684
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,29381,-0.00506419101790164,0.00220559483659567,-0.00938715689762916,-0.000741225138174118,0.0216791244442104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,24529,0.00595170043270521,0.00259657195499216,0.000862419400920584,0.0110409814644898,0.021906132614174
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,29010,0.00673148611999244,0.00294154847842951,0.000966051102270606,0.0124969211377143,0.0221204760257377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,28631,-0.00457425659254804,0.00200192084252168,-0.00849802144389053,-0.000650491741205538,0.0223239926953313
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,24529,0.00848049804242279,0.00371332891708186,0.00120237336494235,0.0157586227199032,0.0223918400387844
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,23756,-0.00753112103713861,0.00330099540376871,-0.0140010720285253,-0.00106117004575194,0.0225294789865085
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29232,0.00816951811751231,0.00359633600400322,0.001120699549666,0.0152183366853586,0.0231165535917408
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,24579,0.0110258415720491,0.00485855925667017,0.00150306542897561,0.0205486177151227,0.0232548041108346
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,23974,0.00892831343828181,0.00394628404638262,0.00119359670737188,0.0166630301691917,0.0236778560696551
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,28914,0.00924676638411424,0.00409549428771943,0.00121959758018416,0.0172739351880443,0.0239661785305003
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,23848,-0.0115943080766066,0.00513699530303259,-0.0216628188705504,-0.0015257972826627,0.0240157558911577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28093,0.0101151226295887,0.00448479605108,0.00132492236947189,0.0189053228897055,0.0241143093977738
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28467,0.00853359659630441,0.00379002121719129,0.00110515501060947,0.0159620381819993,0.0243554099038424
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,23940,-0.0110011013712754,0.00488753870987232,-0.0205806772426252,-0.00142152549992565,0.0244042756410404
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23974,0.00492771948877444,0.00219809200892482,0.000619459151281803,0.00923597982626708,0.0249823318820029
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,23848,0.00577950953803261,0.00259852232618677,0.000686405778706547,0.0108726132973587,0.0261475274357455
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,23974,-0.00889147903567378,0.00400380988251169,-0.0167389464053967,-0.00104401166595087,0.0263769050864288
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,29409,-0.00931071221783853,0.00419369823411175,-0.0175303607566976,-0.00109106367897951,0.0264150016876175
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,23756,-0.00986457066652828,0.00446578065901335,-0.0186175007581945,-0.0011116405748621,0.0271894322116811
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,28908,-0.00664025982490965,0.00300882252444005,-0.0125375519728122,-0.000742967677007145,0.0273268033802297
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24602,0.00756728259095557,0.00343354185391621,0.000837540557279804,0.0142970246246313,0.0275385676461082
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24579,0.00849658915661133,0.00386782095859852,0.000915660077758236,0.0160775182354644,0.0280484728782207
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,24683,-0.00404261318999115,0.00184272829450324,-0.00765436064721749,-0.000430865732764803,0.0282576861473167
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,24683,-0.00435447829396836,0.00199085341062967,-0.00825655097880251,-0.000452405609134215,0.0287342135268253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,23940,0.0118177001013216,0.00543234963851833,0.00117029480982571,0.0224651053928176,0.0296076129670883
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23155,-0.0169682471729952,0.00780497921496891,-0.0322660064343342,-0.00167048791165611,0.0297130960934603
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23848,-0.00764805452884931,0.00351915380199034,-0.0145455959807504,-0.000750513076948242,0.0297701761181962
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23974,0.00946850410838837,0.00435802735207331,0.000926770498324677,0.0180102377184521,0.0298158156439217
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24539,0.0065393088422382,0.00301353386792691,0.000632782461101454,0.0124458352233749,0.0300179126955962
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,23711,-0.00623404322429704,0.00287724610949473,-0.0118734455989067,-0.000594640849687378,0.0302699477055151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28491,0.00503065529244925,0.00232860708287708,0.000466585410010168,0.00959472517488833,0.0307522722436033
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,23843,-0.0138596275134176,0.00642147629369064,-0.0264457210490512,-0.0012735339777839,0.0309125917018196
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,23848,-0.00768046552048147,0.00355881737814996,-0.0146557475816554,-0.000705183459307554,0.0309260431470094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,29132,0.00636252811475523,0.00295176110755989,0.000577076343937846,0.0121479798855726,0.0311307102393768
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,23940,0.00606996900274105,0.0028162656810712,0.000550088267841492,0.0115898497376406,0.0311463206730473
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23843,-0.00747217789102061,0.00346716808162901,-0.0142678273310135,-0.000676528451027752,0.0311621000730112
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,24522,0.00863815772638441,0.00401158640171344,0.000775448379026066,0.0165008670737428,0.0313046624888323
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,23843,-0.0117083000640422,0.00544519848190876,-0.0223808890885834,-0.00103571103950103,0.0315489305698682
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,23848,-0.00786382931202982,0.00365768238319682,-0.0150328867830956,-0.000694771840964059,0.0315693071260227
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,24648,0.00222754192131417,0.00103648730427,0.000196026804944979,0.00425905703768336,0.0316341171898467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23848,-0.00607478202297241,0.00282890700115493,-0.0116194397452361,-0.000530124300708747,0.0317718666644448
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,23940,-0.0052178932085589,0.0024383746435815,-0.00999710750997864,-0.00043867890713915,0.0323724256121778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,24185,0.00657465593519868,0.00308282747034396,0.00053231409332452,0.0126169977770728,0.0329617929891469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28467,0.0217409175292245,0.0102056950574036,0.0017377552167135,0.0417440798417354,0.0331576272275105
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,23756,-0.0046427109293392,0.00219075241161934,-0.00893658565611309,-0.000348836202565297,0.0340812811008251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29041,0.0275399308100514,0.0130078601646486,0.00204452488734015,0.0530353367327627,0.0342533854492996
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24185,-0.0106809092610317,0.00504495467132375,-0.0205690204168262,-0.000792798105237129,0.0342575829254652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,23848,-0.00560490146617488,0.00264894742523134,-0.0107968384196283,-0.000412964512721459,0.0343638597023
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,23843,-0.00447370671512437,0.00212651871793412,-0.00864168340227524,-0.000305730027973492,0.0354089490393836
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,29361,-0.00639455460944284,0.00304101213223992,-0.0123549383886331,-0.000434170830252595,0.0354942144704597
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,29122,0.0096123832529499,0.00457773906324393,0.000640014688991806,0.018584751816908,0.0357541242931877
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24539,0.0167698163033828,0.0079948105152636,0.00109998769346609,0.0324396449132994,0.0359517900669458
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,28907,0.00760206931766765,0.00362829487102905,0.000490611370450712,0.0147135272648846,0.0361602858908426
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24185,-0.00927804026193861,0.00443877249314014,-0.0179780343484933,-0.000578046175383944,0.0366078729256707
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28467,0.0040553912710181,0.00194198205866719,0.000249106436030401,0.0078616761060058,0.0367819643173301
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29437,0.00766631871612292,0.00367262869888133,0.000467966466315518,0.0148646709659303,0.0368587645978553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,23974,-0.00430222676982209,0.00206821692645649,-0.0083559319456768,-0.000248521593967372,0.0375212554928303
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,23843,-0.0067406093073892,0.00325986574036372,-0.0131299461585021,-0.000351272456276313,0.0386736724995707
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,29034,0.0041236963799079,0.00199601137479398,0.000211514085311705,0.0080358786745041,0.0388403198041456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,23843,-0.0112129048750499,0.00545669809333237,-0.0219080331379813,-0.00051777661211847,0.0399006759736513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,23974,-0.0048155893170423,0.00234788715164346,-0.00941744813426348,-0.000213730499821126,0.0402747793791222
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,24529,-0.00833569379411895,0.00406654035834612,-0.0163061128964773,-0.000365274691760561,0.0403921812570928
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24653,0.00396269867680531,0.00193448625926292,0.000171105608649985,0.00775429174496063,0.0405264842974297
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,23843,-0.00696390592021689,0.00340014382997448,-0.0136281878269669,-0.000299624013466914,0.0405590815068272
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,23848,-0.00872855183299788,0.00427394842878082,-0.0171054907534083,-0.000351612912587469,0.0411358500513056
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,23979,-0.00359284827310761,0.00175951708547563,-0.00704150176063984,-0.000144194785575374,0.0411672827557803
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,29381,0.00425317326627797,0.00209881472573538,0.000139496403836621,0.00836685012871932,0.0427262393107761
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,23843,-0.0105856117849914,0.00522530189380543,-0.0208272034968501,-0.000344020073132764,0.0427925747255056
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24503,0.0124540373312768,0.00615048980971205,0.000399077304241201,0.0245089973583124,0.0428899562981835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,28612,0.00709512560574158,0.00350660648340386,0.000222176898270011,0.0139680743132131,0.0430453775847147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23979,0.00893346551496512,0.00441539302789217,0.000279295180296461,0.0175876358496338,0.0430579540488011
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,23355,-0.00996322901889665,0.00493004427613494,-0.0196261158001211,-0.000300342237672169,0.0432993585335221
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,23756,0.0103680734366181,0.00514252011631634,0.000288734008638103,0.0204474128645982,0.0437959095921323
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,24602,0.00973305874431351,0.00483557268433279,0.00025533628302123,0.0192107812056058,0.0441461612467857
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,23979,-0.00813340433205238,0.00404242595669333,-0.0160565592071713,-0.000210249456933445,0.044229976959358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,28631,-0.00664973781991347,0.00331137374128791,-0.0131400303528378,-0.000159445286989173,0.0446366490487133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_A,,24602,-0.00461579673645111,0.00230215563208726,-0.00912802177534214,-0.000103571697560084,0.0449751630567217
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,23843,-0.012911748802665,0.0064437187653748,-0.0255414375827996,-0.000282060022530412,0.0451056960295213
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,24602,0.00700555767477605,0.0035059338926178,0.000133927245245161,0.0138771881043069,0.0457059570705853
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,23848,-0.00622042877803127,0.00311317865903047,-0.012322258949731,-0.00011859860633155,0.0457176315728457
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,23843,-0.0103289804335696,0.00517658759944039,-0.0204750921284728,-0.00018286873866644,0.0460186892281489
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,29187,0.00414860308836824,0.00208335114867597,6.52348369633363e-05,0.00823197133977314,0.0464558567817346
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24683,-0.00560389328692314,0.00281479608114776,-0.0111208936059728,-8.68929678735217e-05,0.0465061855789162
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23848,-0.00682640885702374,0.003437820177294,-0.01356453640452,-8.82813095274991e-05,0.0470803679795523
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,24529,0.00620731528006316,0.00314673171035144,3.97211277743392e-05,0.012374909432352,0.0485497517891777
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,23756,-0.00513696516260912,0.00260502574570548,-0.0102428156241919,-3.11147010263711e-05,0.0486275769072444
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,23843,-0.0097697256005903,0.00495458937888485,-0.0194807207832046,-5.87304179759992e-05,0.048637853020643
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29132,-0.0163939138201603,0.00832431557998672,-0.0327095723569342,-7.82552833863033e-05,0.0489165484711741
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,23756,-0.00645314643556736,0.00327855513246381,-0.0128791144951964,-2.71783759382823e-05,0.049046326600247
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24185,-0.00952699807332738,0.00485545086239082,-0.0190436817636134,-1.03143830413772e-05,0.0497594722106126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29381,0.00629897830703895,0.00321777447142905,-7.85965696198203e-06,0.0126058162710399,0.0502914243698618
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,23756,-0.00909119331220567,0.00464540408753147,-0.0181961853237674,1.37986993560112e-05,0.0503556897251267
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24529,0.00653913179638131,0.00334209416949746,-1.13727758337219e-05,0.0130896363685963,0.0504061906902564
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,23974,-0.0058163942954204,0.00297410647021079,-0.0116456429770335,1.28543861927467e-05,0.0505147148210183
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,28467,-0.00899582666784965,0.0046044359342601,-0.0180205210989994,2.88677633001385e-05,0.0507428883109369
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,23940,0.0103851207660611,0.00531724642303436,-3.6682223086202e-05,0.0208069237552085,0.0508192364714272
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,29445,-0.00410675345550717,0.00210477528672469,-0.00823211301748756,1.86061064732321e-05,0.0510474842434596
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,29256,-0.00436237323895859,0.00224142604188406,-0.00875556828105136,3.08218031341775e-05,0.0516343991995282
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,29507,-0.00987357428429771,0.00509129360070808,-0.0198525097416855,0.000105361173090119,0.0524736594488547
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28491,0.0107722197173084,0.00556604177788279,-0.000137222167341912,0.0216816616019586,0.0529576721482311
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23848,0.00659832417048379,0.00341109125815517,-8.74146955003379e-05,0.0132840630364679,0.0530790563064333
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24529,-0.00707973690468303,0.00367043664078343,-0.0142737927206185,0.000114318911252486,0.0537605031134481
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,28908,0.00823387764699078,0.00427768126534802,-0.000150377633091338,0.0166181329270729,0.054258434129911
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,24602,0.00408878293566303,0.00213218511539957,-9.02998905201293e-05,0.00826786576184619,0.0551670875934321
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,29145,-0.0031308266869231,0.00163315454168997,-0.00633180958863544,7.01562147892489e-05,0.055242301476538
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,23848,0.00519926255462723,0.00271541306414452,-0.000122947051096033,0.0105214721603505,0.0555398575384223
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,23974,-0.00734171218581667,0.00383478248075434,-0.0148578858480952,0.000174461476461832,0.0555674924300427
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,29151,0.00712351137143162,0.00372739277498574,-0.000182178467540426,0.0144292012104037,0.0559983946826379
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24145,-0.00713495077743996,0.00373351200377141,-0.0144526343048319,0.000182732749952004,0.0560092111843416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,24651,-0.0146660433931698,0.00768180475013843,-0.0297223807034411,0.00039029391710153,0.056248878467951
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,23756,-0.0107421022310455,0.00564835079481687,-0.0218128697888866,0.000328665326795591,0.0572078075552244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_DRA,,29010,-0.0048214679990354,0.00253756331499287,-0.00979509209642142,0.000152156098350629,0.0574379775393571
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,28631,0.0108988659849363,0.00574411473419071,-0.000359598894077511,0.0221573308639501,0.0577856192569166
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,23974,0.010268135407796,0.0054148081150595,-0.000344888497720611,0.0208811593133126,0.0579315553262364
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23715,-0.00344483723010375,0.00182026518257977,-0.00701255698796009,0.000122882527752602,0.0584376376480131
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,23756,-0.0105568949669931,0.00559788408212677,-0.0215287477679615,0.000414957833975405,0.0593243507384441
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29280,-0.0056556713866276,0.00300802074765669,-0.0115513920520347,0.000240049278779512,0.0600911669179453
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,29305,-0.00545425804333944,0.00290435925539528,-0.0111468021839142,0.0002382860972353,0.0603971510296516
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,23843,-0.00817669502383856,0.00435554158389118,-0.0167135565282653,0.000360166480588151,0.0604880366733605
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24602,0.00390937091140106,0.00208693863636963,-0.000181028815883415,0.00799977063868553,0.0610448574796205
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,24529,-0.0072820458912175,0.00389132550331805,-0.0149090438777209,0.000344952095285874,0.0613079898206646
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28631,0.00779406342763266,0.00417537623932883,-0.000389674001451837,0.0159778008567172,0.0619574403934636
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,24653,-0.0139104804409063,0.00745571003005379,-0.0285236720998117,0.000702711217999143,0.0620884227024603
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24653,0.00966667704577478,0.00520337113089096,-0.000531930370771498,0.0198652844623211,0.0632133235273133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24669,-0.00389400612906685,0.00209763852887015,-0.00800537764565235,0.000217365387518647,0.063411883158152
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,23756,-0.0152606442382986,0.00823006403625573,-0.0313915697493598,0.000870281272762615,0.06371495973055
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,29037,0.0140889781869168,0.0076237211936996,-0.000853515352734409,0.029031471726568,0.0646060314966296
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24137,-0.00657844023236508,0.00356623840097909,-0.0135682674982841,0.000411387033553932,0.0651015951421229
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,23940,-0.00766738064103558,0.00416609262390462,-0.0158329221838886,0.000498160901817465,0.0657182557738805
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,23940,0.0067693084248697,0.00368944382658269,-0.000462001475232372,0.0140006183249718,0.0665510759157607
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,28446,0.00724774837403347,0.00395334241880513,-0.000500802766824593,0.0149962995148915,0.0667651954270655
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29063,0.00421629516084043,0.00230153457324157,-0.000294712602713049,0.0087273029243939,0.0669691744698228
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24602,-0.00453061191893198,0.00248246295758283,-0.00939623931579432,0.000335015477930371,0.0680060423793713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,23756,-0.0071202206879383,0.00391151119963465,-0.0147867826392222,0.000546341263345613,0.068722146782792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,23974,-0.00740133308662487,0.00406750089249949,-0.0153736348359239,0.000570968662674126,0.0688283511655554
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29061,0.0110987710652968,0.0061534089319222,-0.000961910441270725,0.0231594525718643,0.0712920870504537
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,23756,-0.00556933603001178,0.00309054127547127,-0.0116267969299355,0.000488124869911902,0.0715488886471688
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,28415,0.00457837135133383,0.00254334593211825,-0.000406586675617942,0.00956332937828561,0.0718496012738423
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,24443,-0.00913220552663553,0.00507347704888427,-0.0190762205424487,0.000811809489177646,0.0718746254934146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23940,-0.00400831686863405,0.00223720175646548,-0.00839323231130639,0.000376598574038284,0.0731992209101922
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",23848,0.00496689533191961,0.00277866513586116,-0.00047928833436826,0.0104130789982075,0.0738675888217208
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23940,0.0129886093321023,0.00729463971775846,-0.00130888451470425,0.0272861031789089,0.0749955734920553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,28631,0.0074119996118086,0.00417826371234556,-0.000777397264388698,0.0156013964880059,0.0760832916248177
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23848,-0.00866878641888465,0.00488820418492762,-0.0182496666213428,0.000912093783573471,0.0761736877783493
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,23974,-0.00513617017530567,0.00290291383283764,-0.0108258812876674,0.000553540937056099,0.0768539715636737
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,23756,-0.00751943514769272,0.00425530140142959,-0.0158598258944947,0.000820955599109267,0.077228575627446
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,24185,0.00896472369823676,0.00507586344126652,-0.000983968646645624,0.0189134160431191,0.0773837215043355
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,29470,-0.0051723779789992,0.00293098018608802,-0.0109170991437317,0.000572343185733321,0.0776201285871764
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,28855,0.00870541916810694,0.00493700188523926,-0.000971104526962021,0.0183819428631759,0.0778603650627205
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23848,-0.00778146798881125,0.00441486167239248,-0.0164345968667005,0.000871660889078015,0.0779871840753275
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,23974,0.00507449437580797,0.0028799224283954,-0.000570153583847022,0.010719142335463,0.0780778787700638
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,29284,0.0138636648565134,0.00787455746839836,-0.00157046778154734,0.0292977974945742,0.0783226153255317
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,24185,-0.00705391043834988,0.00401348652533895,-0.0149203440280142,0.000812523151314462,0.0788364593339489
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28491,0.00369127896007715,0.00210353154234744,-0.000431642862923836,0.00781420078307814,0.0793041295539769
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,23843,-0.00648515341447534,0.00370879089454316,-0.0137543835677799,0.000784076738829248,0.0803748508320757
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,27998,-0.00463162179501443,0.0026517637905684,-0.00982907882452849,0.000565835234499623,0.0807143695634532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23979,-0.00403680763350303,0.00232292038436792,-0.00858973158686415,0.000516116319858094,0.0822561296713096
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29122,0.00414221167852361,0.00238425501933014,-0.000530928159363457,0.00881535151641068,0.082341447205534
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,29384,-0.00392016084738331,0.00225753437198235,-0.00834492821646871,0.000504606521702093,0.0824896741637995
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,29507,0.00384255768410275,0.00223301745082796,-0.000534156519520064,0.00821927188772556,0.0852991346298075
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,24669,0.0106344047766155,0.00618071099433826,-0.0014797887722875,0.0227485983255185,0.0853396990123558
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,23979,0.0104113806311193,0.00607926498866371,-0.00150397874666157,0.0223267400089002,0.086798137743041
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,24119,-0.0112429518508194,0.00657606766665617,-0.0241320444774655,0.00164614077582669,0.0873384823767201
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24185,-0.00884391960371751,0.00518477268148884,-0.0190060740594356,0.00131823485200061,0.0880677134761545
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23974,0.00527172764102128,0.00309057107275317,-0.000785791661574942,0.0113292469436175,0.0880684385240744
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29034,0.00550915651398526,0.00323064162005553,-0.000822901061323581,0.0118412140892941,0.0881524579514794
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,23974,0.00438594143153404,0.00257793203953624,-0.000666805365956984,0.00943868822902506,0.0888919510372306
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28491,-0.00604350876703283,0.00355292461013701,-0.0130072410029014,0.000920223468835706,0.0889547500938112
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28612,0.0100468501859011,0.00591327386965716,-0.00154316659862695,0.0216368669704291,0.089323755012474
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,23756,0.00952072469317513,0.00562574343588553,-0.0015057324411605,0.0205471818275108,0.0905924558039777
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,23940,0.0071768875032838,0.00424267349693392,-0.00113875255070667,0.0154925275572743,0.0907361427678092
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,23756,0.00862354877299274,0.00509926477375134,-0.00137101018355987,0.0186181077295454,0.0908240103910716
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,23756,-0.00483260519645194,0.00285783489474731,-0.0104339615901567,0.000768751197252776,0.0908495008392671
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23940,-0.00564306256993478,0.00333911710557388,-0.0121877320968596,0.00090160695699002,0.0910435795284322
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,23848,-0.00706738242247225,0.00418319289509518,-0.0152664404968588,0.0011316756519143,0.0911423140270231
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,29122,-0.0072576937289465,0.00429736831495139,-0.0156805356262512,0.00116514816835822,0.0912551764719104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,23848,-0.00994454295031914,0.0058892593731343,-0.0214874913216624,0.00159840542102409,0.0913111598566491
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,28860,0.00294054331361176,0.00174356963554455,-0.000476853172055555,0.00635793979927908,0.0917089001167919
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,23974,-0.00494059880915298,0.00293473299591436,-0.0106926754811451,0.000811477862839168,0.0922929606895958
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29327,0.0034203369499248,0.00203311879208494,-0.00056457588256168,0.00740524978241129,0.0925193103612341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29127,0.00377948815461538,0.00225055197813187,-0.000631593722523081,0.00819057003175384,0.0930925319254006
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,29507,0.00293441856653672,0.00174832065287709,-0.000492289913102377,0.00636112704617582,0.0932754828569769
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,24602,0.00726384635027961,0.00437921417989402,-0.00131941344231267,0.0158471061428719,0.0971869980963354
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24119,-0.00437405677007289,0.00265072220916845,-0.00956947230004306,0.000821358759897283,0.0989277947942551
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,23940,0.00345863448933756,0.00209638680767204,-0.000650283653699648,0.00756755263237476,0.0989954594854119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,24185,-0.0195814057160422,0.0118961851070834,-0.0428979285259257,0.00373511709384135,0.0997718274725733
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,28865,-0.00552495696634135,0.00336728273498202,-0.0121248311269061,0.00107491719422341,0.100854806031289
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,28491,-0.00999624004047269,0.00610277784068202,-0.0219576846082094,0.00196520452726407,0.101436504167971
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,24539,0.00704153831767265,0.00430144742594501,-0.00138929863717956,0.0154723752725249,0.101639953823696
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,28324,-0.00769219441647376,0.00472195047422376,-0.0169472173459523,0.0015628285130048,0.103317999263498
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,23843,-0.00390324512759923,0.00240802029869535,-0.00862296491304212,0.000816474657843663,0.105044744428346
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,23974,-0.0117557445174082,0.00726000900008068,-0.0259853621575663,0.00247387312274998,0.105407387418214
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29122,0.00377182600840595,0.00233217577133094,-0.000799238503402697,0.0083428905202146,0.105824547778802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,23974,-0.00788418928232121,0.00487806191323723,-0.0174451906322662,0.00167681206762377,0.106052475681049
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,23756,-0.0105952175249472,0.00657730207896658,-0.0234867295997217,0.00229629454982731,0.107220063098986
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,29172,0.0131719070029183,0.0081973276283417,-0.00289485514863144,0.029238669154468,0.10809727241037
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,23974,0.00724110816913243,0.00452150276195359,-0.0016210372442966,0.0161032535825615,0.109283245531037
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,24602,0.00402978136254357,0.00251680376938858,-0.000903154025458042,0.00896271675054518,0.109356458111604
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,29409,0.00317769310202524,0.00198866623308256,-0.000720092714816579,0.00707547891886706,0.110075610020039
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28631,0.00408035011390761,0.00255436957526334,-0.00092621425360853,0.00908691448142376,0.110187600062584
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,23756,-0.00468517301657069,0.00296584217698422,-0.0104982236834598,0.00112787765031838,0.114186425203612
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24185,-0.00456090422897812,0.00290005259723936,-0.0102450073195673,0.00112319886161102,0.115802066692192
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,24160,-0.00423810796491929,0.0026988517158703,-0.00952785732802508,0.00105164139818651,0.116349725294944
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23843,-0.00353513832564825,0.00225395756048072,-0.00795289514419047,0.000882618492893961,0.116797851644196
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,28491,0.00341980008123953,0.00218384340046596,-0.000860532983673755,0.00770013314615281,0.117370307878454
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,23756,-0.00337720954904134,0.00215786547565731,-0.00760662588132967,0.000852206783246988,0.117579930034691
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23940,0.006010417899978,0.00384233629745796,-0.0015205612430396,0.0135413970429956,0.117769446263685
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,28631,-0.0083823196205972,0.00536183019047341,-0.0188915067939251,0.00212686755273069,0.117985630868268
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,29507,0.00575017718690194,0.00368309167263095,-0.00146868249145472,0.0129690368652586,0.118478687137398
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,28491,-0.00432287136064035,0.00277062754866284,-0.00975330135601953,0.00110755863473882,0.118711949643463
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,23979,-0.00197643405178898,0.00126893758781928,-0.00446355172391477,0.000510683620336822,0.119353105717699
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,29381,-0.00293621721135309,0.00188770860634334,-0.00663612607978604,0.000763691657079866,0.119852123009471
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,28491,-0.0180486964580851,0.0116061183150634,-0.0407966883556093,0.0046992954394392,0.119932919082076
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,23756,-0.00540595799695474,0.00347947764684235,-0.0122257341847657,0.00141381819085625,0.120276621420944
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29132,0.00383132341928708,0.00246655768683378,-0.00100312964690713,0.00866577648548129,0.120360473714269
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29089,-0.00318086380971736,0.0020499739324352,-0.00719881271729034,0.00083708509785562,0.120754335726804
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28467,0.00329058801245102,0.00212325243543203,-0.000870986760995762,0.00745216278589781,0.12120388444278
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24602,-0.00412127783611278,0.00266359604638721,-0.00934192608703171,0.00109937041480615,0.121813232303774
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,28908,-0.00131967250313527,0.000853590502536201,-0.00299270988810622,0.000353364881835688,0.122109412326765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,24699,0.00787203495964076,0.00509689606030517,-0.00211788131855738,0.0178619512378389,0.122485817256472
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,24119,0.00910458550651938,0.00593033889676994,-0.00251887873114971,0.0207280497441885,0.124734200793862
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24185,0.00702783842259972,0.00458053044852366,-0.00195000125650665,0.0160056781017061,0.124972682163233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,23848,0.00796974185958265,0.00520333249365769,-0.00222878982798642,0.0181682735471517,0.125619363881611
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28491,-0.0134353564015968,0.00877531098637386,-0.0306349659348895,0.00376425313169599,0.125770494836933
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,23756,-0.00273550211817629,0.00178763536991803,-0.00623926744321562,0.000768263206863047,0.12597190651126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24539,-0.00595755437774745,0.00390533661425443,-0.0136120141416861,0.00169690538619122,0.127149665970291
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29349,0.00681104766949134,0.00447287943079836,-0.00195579601487346,0.0155778913538561,0.12783369238118
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,28491,-0.00973771355228988,0.00641030973566092,-0.0223019206341853,0.00282649352960553,0.128755808265483
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,24653,0.00402192198439358,0.00264980857835594,-0.00117170282918407,0.00921554679797122,0.129073608298282
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,28569,-0.00598493138876526,0.0039460948309725,-0.0137192772574714,0.00174941447994083,0.129360596404917
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,28860,-0.00491847170325461,0.00324300191632384,-0.0112747554592493,0.00143781205274012,0.129368147496285
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24119,0.00267250519512524,0.00176734462401237,-0.000791490267939007,0.00613650065818948,0.130506655084847
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23848,-0.00650966571262226,0.00430826495306187,-0.0149538650206235,0.001934533595379,0.130808960515563
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,23974,-0.0108304608415945,0.00716864034423422,-0.0248809959162935,0.00322007423310461,0.130849793301322
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,29280,-0.00493187836702555,0.00326714352692058,-0.0113354796797899,0.00147172294573877,0.131172064547252
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23848,-0.00509086689606901,0.00338033963094893,-0.0117163325727289,0.00153459878059089,0.132074699232677
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23974,0.00921243372714892,0.00611993891019637,-0.00278264653683596,0.0212075139911338,0.132256381240601
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,23974,0.00522588183386249,0.00347299358703656,-0.00158118559672917,0.0120329492644542,0.132409339957762
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29349,-0.00428295759013462,0.00285772128876762,-0.00988409131611915,0.00131817613584991,0.133954000511537
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29332,-0.0023792875471796,0.00159293123740894,-0.00550143277250113,0.000742857678141922,0.135276932139436
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,28908,0.00372295058788126,0.00249645787039405,-0.00117010683809108,0.0086160080138536,0.135895456405064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29172,-0.00184109368284926,0.00123625468006512,-0.00426415285577689,0.000581965490078382,0.136432066192955
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29049,-0.00353801446364937,0.00237765622794431,-0.00819822067042022,0.00112219174312148,0.136754877330876
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24602,-0.00438524936007484,0.00295024668531803,-0.0101677328632982,0.00139723414314851,0.137185930863834
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,23940,0.00370290568163324,0.00249131619379365,-0.00118007405820232,0.00858588542146879,0.137206338732523
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23843,-0.00681428849919595,0.00459077045927101,-0.0158121985993671,0.00218362160097523,0.137730568572982
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,29132,-0.00542646467124687,0.00366011575558906,-0.0126002915522014,0.00174736220970769,0.13819320623476
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,29409,-0.00627177438921159,0.00423139477023932,-0.0145653081388807,0.00202175936045747,0.138297739719486
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,23843,0.0115942365596219,0.0078239233675729,-0.00374065324082098,0.0269291263600648,0.13838133508892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29201,-0.00235840261857965,0.00159371160415308,-0.00548207736271968,0.000765272125560383,0.138932700493304
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,28580,0.00441983273231457,0.00299912596931015,-0.00145845416753333,0.0102981196321625,0.140571534528966
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,28778,-0.00612452952382285,0.00416661544510209,-0.0142910957962229,0.00204203674857724,0.141598380543366
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,24579,-0.00274546936128346,0.00186916532834325,-0.00640903340483623,0.000918094682269302,0.141894140810369
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,29409,0.0032672665482039,0.0022253605835504,-0.00109444019555488,0.00762897329196268,0.142061563557211
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24539,0.00903079836594557,0.00616525246500483,-0.00305309646546389,0.021114693197355,0.14299111876173
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,28631,-0.0145867347548949,0.00995971267345854,-0.0341077715948736,0.00493430208508384,0.143048205448243
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,23974,-0.00475783548674132,0.00325577874559702,-0.0111391618281115,0.00162349085462884,0.143932257594835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24539,-0.00446797748566497,0.00306525616047532,-0.0104758795601966,0.00153992458886666,0.144958225811261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,29004,-0.00709746191875904,0.00487855337024439,-0.016659426524438,0.00246450268691997,0.145727378083203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,29034,0.0192862937787882,0.0132761756510558,-0.00673501049728113,0.0453075980548575,0.146318016939819
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,28344,0.00311300449619426,0.00214347869061378,-0.00108821373740876,0.00731422272979727,0.146425341227602
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24539,0.00266217406834432,0.00183407030774325,-0.000932603734832455,0.0062569518715211,0.146650284852412
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23711,-0.00534933429840875,0.00369606508437791,-0.0125936218637895,0.00189495326697196,0.147824685436501
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24653,-0.00271387894150227,0.00187644815965872,-0.00639171733443337,0.000963959451428834,0.148109984247098
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29363,0.00275116652203016,0.00190561438893859,-0.000983837680289482,0.0064861707243498,0.148829473121196
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28415,-0.00544277354252596,0.00377252174689601,-0.0128369161664421,0.00195136908139022,0.149104342706129
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,24683,0.0060627444060714,0.00420819822169138,-0.0021853241084437,0.0143108129205865,0.149682601318134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28279,0.00387966125201242,0.00269325281742863,-0.00139911427014769,0.00915843677417252,0.149733857730338
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,24579,-0.0095896755372461,0.00666051782262856,-0.0226442904695981,0.00346493939510588,0.14994259891345
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,23756,-0.00484580536702439,0.00336565534598983,-0.0114424898451645,0.00175087911111568,0.149942658442547
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,23940,-0.00381999734961414,0.00265450442256411,-0.00902282601783979,0.0013828313186115,0.150145942110189
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,24185,-0.00758430064553818,0.00527203505324123,-0.017917489349891,0.00274888805881463,0.150279468096268
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,23940,-0.0070478658012642,0.00490255679436406,-0.0166568771182178,0.00256114551568936,0.150563545318939
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24185,0.00705298056115921,0.00491402051322718,-0.00257849964476607,0.0166844607670845,0.151221121965211
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,23756,-0.00844712149377124,0.00589418753976284,-0.0199997290717064,0.00310548608416392,0.151834608116121
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,29209,-0.00307083791391851,0.00214464058273968,-0.00727433345608829,0.00113265762825127,0.152192882145691
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,24699,-0.0019685033292946,0.00137488124912698,-0.00466327057758348,0.000726263918994276,0.152224481404904
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,24491,-0.0059051659703677,0.00413998275947865,-0.0140195321789459,0.00220920023821047,0.153773015195004
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,23940,0.00922330632617661,0.00646776662334524,-0.00345351625558006,0.0219001289079333,0.15386928927291
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,24561,-0.00239013493123455,0.00167871520516033,-0.0056804167333488,0.000900146870879703,0.154520497781107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,24699,0.00184389194464333,0.00130198388215351,-0.000707996464377551,0.0043957803536642,0.156724544694577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,23848,-0.00702134691172204,0.00498729658213974,-0.0167964482127159,0.00275375438927186,0.159189636977199
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24653,0.00293848020217697,0.00209470931639905,-0.00116715005796516,0.0070441104623191,0.160685958344308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,24048,0.00829367473355817,0.00591502812195314,-0.00329978038546998,0.0198871298525863,0.160887510285158
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28199,-0.00841070036823153,0.00600590445884669,-0.020182273107571,0.00336087237110799,0.161402995336928
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24669,-0.0135178351214289,0.00970573679211443,-0.0325410792339731,0.00550540899111542,0.163702656956593
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24600,0.00221841036275789,0.00159372883930416,-0.000905298162278261,0.00534211888779405,0.163946424288023
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,23848,-0.00365756064226675,0.00263115868735997,-0.00881463166949228,0.00149951038495879,0.16451300084718
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29132,-0.00308973522385443,0.00222555605996292,-0.00745182510138175,0.00127235465367289,0.165056914729041
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,23756,-0.00433458023871914,0.00312899311811442,-0.0104674067502234,0.00179824627278513,0.165975128721394
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,23756,-0.0049911387333211,0.00360866572142791,-0.0120641235473198,0.0020818460806776,0.166647791854062
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,24529,0.00368314869347036,0.00267126900332973,-0.00155253855305591,0.00891883593999663,0.167968661597015
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,24669,-0.00861419078816194,0.00625443333747717,-0.0208728801296172,0.00364449855329332,0.16843400717911
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,28915,-0.00390823080012597,0.00283938359277367,-0.00947342264196236,0.00165696104171042,0.168697242886203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,23895,0.00655200532740158,0.00477689373575569,-0.00281070639467958,0.0159147170494827,0.170199714108668
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,23979,0.00219934739405552,0.00160685954745007,-0.000950097318946607,0.00534879210705765,0.171098362199572
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,28612,-0.0102832541255942,0.00753527430865959,-0.025052391770567,0.00448588351937855,0.17236371860428
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29226,0.00852019184723078,0.00624539033478809,-0.00372077320895388,0.0207611569034154,0.172503533268908
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23940,-0.00396714825731032,0.00292343068471102,-0.00969707239934391,0.00176277588472327,0.174788271423634
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,29381,-0.00721225153456008,0.00531799989287875,-0.0176355313246024,0.00321102825548226,0.175047160393657
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,23848,-0.00467013771824143,0.00345190151555784,-0.0114358646887348,0.00209558925225193,0.176094844320479
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,28612,-0.00505048418218064,0.0037441907687246,-0.0123890980888809,0.00228812972451958,0.177384465780157
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24683,-0.00407814384891654,0.00303963352475061,-0.0100358255574277,0.00187953785959467,0.179719771467275
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29256,-0.00345138681002045,0.00258723138317164,-0.00852236032103687,0.00161958670099597,0.182211693816564
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,23974,0.00274979330726198,0.00206724667055261,-0.00130201016702115,0.0068015967815451,0.183474320954466
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29132,-0.00471976470604383,0.00355602335322973,-0.0116895704783741,0.00225004106628644,0.184433362230595
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,23848,-0.00400457305785294,0.00302634648419918,-0.00993621216688334,0.00192706605117746,0.185769332947113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,23940,-0.00442467972988723,0.00334880678125146,-0.0109883410211401,0.00213898156136562,0.186423809597316
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,23843,-0.00581294164701025,0.00441180919248962,-0.0144600876642899,0.00283420437026939,0.187654667487164
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,23843,-0.00522016628321058,0.00396601907538357,-0.0129935636709624,0.00255323110454121,0.188111802682694
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,24529,0.00732568074830117,0.00558179963346066,-0.00361464653328173,0.0182660080298841,0.189389826804723
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,23974,-0.00498613358827752,0.00381960796526137,-0.0124725652001898,0.00250029802363477,0.191767667221439
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,24529,0.00368035697102895,0.00282024883480715,-0.00184733074519306,0.00920804468725097,0.191913277726769
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,29132,0.00328190206123163,0.00252075925940176,-0.00165878608719582,0.00822259020965907,0.192943839497145
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29034,0.00198264742368218,0.00152857354408753,-0.00101335672272937,0.00497865157009373,0.19462179516921
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28491,-0.00323020350396859,0.00249130790898681,-0.00811316700558275,0.00165275999764556,0.194782997208358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29034,0.00313940765404328,0.00242803773027844,-0.00161954629730245,0.00789836160538902,0.196027781038268
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,29226,-0.00749673615046998,0.00580180448676419,-0.0188682729445278,0.00387480064358784,0.1963193348545
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,29409,0.00414430113375343,0.00320828938665163,-0.00214394606408377,0.0104325483315906,0.196454613512793
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,29449,0.005415757448968,0.00420927599566481,-0.00283442350253502,0.013665938400471,0.19823533321736
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24650,0.00225126763495083,0.00175035807657741,-0.00117943419514089,0.00568196946504255,0.198393914669473
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,23843,-0.00344034646582112,0.00267638641771416,-0.00868606384454088,0.00180537091289864,0.198649457153509
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,23843,0.00428779814438972,0.00333586108916168,-0.00225048959036717,0.0108260858791466,0.198677356779604
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",23848,-0.00510394579657614,0.00397394008917786,-0.0128928683713647,0.00268497677821245,0.199030608609256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,23940,-0.00617519207683032,0.00481968582575938,-0.0156217762953187,0.00327139214165806,0.200120500349599
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28491,-0.00517911675678678,0.00405486031871149,-0.0131266429814613,0.00276840946788774,0.201520373313614
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,24185,-0.00319120605656358,0.00250209513938434,-0.00809531252975688,0.00171290041662972,0.20217516114557
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28631,-0.00377667279339103,0.00297831960836158,-0.00961417922577973,0.00206083363899767,0.204788659686645
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28491,-0.00435058953689604,0.00343306894971326,-0.011079404678334,0.00237822560454194,0.205072848986716
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28631,0.00516931730505867,0.00408428597580093,-0.00283588320751114,0.0131745178176285,0.205645146320398
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,29328,0.00359685209640981,0.00285567351876621,-0.00200026800037196,0.00919397219319157,0.207843222134196
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,28908,0.00495757708691911,0.00393800742672621,-0.00276091746946425,0.0126760716433025,0.208074832346709
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,23974,-0.00192979153268794,0.001539603849118,-0.00494741507695923,0.00108783201158334,0.210060100741236
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23974,-0.0039172825681417,0.00312575797788286,-0.0100437682047921,0.00220920306850871,0.210135536632149
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",23756,0.00817247071415404,0.00652537394966591,-0.00461726222719114,0.0209622036554992,0.210431326742716
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,28631,0.00441126571667701,0.00352326712644563,-0.00249433785115642,0.0113168692845104,0.210566106733747
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28467,-0.00449065050354031,0.00358984697965316,-0.0115267505836605,0.00254544957657987,0.210969975940158
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,23848,-0.0099858888019342,0.00799005888898032,-0.0256464042243356,0.00567462662046724,0.211388857311778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,24699,0.00129862187927222,0.00104148491341803,-0.000742688551027129,0.00333993230957157,0.212447990142828
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,23756,-0.00487051983464055,0.00392483844375612,-0.0125632031844025,0.00282216351512145,0.214637275370538
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,23804,-0.00299000357532699,0.00242393838917829,-0.00774092281811644,0.00176091566746246,0.217389839083252
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,23974,-0.00478078427186702,0.00388082128514594,-0.0123871939907531,0.00282562544701902,0.217998479852318
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,29152,-0.0161723054539168,0.0131596304925301,-0.0419651812192757,0.00962057031144217,0.219106815786995
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,23711,-0.00691117480142755,0.0056253173411338,-0.0179367967900498,0.00411444718719469,0.219240023615751
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,24669,0.00763113610495883,0.00621628796941495,-0.00455278831509447,0.0198150605250121,0.219607613799034
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28467,-0.00474462628488934,0.00387259946713291,-0.0123349212404699,0.00284566867069117,0.220518049212974
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,23848,-0.0038337462057741,0.00314301185338555,-0.00999404943840977,0.00232655702686157,0.222564793703056
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,29226,-0.00256020269392361,0.00210011428606617,-0.00667642669461329,0.00155602130676608,0.222824510471212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23848,-0.00441974954953574,0.0036260561986264,-0.0115268196988435,0.002687320599772,0.222899484294369
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,23848,-0.0041632132053157,0.00342143061055417,-0.0108692172020019,0.00254279079137048,0.223690540487655
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,23843,-0.0036843220742908,0.00303621146280435,-0.00963529654138732,0.00226665239280573,0.224965911439932
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,23940,-0.00310181342608664,0.00256264213287139,-0.00812459200651457,0.00192096515434128,0.226138687863516
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,28804,0.00279152393741118,0.00233014027587198,-0.0017755510032979,0.00735859887812027,0.230924225002706
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,29381,0.00289863503074329,0.00242214350991983,-0.00184876624869957,0.00764603631018615,0.231424170546282
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,23974,-0.00234470204397824,0.00196870415017429,-0.00620336217831984,0.00151395809036336,0.233670288424856
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,23974,0.00631935367842581,0.00530745119228954,-0.00408325065846169,0.0167219580153133,0.233800078346509
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24185,0.00590536810845942,0.00496202584876785,-0.00382020255512557,0.0156309387720444,0.23401393638406
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,29122,0.00333908251061229,0.00281359778475853,-0.00217556914751442,0.00885373416873901,0.23532957388255
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,28631,-0.00400292391071719,0.00338463095834033,-0.0106368005890642,0.00263095276762986,0.236947158344899
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,23756,-0.00775522177296751,0.00659677171897683,-0.0206848943421621,0.00517445079622708,0.239763093372974
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24653,-0.00227588382923657,0.00193843177681507,-0.00607521011179412,0.00152344245332097,0.240372296634488
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,23940,-0.00302783230324859,0.00258395278995326,-0.00809237977155698,0.0020367151650598,0.241295803262436
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,23843,0.00361251260107884,0.00308771710944483,-0.00243941293343302,0.00966443813559069,0.242027843392711
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,28612,0.00399655413267875,0.00341965527867222,-0.00270597021351881,0.0106990784788763,0.24253390920381
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,29002,0.00201980130013028,0.00172934231288882,-0.0013697096331318,0.00540931223339237,0.242832820317524
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29208,0.00220457749168917,0.0018883416580648,-0.00149657215811785,0.00590572714149619,0.243031165614279
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23843,0.00264284116004514,0.0022659415889857,-0.00179840435436682,0.0070840866744571,0.24349173888473
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24185,-0.00652098683862705,0.00561656593708588,-0.0175294560753154,0.00448748239806127,0.245642230560963
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,23940,-0.00531154010761924,0.00461308421480359,-0.0143531851686343,0.0037301049533958,0.24957610480999
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29381,0.00188242421034932,0.00163554431228802,-0.0013232426417352,0.00508809106243383,0.249763564573247
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,29122,0.00716882789898667,0.00624923288194434,-0.00507966854962424,0.0194173243475976,0.251327712178284
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,29132,0.00353693718871537,0.00309081782305477,-0.00252106574447197,0.00959494012190271,0.252493311821686
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,23756,-0.00329446637951902,0.00288260206876309,-0.00894436643429467,0.00235543367525663,0.253100211620279
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,24119,0.00240539372596159,0.00210875289888357,-0.00172776195585019,0.00653854940777338,0.254018103223435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23979,-0.00560710883023279,0.00492174712885022,-0.0152537332027792,0.00403951554231363,0.254609570693309
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,29132,0.0030925558174413,0.00272498866284004,-0.00224842196172517,0.00843353359660777,0.256431762058461
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,28631,-0.0025957279555009,0.00232081520042943,-0.00714452574834258,0.00195306983734078,0.263381995336242
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23242,-0.00393913908199001,0.00352857280101353,-0.0108551417719765,0.00297686360799652,0.264281853393713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,23843,-0.00556778464579624,0.0049938359895973,-0.0153557031854069,0.00422013389381446,0.264891055887435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24185,-0.00343452709386201,0.00308243626789113,-0.00947610217892863,0.0026070479912046,0.265193815518921
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,23848,-0.00264796596914642,0.00237988086205008,-0.00731253245876458,0.00201660052047173,0.265871528829518
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23940,-0.00433554262403542,0.00391192360091172,-0.0120029128818224,0.00333182763375155,0.267748084794348
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29381,0.00552568383086926,0.00499129584555815,-0.00425725602642472,0.0153086236881632,0.268275336375997
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,23711,0.00275429668063628,0.00250369856291143,-0.00215295250267013,0.00766154586394268,0.271303575928525
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24602,0.00526742670735249,0.00481079987264819,-0.00416174104303796,0.0146965944577429,0.273563712667748
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,23843,-0.00463385062659927,0.00423471865199982,-0.0129338991845189,0.00366619793132038,0.273855399893209
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,23843,-0.00499880392450354,0.0045710874260266,-0.0139581352795157,0.00396052743050859,0.274154681836244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,24579,-0.0039536917415254,0.00362466693595628,-0.0110580389359997,0.00315065545294891,0.275383124841237
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,23940,0.0059581320810179,0.00547544705845232,-0.00477374415354866,0.0166900083155845,0.276537890428131
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,29122,-0.00296584755063795,0.00272670040697087,-0.00831018034830085,0.00237848524702495,0.276734060726374
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,23940,-0.00325168159280655,0.00299153108301944,-0.00911508251552464,0.00261171932991155,0.277064408553705
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28631,0.00283967026270092,0.00261627454353581,-0.00228822784262927,0.00796756836803112,0.277759450297984
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24602,0.0027228470634215,0.00251159363666863,-0.00219987646444903,0.00764557059129202,0.278326079475856
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24185,0.00348301195168515,0.00321429102434059,-0.0028169984560224,0.00978302235939271,0.278552144309016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,23974,0.00155416899824977,0.00143726118801836,-0.00126286293026622,0.00437120092676576,0.279556479045162
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,23843,-0.00376071359061434,0.00348310569556021,-0.0105876007539123,0.00306617357268367,0.280286162932622
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,24529,-0.00205532321375975,0.00190901354644061,-0.00579698976478335,0.00168634333726384,0.281651049980489
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,23848,-0.00348633564800226,0.00323902667307638,-0.00983482792723197,0.00286215663122744,0.28178036769906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,23756,-0.00370887697762721,0.00345530797023112,-0.0104812805992802,0.00306352664402579,0.283109161291718
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,28631,0.00327639965835604,0.00305601604847888,-0.00271339179666256,0.00926619111337464,0.283677568505844
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,28674,0.00255794952129916,0.00238849298205425,-0.00212349672352717,0.00723939576612548,0.284202255594715
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,23940,-0.00589859420472415,0.00551332979034861,-0.0167047205938074,0.00490753218435912,0.284684696875909
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,28467,0.00449013540469559,0.00420303402225579,-0.00374781127892576,0.0127280820883169,0.285390607085415
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,23940,-0.00377853313547652,0.00354924101481766,-0.0107350455245191,0.0031779792535661,0.287066301088502
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,23843,0.00463023744276819,0.0043605500672505,-0.00391644068904278,0.0131769155745792,0.288315865013444
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",29409,0.00545311740074887,0.00514390362304459,-0.00462893370041853,0.0155351685019163,0.289102055068672
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23848,-0.00250553594319516,0.00237703838847152,-0.00716453118459933,0.00215345929820901,0.291867123164335
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,23974,-0.00260431603119496,0.00247136997584283,-0.00744820118384691,0.002239569121457,0.291987649113062
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,23756,0.00440035509741367,0.00418254063802092,-0.00379742455310734,0.0125981347479347,0.292774899213261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,23848,0.00372667588521646,0.00355174321410012,-0.00323474081441976,0.0106880925848527,0.294072503754493
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,23848,-0.00365911640436344,0.003504098501442,-0.0105271494671898,0.00320891665846288,0.296385406344314
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,24653,0.00194697654070496,0.00186892203533262,-0.00171611064854698,0.0056100637299569,0.297531120398694
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23843,0.00334703729245977,0.00321958201452584,-0.00296334345601087,0.00965741804093041,0.298542123947616
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29122,0.00614609767463265,0.00596366013562191,-0.00554267619118629,0.0178348715404516,0.302740968725602
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,29256,-0.00570452801932503,0.00556594166802545,-0.0166137736886549,0.00520471765000484,0.305419327164908
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24529,-0.00320306445452555,0.00314010557104356,-0.00935767137377093,0.00295154246471983,0.307714849448299
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28612,0.00348081292413718,0.00342615182708334,-0.00323444465694616,0.0101960705052205,0.309659849496601
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,23940,-0.00296629929207078,0.00292289614352705,-0.0086951757333838,0.00276257714924224,0.310187900858746
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,23940,-0.00206613830362168,0.00204209423201492,-0.00606864299837092,0.00193636639112757,0.311656249364031
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,24602,0.0032068558782933,0.00318554900110606,-0.00303682016387458,0.00945053192046119,0.314094346514736
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,29122,-0.00393676617907053,0.00392977668876793,-0.0116391284890557,0.00376559613091462,0.316458863908799
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,23545,0.00276115944890805,0.00275646283219011,-0.00264150770218457,0.00816382660000067,0.316496944078125
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,29187,-0.0022989708302786,0.00230130729284794,-0.00680953312426056,0.00221159146370336,0.317810377369737
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,23843,-0.0051503833609517,0.00517508635061501,-0.0152935526081571,0.00499278588625371,0.319636194957101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,24087,-0.00257497286280838,0.00258759438553348,-0.007646657858454,0.00249671213283723,0.319686790846682
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24185,0.00371994952062615,0.00374956320809017,-0.00362919436723058,0.0110690934084829,0.321157655140261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,23843,-0.00440483892867144,0.00447204256383435,-0.0131700423537868,0.00436036449644388,0.324647581494212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,23843,-0.00588313155806663,0.00597555146121826,-0.0175952124220544,0.00582894930592115,0.32486318530014
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,23756,-0.00439055918274396,0.00446998220965956,-0.0131517243136767,0.00437060594818877,0.325995617211351
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,23843,-0.0052911237074463,0.00539378580463161,-0.0158629438845243,0.00528069646963166,0.326619173152803
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",23940,0.00584160568199587,0.0059563000960861,-0.00583274250633289,0.0175159538703246,0.326728908318404
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29507,-0.00478958197823092,0.00491320834530993,-0.0144194703350384,0.00484030637857653,0.329648641786266
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29034,0.00247968011790906,0.002544342835771,-0.00250723184020209,0.00746659207602021,0.329773938292227
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,28823,-0.00464401008197015,0.0047655327719878,-0.0139844543150662,0.00469643415112593,0.329816688461576
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,28467,-0.00324499381058539,0.00333915768545233,-0.00978974287407196,0.00329975525290119,0.33115826154793
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,23756,0.00537323313580505,0.00553120522667157,-0.00546792910847123,0.0162143953800813,0.331339192550748
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28491,0.00377147928508917,0.00389585468142562,-0.00386439589050504,0.0114073544606834,0.333015166168951
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,23940,0.00428858097680605,0.00444168226851585,-0.00441711626948501,0.0129942782230971,0.334288782113562
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,28908,0.00888820503598169,0.00923902996311177,-0.00922029369171738,0.0269967037636808,0.336043615907556
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,23940,0.00349556399692646,0.00363667768019923,-0.00363232425626404,0.0106234522501169,0.336462793743645
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29034,0.00256092945284958,0.00267502312697687,-0.00268211587602509,0.00780397478172424,0.338399344271945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28612,-0.00206569780167268,0.00216279418474952,-0.00630477440378175,0.00217337880043638,0.339532145068411
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,28631,-0.00436193451800518,0.00457848909788401,-0.0133357731498578,0.00461190411384748,0.340749259475628
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,23756,-0.0045309709919014,0.00477058263840586,-0.0138813129631769,0.00481937097937409,0.342237232123684
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24144,-0.00361746403946048,0.00383436581612769,-0.0111328210390707,0.00389789296014978,0.345469343510543
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,23940,0.00334165093677357,0.00354600391225876,-0.00360851673125361,0.0102918186048007,0.346012289709931
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29172,0.00186565896580245,0.00198860511371814,-0.00203200705708511,0.00576332498869001,0.348162419258925
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28491,0.00310870808775338,0.00332567778066699,-0.00340962036235391,0.00962703653786068,0.349920307616553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,23974,-0.00378063606564087,0.00405868769479865,-0.0117356639474462,0.00417439181616449,0.351608385702806
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24579,0.00256241506940053,0.00275905732865894,-0.00284533729477099,0.00797016743357205,0.353038952105533
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23974,0.00388632668487494,0.00419561752626376,-0.00433708366660203,0.0121097370363519,0.354308567973022
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28631,-0.00311892550357972,0.00339469455568803,-0.00977252683272826,0.00353467582556882,0.358226406950238
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24529,-0.00493821325978839,0.00539780141637599,-0.0155179040358853,0.00564147751630854,0.360276011128716
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24602,0.0074180887549379,0.00813192659208841,-0.00852048736555539,0.0233566648754312,0.361662982290993
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,29381,0.00816114765770746,0.00900068258938488,-0.0094801902174869,0.0258024855329018,0.364559459594458
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23843,-0.00466244984030055,0.00519426558867433,-0.0148432103941022,0.00551831071350114,0.369399997038524
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,24653,-0.00310648141797627,0.00346160886668893,-0.00989123479668657,0.00367827196073403,0.369509100264642
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,23974,-0.00189627025356081,0.00211309930759703,-0.00603794489645098,0.00224540438932936,0.369520856591263
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,29277,-0.00258546456658312,0.00288638455306219,-0.00824277829058502,0.00307184915741877,0.370396332158557
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24529,-0.00547246290731151,0.00611837826759448,-0.0174644843117967,0.00651955849717367,0.371100487925625
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,23756,-0.0026034253282333,0.00292082426773917,-0.00832824089300207,0.00312139023653547,0.372759900084213
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,29079,0.00175429214159293,0.00197909039325849,-0.00212472502919372,0.00563330931237957,0.375402162975695
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24185,-0.00308448916985466,0.00348169817747406,-0.00990861759770383,0.0037396392579945,0.375672064093107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23848,-0.00321133690647103,0.0036253754028052,-0.0103170726959692,0.00389439888302716,0.375737312841825
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,23974,0.00297442481772457,0.00336976838209235,-0.00363032121117643,0.00957917084662557,0.377418421502296
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24539,-0.00636388663971413,0.00722234203690841,-0.0205196770320546,0.00779190375262635,0.378251270608421
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24529,0.00217929125697759,0.00247565592439735,-0.00267299435484121,0.0070315768687964,0.37871171027067
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24238,0.00261553048887533,0.00298601015071634,-0.0032370494065287,0.00846811038427937,0.381077754714841
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,23756,-0.00536061092831407,0.00615296505640562,-0.0174204224388691,0.00669920058224095,0.38364065843989
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24602,0.00165222163238517,0.00190057536304057,-0.00207290607917434,0.00537734934394469,0.384676740366981
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,28631,-0.00297055790282327,0.00342277966864036,-0.00967920605335837,0.00373809024771183,0.385467964785102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24539,0.00156336455473464,0.00180333541853873,-0.00197117286560127,0.00509790197507055,0.38598915628866
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,23940,0.00503088283911428,0.00583626229011858,-0.00640819124951814,0.0164699569277467,0.38869382389146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29122,0.00145006075887028,0.00170536895890165,-0.00189246240057696,0.00479258391831752,0.395170025672112
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,23756,0.00379467295917887,0.00446696319633929,-0.00496057490564613,0.0125499208240039,0.395613224433239
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24529,0.00240652080279465,0.00286825025937749,-0.00321524970558523,0.00802829131117453,0.401465980027837
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,28979,0.00329949011103903,0.00393789997463936,-0.00441879383925411,0.0110177740613322,0.402104662298789
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,24185,-0.00311224008110712,0.00372738183832353,-0.0104179084842212,0.00419342832200699,0.40374465484895
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,23974,0.00186579817427229,0.00223502954573617,-0.00251485973537061,0.00624645608391518,0.403839780611256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,23756,0.00365059109989276,0.00437906275678633,-0.00493237190340845,0.012233554103194,0.404488503125708
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24602,-0.00208591591241587,0.002520554198389,-0.00702620214125831,0.00285437031642656,0.407926394262032
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,23940,-0.00388430004514843,0.0047152896131403,-0.0131262676869034,0.00535766759660656,0.410080164690057
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTN,Titin,23848,0.00388342292824304,0.00473793412195249,-0.00540292795078385,0.0131697738072699,0.412426839204647
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C5,Complement C5,24699,0.00086580776205838,0.00106544778572159,-0.00122246989795594,0.0029540854220727,0.416441869567652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28631,0.00672166633671111,0.00828217692745179,-0.0095114004410944,0.0229547331145166,0.417038230359975
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,28631,-0.00355191523872713,0.00438033358965755,-0.0121373690744559,0.00503353859700167,0.417442597205356
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,23848,-0.00286833309143811,0.0035578532697005,-0.0098417255000511,0.00410505931717488,0.420136913518498
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24529,0.00551166265057707,0.00684090628574475,-0.00789651366948264,0.0189198389706368,0.42042834697388
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,24529,-0.00194685870952583,0.00242630117111786,-0.00670240900491684,0.00280869158586518,0.422330666540722
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24185,-0.00472434804054408,0.00589117012591813,-0.0162710414873436,0.00682234540625545,0.422597212745234
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFP,Properdin,24699,0.00129347184329175,0.00161752119333673,-0.00187686969564824,0.00446381338223174,0.423913772748475
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24529,-0.00207716176095636,0.0026185281938114,-0.00720947702082671,0.00305515349891399,0.427636684139524
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,28467,0.00166774866810168,0.00210543410270136,-0.00245890217319299,0.00579439950939634,0.428299471370814
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28631,-0.00308770227517232,0.00391142019347098,-0.0107540858543754,0.00457868130403079,0.429880736919706
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,23843,-0.00412149579552634,0.00525577489806931,-0.0144228145957422,0.00617982300468951,0.43293981164072
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24535,0.00211261938286229,0.00270266956399669,-0.00318461296257123,0.00740985172829581,0.4344109367926
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,23979,0.00264585771115613,0.00338811268733359,-0.0039948431560177,0.00928655857832997,0.434855048313701
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,28467,-0.00281411052361046,0.00363151888139785,-0.00993188753115024,0.00430366648392933,0.438397618065159
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,23848,-0.00276437680837263,0.00359791643541921,-0.00981629302179427,0.00428753940504902,0.442300473062102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,23843,-0.00523976817563223,0.00682240002823873,-0.0186116722309801,0.00813213587971568,0.442480431228899
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24185,-0.00421488263556439,0.00551950187693877,-0.0150331063143644,0.00660334104323559,0.445092474734411
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24579,-0.00145090311989955,0.00190114547598633,-0.00517714825283276,0.00227534201303366,0.445367487494814
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29064,0.00197929696200432,0.00259553036528722,-0.00310794255395863,0.00706653647796727,0.445720701626612
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28467,-0.00253995480920139,0.00334511863256586,-0.00909638732903047,0.00401647771062769,0.447678293763643
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28491,0.00244537063516676,0.00325099509159899,-0.00392657974436725,0.00881732101470077,0.451942165862969
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,23848,0.00210894156298354,0.00281210078587152,-0.00340277597732463,0.00762065910329171,0.453290812637069
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23979,0.00137897499460091,0.00184272941726941,-0.00223277466324712,0.00499072465244895,0.454266746109236
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,29034,0.00450951274366258,0.00602832627515391,-0.00730600675563908,0.0163250322429642,0.45443373253031
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,29006,0.00182441259638193,0.00244171199859884,-0.0029613429208718,0.00661016811363566,0.454957458339717
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,23974,0.00240549349618631,0.0032205311197321,-0.00390674749848861,0.00871773449086124,0.455116484111703
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,23756,-0.00301680239817765,0.00404712330830733,-0.01094916408246,0.00491555928610472,0.456025872125436
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,23756,0.00193618072274342,0.00260869049832946,-0.00317685265398232,0.00704921409946916,0.457971041353058
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28491,0.00641937302230908,0.0086517073308761,-0.0105379733462081,0.0233767193908262,0.45810702812889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,23974,-0.00471819744960593,0.00638038058284531,-0.0172237433919827,0.00778734849277088,0.459619626425705
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,23756,-0.00328472760751856,0.00450026685580365,-0.0121052506448937,0.0055357954298566,0.465460845922966
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29507,0.00159795383109562,0.00223421520569572,-0.00278110797206798,0.00597701563425923,0.474479207861898
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24185,0.0027920787800844,0.00393991923274512,-0.00493016291609604,0.0105143204762648,0.478539866990172
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,28467,-0.00263602395619465,0.00372297112608247,-0.0099330473633163,0.004660999450927,0.478924302883352
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,28527,-0.00242248068483372,0.00342379485893993,-0.00913311860835598,0.00428815723868854,0.479235137772402
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24683,-0.00129069864400822,0.00182584035763924,-0.00486934574498114,0.00228794845696469,0.479631184051519
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,23974,0.0013469059700434,0.00192084332154332,-0.0024179469401815,0.00511175888026831,0.483181565709525
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,23848,-0.00234390831798706,0.00334892574838108,-0.00890780278481397,0.00421998614883986,0.483997486131086
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23843,0.00292420379363663,0.00420260702756353,-0.0053129059803879,0.0111613135676611,0.486556430292313
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24669,-0.00124198506440039,0.00178799650997769,-0.00474645822395666,0.00226248809515588,0.487297591451949
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,23974,0.00517088270659717,0.00746466125503163,-0.00945985335326483,0.0198016187664592,0.488495147172906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,23848,0.00440485811747961,0.00637297528189681,-0.00808617343503814,0.0168958896699974,0.489460635364415
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23843,0.00299797371740858,0.00434911659948739,-0.0055262948175867,0.0115222422524039,0.490622744363983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29477,0.0027785092293307,0.00403455081800041,-0.00512921037395011,0.0106862288326115,0.491030903061926
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,23974,0.00301753811913286,0.00440362841065428,-0.00561357356574954,0.0116486498040152,0.493199719240251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,29271,0.00160479222984737,0.002343548961246,-0.00298856373419479,0.00619814819388953,0.493494437661252
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,24185,0.00290563481951535,0.00424952084979068,-0.00542342604607439,0.0112346956851051,0.494135892731652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,29205,-0.00216513114746027,0.00317169493710146,-0.00838165322417913,0.0040513909292586,0.494838709624666
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,23974,-0.00291266645322234,0.00426899235738781,-0.0112798914737024,0.00545455856725777,0.495065795602705
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23919,-0.00183613537886128,0.00271259480601322,-0.00715282119864719,0.00348055044092462,0.498480642822833
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,29423,0.00131279951116384,0.00194013460139192,-0.00248986430756433,0.005115463329892,0.49863093763383
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28491,-0.00150346211685002,0.00223870376724587,-0.00589132150065192,0.00288439726695189,0.501858427645482
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,24185,-0.00281494553049009,0.00419172234509919,-0.0110307213268845,0.00540083026590432,0.501877488559098
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29187,0.00159565659019871,0.00238076380296031,-0.0030706404636035,0.00626195364400093,0.502717219452454
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28467,0.00401359356824786,0.00599774547250768,-0.0077419875578672,0.0157691746943629,0.503383725759873
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,28467,0.00313319347163242,0.00473829415996377,-0.00615386308189657,0.0124202500251614,0.508457834362422
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29341,0.00130252065902721,0.00197157115677788,-0.00256175880825744,0.00516680012631187,0.508841277663918
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,23848,-0.0023633307375561,0.00358376602989872,-0.00938751215615759,0.00466085068104539,0.509610308035891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24185,0.00248071442758926,0.00377281901936876,-0.0049140108503735,0.00987543970555203,0.510851093463506
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,23756,-0.0015416900121732,0.00235750030497113,-0.00616239060991661,0.00307901058557021,0.513149618512084
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29470,0.00205075335897497,0.00314028219133002,-0.00410419973603186,0.0082057064539818,0.513730768879226
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,28491,-0.00632994901960227,0.00971978393444903,-0.0253807255311224,0.0127208274919178,0.514894375845052
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24602,-0.00167047331576032,0.00256822922328031,-0.00670420259338974,0.0033632559618691,0.515415557250846
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,29401,0.00096128201167402,0.00148472652274313,-0.00194878197290252,0.00387134599625056,0.517347621845497
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,23940,-0.00220564544487413,0.00341066496406882,-0.00889054877444902,0.00447925788470076,0.517838321674708
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,24162,-0.00448906477257883,0.00694524498814193,-0.018101744949337,0.00912361540417936,0.518058327215805
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,23843,-0.00241215445362161,0.00375844819987488,-0.00977871292537636,0.00495440401813315,0.521012264186796
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,29256,0.00168473242203981,0.00264922799856515,-0.00350775445514788,0.00687721929922751,0.524824844823536
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24487,-0.00180039599391682,0.00283250991473311,-0.00735211542679371,0.00375132343896007,0.525030984848566
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24185,0.00195590765027217,0.00307818051265049,-0.0040773261545228,0.00798914145506714,0.525166857382418
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24185,-0.00299990283403569,0.00472996144597711,-0.0122706272681508,0.00627082160007944,0.525934059618066
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24185,0.0024031097480527,0.00381548739498753,-0.00507524554612286,0.00988146504222826,0.528811542076407
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28631,0.00172302373057299,0.00274682606271605,-0.00366075535235046,0.00710680281349644,0.530481985509151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,23940,-0.0018160076421013,0.00290712360366665,-0.00751396990528793,0.00388195462108532,0.532190294849551
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28631,-0.0013138555022094,0.00210474798988839,-0.00543916156239066,0.00281145055797185,0.532478820613345
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,23843,0.00210572608095258,0.00337454885327833,-0.00450838967147295,0.00871984183337811,0.532632080140237
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23848,-0.00179463816111608,0.00288237691117297,-0.00744409690701509,0.00385482058478293,0.533537337536804
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24602,-0.00331610231375549,0.00532879798536955,-0.0137605463650798,0.00712834173756883,0.533751461704292
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,29381,0.00124512749708255,0.00200236145537657,-0.00267950095545553,0.00516975594962063,0.534058789132078
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,23756,-0.00194204605912331,0.00312408407791613,-0.00806525085183892,0.0041811587335923,0.534186595621917
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,28371,-0.00205372531983382,0.00332472352806044,-0.00857018343483227,0.00446273279516464,0.536769427097184
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,23756,-0.00137370878545703,0.00224866166878903,-0.00578108565628352,0.00303366808536946,0.541271229125865
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,23843,-0.00210654963007416,0.00346789626120814,-0.00890362630204212,0.0046905270418938,0.543562686077101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,23974,-0.00145463509256199,0.00239683306668517,-0.00615242790326492,0.00324315771814094,0.54392383054309
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29017,-0.00120773747136147,0.00199537656650947,-0.00511867554172002,0.00270320059899709,0.545005713173093
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,27979,0.00097869932542789,0.00161777214504762,-0.00219213407886546,0.00414953272972123,0.545205600591385
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,28467,-0.00162218118555739,0.00268531844731861,-0.00688540534230186,0.00364104297118708,0.545786850212496
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,29256,0.000924670553834121,0.00153153722995833,-0.00207714241688421,0.00392648352455245,0.546012399956818
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29423,0.00196126582252972,0.00325759396895573,-0.00442361835662352,0.00834615000168296,0.547139086354504
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23979,-0.00326717696098347,0.00544010592609628,-0.0139297845761322,0.00739543065416525,0.548130567491674
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23843,-0.00239641660637986,0.00399327185070965,-0.0102232294337708,0.00543039622101106,0.548436259460437
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23848,-0.00276868614507279,0.0046406288028371,-0.0118643185986335,0.00632694630848793,0.55076761812126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,23756,-0.00290814111955046,0.00487928669716446,-0.0124715430459928,0.00665526080689189,0.551169100093348
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,23940,-0.00113318641139053,0.00192635965317764,-0.00490885133161871,0.00264247850883764,0.556368191219983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,23843,-0.00182263152799122,0.00310291064928958,-0.00790433640059879,0.00425907334461636,0.556944595072811
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,24185,0.00171422285876053,0.00292344103730997,-0.00401572157436702,0.00744416729188807,0.557631286785099
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23979,0.00376654414487778,0.00644738499072003,-0.00887033043693347,0.016403418726689,0.559093155873405
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,23756,-0.00247910068759797,0.00426303376299294,-0.0108346468630641,0.00587644548786818,0.56088587650111
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24658,0.00079674861736236,0.0013703181597475,-0.00188907497574273,0.00348257221046745,0.560953773779308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24529,0.00183771359478437,0.00316405562026615,-0.00436383542093729,0.00803926261050602,0.561374183943648
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24529,0.00247458257641764,0.00429277608594282,-0.00593925855203028,0.0108884237048656,0.564314491300471
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29361,0.00122261510466395,0.00213153958287217,-0.0029552024777655,0.00540043268709341,0.566254338720178
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,23756,0.00213966045401681,0.0037361781042421,-0.00518324863029771,0.00946256953833132,0.566862096132401
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,23974,0.00123539138922328,0.00216019727297162,-0.0029985952658011,0.00546937804424767,0.567403065197061
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,29102,-0.00513188510966624,0.00898449731418872,-0.0227414998454761,0.0124777296261437,0.567872999154467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,23974,-0.00164074857444786,0.00287419594955507,-0.00727417263557579,0.00399267548668008,0.568103421340146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,28467,0.00129288757955937,0.00228903251204011,-0.00319361614403925,0.00577939130315799,0.572201773425238
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,28467,-0.00132405628030274,0.00235503070659658,-0.00593991646523204,0.00329180390462656,0.57396740771566
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,23848,-0.00223906013510821,0.00399682985025041,-0.010072846641599,0.0055947263713826,0.575342140282916
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,23940,0.001645368939783,0.00294976525195554,-0.00413617095404985,0.00742690883361585,0.576988523948705
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,28631,-0.00174122591633989,0.00314331727966656,-0.00790212778448635,0.00441967595180656,0.579620591847834
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,24529,-0.00135870680864894,0.00246085677906447,-0.00618198609561529,0.00346457247831742,0.580866005325881
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,23843,-0.00420095457951937,0.0076373126732747,-0.0191700874191378,0.010768178260099,0.582285678213106
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,24602,0.00144043516581389,0.00263353133636543,-0.00372128625346235,0.00660215658509013,0.584411472689526
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,24185,-0.00116226214061148,0.00216236953434807,-0.0054005064279337,0.00307598214671073,0.59093090058859
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24123,0.00241682664295673,0.00451546501696729,-0.00643348479029916,0.0112671380762126,0.592493570711308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",23756,-0.00207861030719122,0.00388459694760343,-0.00969242032449394,0.00553519971011149,0.592592399836522
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,23843,-0.00141640774218588,0.00265184813114099,-0.00661403007922223,0.00378121459485047,0.59326281291572
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,23756,-0.00238979252304551,0.00448453615182807,-0.0111794833806285,0.0063998983345375,0.594110385058212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,28631,-0.00145462412484689,0.0027381564352634,-0.00682141073796315,0.00391216248826937,0.595255107605065
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24602,-0.00285537121198203,0.00539047304115543,-0.0134206983726467,0.00770995594868261,0.596319888252107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,29187,-0.000893455112614328,0.00169031950490574,-0.00420648134222957,0.00241957111700092,0.597106593431302
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28491,-0.00135189871139497,0.00255814784257168,-0.00636586848283547,0.00366207106004553,0.59717882258417
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,23974,0.00120391697957374,0.00227823995351748,-0.00326143332932052,0.005669267288468,0.597197700121558
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,24185,-0.0015456807962636,0.00293457149243054,-0.00729744092142746,0.00420607932890025,0.598396830695972
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23848,0.00220495348794659,0.00420297655668867,-0.0060328805631632,0.0104427875390564,0.59985425701704
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,23974,-0.00332959058929735,0.00638072319072785,-0.0158358080431239,0.00917662686452924,0.601800310592132
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24653,0.00111024593774604,0.0021405262189327,-0.00308518545136205,0.00530567732685413,0.603989286273972
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,28908,0.00151471191769684,0.0029276020059823,-0.00422338801402846,0.00725281184942214,0.604887919743777
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,23796,-0.00311564514315761,0.00602378689134947,-0.0149222674502026,0.00869097716388736,0.6050048431415
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29271,-0.00101671380870294,0.00197813507225019,-0.00489385855031332,0.00286043093290744,0.60727270278575
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,28631,-0.00194709487197494,0.00379654078838074,-0.00938831481720119,0.00549412507325131,0.608053036725923
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,28631,0.00326465565626064,0.00643811155733061,-0.00935404299610736,0.0158833543086286,0.612100627911794
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23940,-0.00175828777210453,0.00346826163023574,-0.00855608056736657,0.00503950502315752,0.61218394465414
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28491,0.00191076102508156,0.0037721739202689,-0.0054826998586455,0.00930422190880861,0.61248078536894
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,23848,-0.0023154453904704,0.00460981030637196,-0.0113506735909594,0.00671978281001864,0.615470658788392
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29172,0.00157790838635124,0.00315653294780311,-0.00460889619134285,0.00776471296404534,0.61715873087551
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,23756,0.000932688479074787,0.0018674522057727,-0.00272751784423971,0.00459289480238928,0.617471000223548
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,23974,-0.00131983078279755,0.00266241095614723,-0.00653815625684612,0.00389849469125102,0.620091108143736
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24529,0.00172204585339137,0.00347829008544817,-0.00509540271408706,0.00853949442086979,0.620545247440053
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23940,-0.00178416167197558,0.0036061371860094,-0.008852190556554,0.00528386721260285,0.620776192674895
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,28811,-0.00149291100386757,0.00302916977656752,-0.00743008376593992,0.00444426175820477,0.622125910279138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,23974,-0.000906199619919344,0.00184310611353002,-0.00451868760243818,0.0027062883625995,0.622957292693802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,23940,0.00207078653498068,0.00426190165374037,-0.00628254070635045,0.0104241137763118,0.627054409769678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,23974,0.00103371227871196,0.00212831750683806,-0.00313779003469064,0.00520521459211456,0.627188167987627
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24185,0.00179375263488164,0.0036934407283823,-0.00544539119274767,0.00903289646251095,0.627213378063067
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,23848,-0.00208473430124056,0.00429983077711616,-0.0105124026243882,0.00634293402190711,0.62779358476286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24119,0.00180151889199837,0.00372480917295402,-0.00549910708699151,0.00910214487098825,0.628635830754494
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24185,0.00293404180092776,0.00609635424709568,-0.00901481252337978,0.0148828961252353,0.630323215086439
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24653,-0.00132113081252474,0.00277422699559441,-0.00675861572388979,0.0041163540988403,0.633924845211251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29034,0.00147663517006225,0.00314855172666348,-0.00469452621419817,0.00764779655432267,0.639081238732303
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,24529,-0.00361328409109164,0.00774178180731607,-0.0187871764334311,0.0115606082512479,0.640700698221442
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,23756,-0.00133160924834634,0.00287355276249928,-0.00696377266284493,0.00430055416615225,0.643080704930249
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24602,0.00231274916397761,0.00501442489072904,-0.00751552362185131,0.0121410219498065,0.644645409481117
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,29122,0.00111870754380708,0.00243428865592031,-0.00365249822179673,0.00588991330941089,0.645833783015864
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,24185,-0.00144677873263834,0.00315960109815871,-0.0076395968850294,0.00474603941975273,0.647028996581784
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,28631,0.00102590144953536,0.00224706968352296,-0.00337835513016965,0.00543015802924037,0.647997418375676
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,23974,-0.00153359974794816,0.00336025047657456,-0.00811969068203429,0.00505249118613797,0.648110475817098
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,23756,-0.00131066475345641,0.00288936762454268,-0.00697382529756007,0.00435249579064725,0.650109040343307
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29034,0.00180216540769868,0.00398916911933352,-0.00601660606619502,0.00962093688159238,0.651441947848573
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,28853,-0.00100670413166278,0.00223414458152942,-0.00538562751146045,0.00337221924813488,0.652281711272248
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24185,0.00269792013125065,0.00600748337114528,-0.0090767472761941,0.0144725875386954,0.653368427953278
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24185,-0.00114823987424188,0.0025655357800089,-0.00617669000305932,0.00388021025457555,0.654472345114363
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,23979,0.00222529448104046,0.00497207339068695,-0.00751996936470596,0.0119705583267869,0.654475792540948
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,23979,-0.00124542469899718,0.0028018244028737,-0.00673700052862962,0.00424615113063526,0.656681595069275
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,23756,-0.00166425823790136,0.00377076143874854,-0.00905495065784849,0.00572643418204577,0.65895738035661
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,28612,0.00414693816601842,0.00940270421820214,-0.0142823621016578,0.0225762384336946,0.659189721707031
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,29271,-0.00130737468481403,0.00297595684775215,-0.00714025010640824,0.00452550073678017,0.660438449717346
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24185,-0.0019960392206589,0.00455348412291398,-0.0109208681015703,0.0069287896602525,0.661133406567742
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",23974,0.000884217999868503,0.00204555587867281,-0.0031250715223302,0.00489350752206721,0.665554208570568
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29470,-0.00178050680360091,0.004130200367911,-0.00987569952470647,0.00631468591750466,0.666402789393401
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,24579,0.000814729227927836,0.00190029317240305,-0.00290984538998215,0.00453930384583782,0.668117151795963
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23979,-0.000777228689557445,0.00183746540376105,-0.0043786608809291,0.00282420350181421,0.67230667081908
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24529,0.00183050253832277,0.004384844343052,-0.00676379237405914,0.0104247974507047,0.676344728260983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,23940,0.00192924282195714,0.00463858524145316,-0.00716238425129106,0.0110208698952053,0.677478198332902
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,28612,0.000801535662949947,0.00192920538453769,-0.00297970689074393,0.00458277821664382,0.677797688124967
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29409,-0.00111481724062543,0.00269128187958621,-0.00638972972461441,0.00416009524336355,0.67870664191612
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,23843,-0.00146018450962811,0.00354764201327596,-0.008413562855649,0.00549319383639277,0.680641487681634
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,28631,0.00171373796382334,0.00420409309838032,-0.00652628450900208,0.00995376043664876,0.683544281857517
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,23940,-0.00165279854447501,0.0040780286851873,-0.00964573476744212,0.00634013767849209,0.685265402960983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24185,-0.00179811929774564,0.00445513305333042,-0.0105301800822733,0.00693394148678198,0.686505900111087
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,24119,0.000812318074958993,0.00201484418383829,-0.00313677652536405,0.00476141267528204,0.686829172971037
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28612,0.000933683425016268,0.00234561015132781,-0.00366371247158625,0.00553107932161878,0.69059212016888
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23715,-0.00135255741919968,0.00342020959353707,-0.00805616822253235,0.00535105338413299,0.692506707839473
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,29172,0.0012774238465842,0.00324488490639971,-0.00508255056995923,0.00763739826312764,0.693825294781751
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,24669,-0.00118427074198756,0.00305255021255573,-0.00716726915859679,0.00479872767462167,0.698048169535088
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,23974,0.000785032713209641,0.0020337785596576,-0.00320117326371926,0.00477123869013855,0.699502212021029
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,29172,-0.00077294157827197,0.00200939856180258,-0.00471136275940503,0.00316547960286109,0.70048980653152
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,23974,0.000901684387254201,0.00234860915173033,-0.00370158955013724,0.00550495832464564,0.701039141423886
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,24185,-0.00143946441162188,0.00378168821043374,-0.00885157330407201,0.00597264448082825,0.70347322857717
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,23974,0.0012464457947343,0.00329591390598742,-0.00521354546100105,0.00770643705046964,0.705300891627233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29470,0.000924149099136289,0.00245480272631979,-0.0038872642444505,0.00573556244272307,0.706573400151362
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29206,-0.00129706698965535,0.00344790395482334,-0.0080549587411091,0.0054608247617984,0.706778382833652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23843,-0.00144362272792104,0.00384027832711956,-0.00897056824907538,0.0060833227932333,0.706982563806367
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,23974,-0.00174399961200517,0.00467548720149212,-0.0109079545269297,0.00741995530291938,0.709144916881925
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,23848,-0.00256781235223775,0.00692958559271906,-0.0161498001139671,0.0110141754094916,0.710970172749759
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,23974,-0.000685616327758691,0.00185916901735349,-0.00432958760177153,0.00295835494625415,0.712298188227616
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,23848,0.000870141378767619,0.00236559485370622,-0.00376642453449657,0.00550670729203181,0.713001806920341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24653,0.000871407468332814,0.00237197763885382,-0.00377766870382067,0.00552048364048629,0.71334178577776
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,23974,-0.000437955757378534,0.00119255086824703,-0.00277535545914271,0.00189944394438564,0.713441136545112
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,28612,-0.00182467773512266,0.00501021659035217,-0.0116447022522129,0.00799534678196759,0.71571778984391
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,28631,-0.0016565488351807,0.00458059274406303,-0.0106345106135442,0.00732141294318284,0.717619941706158
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24539,-0.00372736311945859,0.0103752164645698,-0.0240627873900154,0.0166080611510982,0.719406366054371
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24119,-0.000636734765136513,0.00179820581678468,-0.00416121816603448,0.00288774863576145,0.723271171130231
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,29080,0.00195477776586132,0.00553180493589882,-0.00888755990850038,0.012797115440223,0.723813113766565
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28491,0.00190795126689496,0.00542599125714627,-0.00872699159711172,0.0125428941309016,0.725116988242881
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,28491,0.00131695198880192,0.00375406239537249,-0.00604101030612816,0.00867491428373201,0.725735615973895
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,28491,0.002100657661505,0.0060989847981035,-0.00985335254277786,0.0140546678657879,0.730527406341432
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23974,-0.00118512738783305,0.00344247124047685,-0.00793237101916767,0.00556211624350157,0.730648926658993
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24539,0.000518912281485079,0.00151004875935298,-0.00244078328684676,0.00347860784981692,0.731120420217737
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24529,-0.00107278842484595,0.00320017106646261,-0.00734512371511267,0.00519954686542077,0.737455621725518
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,29331,-0.00113857272434945,0.00345811145523336,-0.00791647117660683,0.00563932572790794,0.741971373996385
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",24529,-0.000997134723489555,0.00304589059712574,-0.00696708029385601,0.0049728108468769,0.743390472216611
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BSND,Barttin,23756,-0.00076994397341452,0.00238027166863524,-0.00543527644393958,0.00389538849711054,0.746342969191568
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24699,-0.000379316740515481,0.00118040241948634,-0.00269290548270871,0.00193427200167774,0.747951470133906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,23879,0.000891116795590984,0.00278021004746173,-0.00455809489743401,0.00634032848861597,0.748575922576152
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,23974,-0.00105096870746301,0.00330204358299608,-0.00752297413013534,0.00542103671520931,0.750276642640587
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,24669,-0.000978585371964704,0.0030965172527083,-0.00704775918727298,0.00509058844334357,0.75198412245983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",23756,0.00112683769261092,0.00360287423420025,-0.00593479580642157,0.00818847119164341,0.754465174862694
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24185,0.0008553174617754,0.00273908508297987,-0.00451328930086515,0.00622392422441594,0.754842646755757
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,29409,0.000639010130864523,0.00206724462193027,-0.00341278932811881,0.00469080958984785,0.757238517881153
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29507,0.000659133193729036,0.00213248414229957,-0.00352053572517813,0.0048388021126362,0.757253940045475
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,24185,-0.000499073611956744,0.00162561228666883,-0.00368527369382765,0.00268712646991416,0.758841035037433
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,29268,0.00324135427702218,0.0107008530370745,-0.0177323176756438,0.0242150262296882,0.761963532337356
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29069,-0.000858333849847899,0.0028519465371423,-0.0064481490626468,0.004731481362951,0.763443936218635
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,23979,-0.000889081588427181,0.0029557796079866,-0.00668240962008092,0.00490424644322656,0.763573982561713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29034,0.000510633342359706,0.00169806190788795,-0.00281756799710067,0.00383883468182008,0.763633689344646
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,23848,0.000804758671415559,0.00267838664055258,-0.0044448791440675,0.00605439648689862,0.763825899251108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23843,0.00122129213524816,0.00407645639988913,-0.00676856240853453,0.00921114667903085,0.764487555015111
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,23940,0.000480152753900643,0.00161181875545473,-0.00267901200679062,0.0036393175145919,0.765785888084911
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,28467,0.00120572623086041,0.0040489990301018,-0.00673031186813913,0.00914176432985995,0.765870370157318
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,23848,0.00096058456958366,0.00322913192474383,-0.00536851400291426,0.00728968314208158,0.766106827037023
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,24185,0.00179861098943854,0.00605326296732792,-0.0100657844265242,0.0136630064054013,0.766369188640545
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28612,0.000903858327176389,0.00305559061507588,-0.00508509927837233,0.00689281593272511,0.767381315703904
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,24529,-0.000918059154150009,0.00311584852707418,-0.00702512226721541,0.00518900395891539,0.768270037752547
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28467,-0.00103660541047401,0.00352832304779682,-0.00795211858415578,0.00587890776320776,0.76891632192537
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,28467,0.00092497847785267,0.00318631866943971,-0.00532020611424917,0.00717016306995451,0.771591214848329
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,29034,-0.000663871092207693,0.00228694160682514,-0.00514627664158497,0.00381853445716958,0.771598197625793
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24185,-0.000817992274025407,0.00281832029901335,-0.00634190006009157,0.00470591551204075,0.7716343151648
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24162,0.00205224366795354,0.00709916114562719,-0.0118621121774757,0.0159665995133828,0.772520681860016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,23756,0.000840658360462923,0.00293642716711723,-0.00491473888708685,0.00659605560801269,0.774661480725765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,23848,-0.000651533206757664,0.00228796633892969,-0.00513594723105985,0.00383288081754452,0.77582650440066
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,23940,-0.000837879551269319,0.00294298745874411,-0.00660613497040777,0.00493037586786913,0.775873585215325
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",23848,-0.000785914901212135,0.00276768565474428,-0.00621057878451093,0.00463874898208666,0.776442703178701
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24119,-0.000739208360585137,0.00260336630723564,-0.00584180632276699,0.00436338960159671,0.776456289270147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,23974,-0.00149280915625044,0.00528340408675701,-0.0118482811662942,0.00886266285379329,0.777526672538516
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,23979,0.00124418912455347,0.00441801902244107,-0.00741512815943104,0.00990350640853797,0.778239659067857
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28612,0.00152205861724927,0.00546700637273183,-0.00919327387330512,0.0122373911078037,0.780701148831798
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,23843,-0.00111371797204301,0.00407258202734043,-0.00909597874563026,0.00686854280154423,0.784496402894679
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",23756,-0.000940822992221713,0.00344368362995548,-0.00769044290693446,0.00580879692249103,0.784699931214221
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24579,0.000489864066834457,0.00180933491418721,-0.00305643236497247,0.00403616049864139,0.786591272771782
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,24579,-0.000427716529604379,0.00158989719594001,-0.00354391503364679,0.00268848197443804,0.787915396548081
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28612,-0.00114049406181441,0.00429220308658289,-0.00955321211151686,0.00727222398788805,0.790462183407704
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,23940,0.00100670336994624,0.00380085178042075,-0.00644296611967843,0.0084563728595709,0.791117615395456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,29132,-0.000608220548928616,0.00237759390796857,-0.00526830460854702,0.00405186351068979,0.798096679007122
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,23940,0.00125096370416817,0.00490085195628185,-0.00835470613014425,0.0108566335384806,0.798528861787519
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,24539,0.00202088484677245,0.00803880461912847,-0.0137351722067194,0.0177769419002642,0.80151376664251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,23940,0.000891167493274571,0.00357697588370622,-0.00611970523878962,0.00790204022533877,0.803254687995726
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,28631,-0.000902699893764187,0.0036724896780732,-0.00810077966278765,0.00629537987525928,0.805838412803968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,28367,-0.000759405425385362,0.0031546341978823,-0.00694248845323468,0.00542367760246396,0.809768501232456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28467,0.00132628210567594,0.00552549952794419,-0.00950369696909467,0.0121562611804465,0.810309226340251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,24490,0.000870230857321499,0.00364064696257347,-0.00626543718932251,0.00800589890396551,0.811082827714057
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,22789,-0.000879703814534762,0.00373860346936383,-0.00820736661448786,0.00644795898541834,0.813975847970088
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,23756,0.000966495134254279,0.00419869439389003,-0.00726294587777017,0.00919593614627873,0.817946546141446
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,23843,0.00118522633852513,0.00518580340065169,-0.00897894832675219,0.0113494010038024,0.819219006825554
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,24602,0.00254436027835726,0.0111519999214712,-0.0193135595677263,0.0244022801244408,0.819529332203222
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,24699,0.000302584805918954,0.00136164877904464,-0.00236624680100854,0.00297141641284645,0.824144913165147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28467,0.000979444545029563,0.00445202868982546,-0.00774653168702834,0.00970542077708747,0.825873042061531
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,23843,-0.000536325064075268,0.00245140349570215,-0.00534107591565148,0.00426842578750094,0.826821074046661
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24529,-0.000634962083693403,0.00296067009557546,-0.00643787547102131,0.00516795130363451,0.830185722448853
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24683,-0.000392536812876382,0.00183181782103953,-0.00398289974211386,0.0031978261163611,0.830324146139513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,23756,-0.000815367515429738,0.0038110315076748,-0.00828498927047235,0.00665425423961287,0.83058843325417
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,29273,0.000512113705929752,0.00239933974029153,-0.00419059218504164,0.00521481959690114,0.830985715628827
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",23843,-0.00123547981774594,0.00592533144875499,-0.0128491294573057,0.0103781698218138,0.834834012464357
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29215,0.000837387309878337,0.00402209457334653,-0.00704591805388086,0.00872069267363754,0.835076741540618
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29381,-0.000665877648079018,0.00329006404692811,-0.00711440318005812,0.00578264788390008,0.839612870750754
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24683,0.00045743000004034,0.00226650335026258,-0.00398491656647432,0.004899776566555,0.840057628544383
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,28631,-0.000429349792084811,0.00213393745904476,-0.00461186721181253,0.00375316762764291,0.840543044249164
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24602,0.000333048272548241,0.00167721168602642,-0.00295428663206354,0.00362038317716002,0.842598736461034
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,23974,0.000388514486004565,0.00207791572891668,-0.00368420034267212,0.00446122931468125,0.851683254096492
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28467,0.000553318050330051,0.00298488833168082,-0.00529706307976436,0.00640369918042446,0.852937714777983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24185,-0.000863818639869688,0.00467792355381584,-0.0100325488053487,0.00830491152560937,0.853498398531278
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,24699,0.000270875098706828,0.00146955771546183,-0.00260945802359836,0.00315120822101202,0.853760618574913
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29507,0.000372895395823941,0.00204361046950891,-0.00363258112441352,0.0043783719160614,0.85521599704852
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23756,0.000727098514135935,0.00406902249703129,-0.00724818558004539,0.00870238260831726,0.858181703787096
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,23843,0.00050210317548015,0.00283156053149384,-0.00504775546624778,0.00605196181720808,0.859255536147948
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28467,-0.000485872927233243,0.00275581651015289,-0.00588727328713291,0.00491552743266643,0.86005310960475
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,23940,-0.00046980869304191,0.00266857780826588,-0.00570022119724304,0.00476060381115922,0.860254511725734
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24539,-0.00212043755334765,0.0121295009302179,-0.0258942593765748,0.0216533842698795,0.861225223570235
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,23974,0.000287019526359123,0.00164498828657553,-0.00293715751532892,0.00351119656804717,0.861488780406834
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23940,-0.000598444333451917,0.00346342376565632,-0.0073867549141383,0.00618986624723446,0.862818108796624
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,23940,-0.000405860848634558,0.00236435298378322,-0.00503999269684967,0.00422827099958055,0.863707611019745
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23848,-0.000799559760903678,0.00473741485811124,-0.0100848928828017,0.00848577336099435,0.865974629083094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,23974,-0.00077291132533643,0.00461838652471874,-0.00982494891378515,0.00827912626311229,0.867091930211228
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,24340,0.000362302251526655,0.00218104970545971,-0.00391255517117437,0.00463715967422768,0.868068847984898
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,29034,0.000220800801055442,0.00134094970050944,-0.00240746061194307,0.00284906221405395,0.869212735633132
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29034,0.000361197200093406,0.00219788326899573,-0.00394665400713822,0.00466904840732503,0.869465690488424
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,24602,-0.000245069903333142,0.00154352521164115,-0.0032703793181498,0.00278023951148351,0.873849140691025
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,24392,-0.000332164107400022,0.00209977072875727,-0.00444771473576428,0.00378338652096423,0.8743078773617
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,23848,-0.000435762815386723,0.00282293532890318,-0.00596871606003696,0.00509719042926351,0.877323143171588
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,24539,-0.00277467228423094,0.0182442466975604,-0.0385333958114494,0.0329840512429875,0.879121317695235
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,23848,0.000508565439677457,0.00335234052365978,-0.00606202198669572,0.00707915286605063,0.879421221955901
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,23940,-0.000388860136306747,0.00256410801382806,-0.00541451184340975,0.00463679157079626,0.879460226766985
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,29172,0.000842437130141538,0.0056636877214988,-0.0102583908039961,0.0119432650642792,0.881757008501497
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,28467,0.000501087655794765,0.00338447153729619,-0.00613247655730577,0.0071346518688953,0.882300476635583
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,28976,-0.000391895239383299,0.00269233437020155,-0.00566887060497834,0.00488508012621174,0.884270038942288
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,28412,0.000351039126989387,0.00242503819405095,-0.00440203573335048,0.00510411398732925,0.884904453320809
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23848,-0.000476302381891954,0.00331175922615511,-0.00696735046515597,0.00601474570137206,0.885642592504968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,28491,0.00102532634688133,0.00725194322138102,-0.0131884823670255,0.0152391350607881,0.887565675696677
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24529,0.000544669758836375,0.0039248913959471,-0.00714811737721993,0.00823745689489268,0.88963050814606
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,24529,0.000468827208155726,0.00338259126094523,-0.00616105166329693,0.00709870607960838,0.889767367853019
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28631,-0.000417419434941244,0.00318499355861263,-0.00666000680982199,0.00582516793993951,0.895730210533588
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,23843,-0.000690958835522008,0.00528313789985559,-0.011045909119239,0.00966399144819494,0.895945947529309
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,23974,0.00055560201287091,0.00431718734512797,-0.00790608518357991,0.00901728920932173,0.897599781125856
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,29158,-0.000358764784459286,0.00280478485551586,-0.00585614310127036,0.00513861353235179,0.898219738491904
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24602,0.000814600976633084,0.00643903498208637,-0.0118059075882562,0.0134351095415224,0.899329432808183
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",23848,-0.000340622258606282,0.00279910720911718,-0.00582687238847597,0.0051456278712634,0.903145869697631
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,28467,-0.000298532213589162,0.00248075325056619,-0.0051608085846989,0.00456374415752058,0.904215189897533
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23843,-0.000454559640911853,0.00383904698419558,-0.00797909172993519,0.00706997244811149,0.905748323040427
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24699,0.000153497132227293,0.00131391141213766,-0.00242176923556252,0.0027287635000171,0.907000025533671
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,23848,0.0009056074909532,0.0078245389124749,-0.0144304887774976,0.016241703759404,0.90786004918359
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,24653,-0.000238447411632799,0.00208081250206988,-0.00431683991568976,0.00383994509242416,0.908768332741286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,23940,-0.000672773689217174,0.00591675203822949,-0.012269607684147,0.0109240603057126,0.909471343574769
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29031,-0.000278122725952723,0.00244641828966497,-0.00507310257369606,0.00451685712179062,0.909487751411196
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,28631,0.000325269593970265,0.00289185726098438,-0.00534277063755913,0.00599330982549966,0.910445400744629
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,23940,-0.000277685933136181,0.00251929418270346,-0.00521550253123496,0.00466013066496259,0.91223288918884
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,23974,0.000306309851598016,0.00302439823566829,-0.00562151069031184,0.00623413039350787,0.919329355101388
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,23843,-0.000830096192422083,0.00834482090766373,-0.017185945171443,0.0155257527865988,0.920762436415458
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,29470,-0.000300833607686061,0.00328673105392818,-0.00674282647338529,0.00614115925801317,0.927072306235197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,23756,0.000895346529981496,0.0101275305364413,-0.0189546133214435,0.0207453063814065,0.92955379145709
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,23940,0.000431944609048062,0.00502938650325587,-0.00942565293733344,0.0102895421554296,0.93155922623374
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24669,-0.000131686647418691,0.00159991804124878,-0.00326752600826629,0.00300415271342891,0.934402166214384
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,23756,-0.000404090237594076,0.00517290803915348,-0.0105429899943349,0.00973480951914674,0.937735922588723
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,23940,0.000318174266312626,0.00424496802843827,-0.00800196306942639,0.00863831160205164,0.940252513107253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24602,-0.00017628821322942,0.00238427148861063,-0.00484946033090626,0.00449688390444742,0.941060337798183
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,23848,0.000232918154237765,0.00334738770985836,-0.00632796175708461,0.00679379806556014,0.944526894943216
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",23979,-0.000405853684036064,0.00598371686753272,-0.0121339387444002,0.0113222313763281,0.945924432370197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,24669,-0.000432954529380289,0.00643083388495551,-0.0130373889438931,0.0121714798851325,0.946323689427297
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,23974,0.000393665395983649,0.0061494538393352,-0.0116592641291133,0.0124465949210806,0.94895776715574
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,28467,-0.000197746817510608,0.00314898178681439,-0.00636975111966682,0.00597425748464561,0.949928543253977
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,29507,0.000120965995248624,0.00192970548748797,-0.0036612567602278,0.00390318875072505,0.950016773780566
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,28631,0.000243721241530577,0.0039138076057892,-0.00742734166581625,0.0079147841488774,0.950346535857914
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,24602,0.000136608490993742,0.00263805829395214,-0.00503398576515245,0.00530720274713994,0.958701442635717
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29367,0.000103989580595835,0.00210267532166816,-0.00401725404987376,0.00422523321106543,0.960556362778877
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28631,-0.000110039342081627,0.00246778054894087,-0.00494688921800573,0.00472681053384247,0.964434099304922
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29172,9.58475914364555e-05,0.00223003452552059,-0.0042750200785839,0.00446671526145681,0.965717518193721
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,23974,0.000265944827367481,0.00651421070393102,-0.0125019081523373,0.0130337978070723,0.967435482784421
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,28612,-8.60228368514634e-05,0.00230084547812385,-0.00459567997397422,0.00442363430027129,0.970176308347749
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,28612,-0.000148136819266228,0.00424950634905809,-0.00847716926342008,0.00818089562488763,0.972191802284896
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,24185,-0.000139985668990659,0.00423577139305975,-0.00844209759938777,0.00816212626140645,0.973636225991718
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,23979,-0.000573502720445197,0.0186050981637942,-0.0370394951214819,0.0358924896805915,0.975409335051016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,24119,-8.40625028081443e-05,0.0027302073177799,-0.00543526884565675,0.00526714384004046,0.975437439960778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,23974,3.99350960927073e-05,0.0015251641796315,-0.00294938669598504,0.00302925688817045,0.979110692583195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,23654,6.1876394428277e-05,0.00243931600239817,-0.00471918297027213,0.00484293575912869,0.979763014118772
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,23940,0.000169656375507759,0.00728169258014458,-0.0141024610815756,0.0144417738325911,0.981411939569726
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,23848,-7.8285422807725e-05,0.00338521076660162,-0.00671329852534691,0.00655672767973146,0.9815501863571
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,23848,6.36355608642887e-05,0.00282245304234397,-0.00546837240212989,0.00559564352385847,0.982012456278805
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,28612,8.15880804264469e-05,0.00426818619332867,-0.00828405685849775,0.00844723301935064,0.984749180714127
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",23756,-7.58757753767392e-05,0.00403928997129631,-0.00799288411911752,0.00784113256836404,0.98501322944637
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,28631,-3.70809410623974e-05,0.00221710765727165,-0.00438261194931483,0.00430845006719003,0.986656185817682
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28467,5.52814959914945e-05,0.00478527622377584,-0.00932385990260915,0.00943442289459214,0.99078279258563
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27688,-2.2435156651375e-05,0.0020526157583695,-0.0040455620430556,0.00400069172975285,0.99127934835992
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,23645,-2.9373259270351e-05,0.00308846484871295,-0.00608276436274773,0.00602401784420703,0.992411806525272
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,23848,8.62682986486551e-06,0.00695211255080297,-0.013617513769709,0.0136347674294387,0.999009921035964
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29034,-2.1445781928896e-06,0.00183508837049062,-0.00359891778435451,0.00359462862796873,0.999067559510104
